10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2015

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 1-815

E. I. du Pont de Nemours and Company

(Exact Name of Registrant as Specified in Its Charter)

Delaware	51-0014090
(State or other Jurisdiction of	(I.R.S. Employer
Incorporation or Organization)	Identification No.)

974 Centre Road, Wilmington, Delaware 19805

(Address of Principal Executive Offices)

(302) 774-1000

(Registrant’s Telephone Number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x   No  o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that registrant was required to submit and post such files.)  Yes  x   No  o

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):

Large Accelerated Filer x	Accelerated Filer o
Non-Accelerated Filer o	Smaller reporting company o

Indicate by check mark whether the Registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).  Yes  o   No  x

The Registrant had 876,407,000 shares (excludes 87,041,000 shares of treasury stock) of common stock, $0.30 par value, outstanding at October 15, 2015.

E. I. DU PONT DE NEMOURS AND COMPANY

Table of Contents

The terms “DuPont” or the “company” as used herein refer to E. I. du Pont de Nemours and Company and its consolidated subsidiaries, or to E. I. du Pont de Nemours and Company, as the context may indicate. 

			Page
Part I	Financial Information
Item 1.	Consolidated Financial Statements (Unaudited)
	Consolidated Income Statements		3
	Consolidated Statements of Comprehensive Income		4
	Condensed Consolidated Balance Sheets		5
	Condensed Consolidated Statements of Cash Flows		6
	Notes to the Consolidated Financial Statements
	Note 1.	Summary of Significant Accounting Policies	7
	Note 2.	Divestitures and Other Transactions	10
	Note 3.	Employee Separation / Asset Related Charges, Net	13
	Note 4.	Other Income, Net	14
	Note 5.	Income Taxes	14
	Note 6.	Earnings Per Share of Common Stock	15
	Note 7.	Inventories	15
	Note 8.	Other Intangible Assets	16
	Note 9.	Long-Term Borrowings	17
	Note 10.	Commitments and Contingent Liabilities	17
	Note 11.	Stockholders’ Equity	20
	Note 12.	Financial Instruments	23
	Note 13.	Long-Term Employee Benefits	28
	Note 14.	Segment Information	30
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		32
	Cautionary Statements About Forward-Looking Statements		32
	Recent Developments		33
	Results of Operations		34
	Recent Accounting Pronouncements		36
	Segment Reviews		37
	Liquidity & Capital Resources		40
	Contractual Obligations		42
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		42
Item 4.	Controls and Procedures		43
Part II	Other Information
Item 1.	Legal Proceedings		44
Item 1A.	Risk Factors		44
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds: Issuer Purchases of Equity		45
Item 5.	Other Information		45
Item 6.	Exhibits		45
Signature			46
Exhibit Index			47

2

PART I.  FINANCIAL INFORMATION

Item 1. CONSOLIDATED FINANCIAL STATEMENTS

E. I. du Pont de Nemours and Company

Consolidated Income Statements (Unaudited)

(Dollars in millions, except per share)

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2015		2014		2015		2014
Net sales	$	4,873	$	5,905	$	19,831	$	22,557
Other income, net	98		364		552		749
Total	4,971		6,269		20,383		23,306
Cost of goods sold	3,084		3,698		11,703		13,350
Other operating charges	91		201		413		609
Selling, general and administrative expenses	1,046		1,157		3,540		3,833
Research and development expense	441		486		1,415		1,491
Interest expense	82		93		260		290
Employee separation / asset related charges, net	—		—		40		244
Total	4,744		5,635		17,371		19,817
Income from continuing operations before income taxes	227		634		3,012		3,489
Provision for income taxes on continuing operations	96		303		886		921
Income from continuing operations after taxes	131		331		2,126		2,568
Income from discontinued operations after taxes	104		103		89		385
Net income	235		434		2,215		2,953
Less: Net income attributable to noncontrolling interests	—		1		9		11
Net income attributable to DuPont	$	235	$	433	$	2,206	$	2,942
Basic earnings per share of common stock:
Basic earnings per share of common stock from continuing operations	$	0.14	$	0.36	$	2.34	$	2.78
Basic earnings per share of common stock from discontinued operations	0.12		0.11		0.10		0.42
Basic earnings per share of common stock	$	0.26	$	0.47	$	2.44	$	3.20
Diluted earnings per share of common stock:
Diluted earnings per share of common stock from continuing operations	$	0.14	$	0.36	$	2.33	$	2.76
Diluted earnings per shares of common stock from discontinued operations	0.12		0.11		0.10		0.42
Diluted earnings per share of common stock	$	0.26	$	0.47	$	2.43	$	3.17
Dividends per share of common stock	$	0.38	$	0.47	$	1.34	$	1.37

See Notes to the Consolidated Financial Statements beginning on page 7.

3

E. I. du Pont de Nemours and Company

Consolidated Statements of Comprehensive Income (Unaudited)

(Dollars in millions, except per share)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Net income	$	235		$	434		$	2,215		$	2,953
Other comprehensive income (loss), before tax:
Cumulative translation adjustment	(125		)	(428		)	(1,405		)	(559		)
Net revaluation and clearance of cash flow hedges to earnings:
Additions and revaluations of derivatives designated as cash flow hedges	(22		)	(3		)	(36		)	23
Clearance of hedge results to earnings	—			(2		)	12			29
Net revaluation and clearance of cash flow hedges to earnings	(22		)	(5		)	(24		)	52
Pension benefit plans:
Net gain (loss)	634			(5		)	628			(107		)
Prior service cost	—			(1		)	—			(1		)
Effect of foreign exchange rates	54			—			92			—
Reclassifications to net income:
Amortization of prior service (benefit) cost	(3		)	1			(6		)	2
Amortization of loss	172			151			591			450
Curtailment gain / settlement loss	37			2			46			8
Pension benefit plans, net	894			148			1,351			352
Other benefit plans:
Net loss	(73		)	(33		)	(73		)	(33		)
Prior service benefit	—			50			—			50
Effect of foreign exchange rates	(1		)	—			(1		)	—
Reclassifications to net income:
Amortization of prior service benefit	(39		)	(54		)	(143		)	(160		)
Amortization of loss	20			15			58			43
Curtailment gain	(274		)	—			(274		)	—
Other benefit plans, net	(367		)	(22		)	(433		)	(100		)
Other comprehensive income (loss), before tax	380			(307		)	(511		)	(255		)
Income tax expense related to items of other comprehensive income	(176		)	(28		)	(312		)	(92		)
Other comprehensive income (loss), net of tax	204			(335		)	(823		)	(347		)
Comprehensive income	439			99			1,392			2,606
Less: Comprehensive income attributable to noncontrolling interests	—			1			9			11
Comprehensive income attributable to DuPont	$	439		$	98		$	1,383		$	2,595

See Notes to the Consolidated Financial Statements beginning on page 7.

4

E. I. du Pont de Nemours and Company

Condensed Consolidated Balance Sheets (Unaudited)

(Dollars in millions, except per share)

	September 30, 2015			December 31, 2014
Assets
Current assets
Cash and cash equivalents	$	3,324		$	6,910
Marketable securities	406			124
Accounts and notes receivable, net	6,656			5,238
Inventories	5,888			6,787
Prepaid expenses	287			264
Deferred income taxes	485			532
Assets of discontinued operations	—			6,227
Total current assets	17,046			26,082
Property, plant and equipment, net of accumulated depreciation    (September 30, 2015 - $14,297; December 31, 2014 - $13,765)	9,769			10,008
Goodwill	4,249			4,332
Other intangible assets	4,214			4,569
Investment in affiliates	712			762
Deferred income taxes	3,252			3,734
Other assets	1,060			1,003
Total	$	40,302		$	50,490
Liabilities and Equity
Current liabilities
Accounts payable	$	2,830		$	3,786
Short-term borrowings and capital lease obligations	1,781			1,422
Income taxes	569			534
Other accrued liabilities	3,174			5,596
Liabilities of discontinued operations	—			2,467
Total current liabilities	8,354			13,805
Long-term borrowings and capital lease obligations	8,155			9,233
Other liabilities	12,212			13,615
Deferred income taxes	359			459
Total liabilities	29,080			37,112
Commitments and contingent liabilities
Stockholders’ equity
Preferred stock	237			237
Common stock, $0.30 par value; 1,800,000,000 shares authorized;    Issued at September 30, 2015 - 963,347,000; December 31, 2014 - 992,020,000	289			298
Additional paid-in capital	10,678			11,174
Reinvested earnings	15,441			16,894
Accumulated other comprehensive loss	(8,911		)	(8,556		)
Common stock held in treasury, at cost (87,041,000 shares at September 30, 2015 and December 31, 2014)	(6,727		)	(6,727		)
Total DuPont stockholders’ equity	11,007			13,320
Noncontrolling interests	215			58
Total equity	11,222			13,378
Total	$	40,302		$	50,490

See Notes to the Consolidated Financial Statements beginning on page 7.

5

E. I. du Pont de Nemours and Company

Condensed Consolidated Statements of Cash Flows (Unaudited)

(Dollars in millions)

	Nine Months Ended
	September 30,
	2015			2014
Operating activities
Net income	$	2,215		$	2,953
Adjustments to reconcile net income to cash used for operating activities:
Depreciation	856			944
Amortization of intangible assets	307			294
Net periodic pension benefit cost	445			305
Contributions to pension plans	(260		)	(231		)
Gain on sale of businesses	(48		)	(418		)
Other operating activities - net	89			272
Change in operating assets and liabilities - net	(5,449		)	(5,921		)
Cash used for operating activities	(1,845		)	(1,802		)
Investing activities
Purchases of property, plant and equipment	(1,291		)	(1,311		)
Investments in affiliates	(59		)	(37		)
Payments for businesses - net of cash acquired	(77		)	—
Proceeds from sales of businesses - net	61			727
Proceeds from sales of assets - net	18			29
Purchases of short-term financial instruments	(928		)	(853		)
Proceeds from maturities and sales of short-term financial instruments	676			431
Foreign currency exchange contract settlements	543			97
Other investing activities - net	12			197
Cash used for investing activities	(1,045		)	(720		)
Financing activities
Dividends paid to stockholders	(1,210		)	(1,268		)
Net increase in short-term (less than 90 days) borrowings	1,161			2,416
Long-term and other borrowings:
Receipts	3,630			96
Payments	(1,529		)	(1,763		)
Prepayments / repurchase of common stock	(2,353		)	(2,000		)
Proceeds from exercise of stock options	208			285
Cash transferred to Chemours at spin-off	(250		)	—
Other financing activities - net	(87		)	1
Cash used for financing activities	(430		)	(2,233		)
Effect of exchange rate changes on cash	(266		)	(204		)
Decrease in cash and cash equivalents	$	(3,586	)	$	(4,959	)
Cash and cash equivalents at beginning of period	6,910			8,941
Cash and cash equivalents at end of period	$	3,324		$	3,982

See Notes to the Consolidated Financial Statements beginning on page 7.

6

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 1.  Summary of Significant Accounting Policies

Interim Financial Statements

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included.  Results for interim periods should not be considered indicative of results for a full year.  These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2014, collectively referred to as the “2014 Annual Report”.  The Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained, as well as variable interest entities (VIEs) for which DuPont is the primary beneficiary. 

Basis of Presentation

Certain reclassifications of prior year's data have been made to conform to current year's presentation. On July 1, 2015, the company completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (Chemours). In accordance with GAAP, the financial position and results of operations of the Performance Chemicals segment are presented as discontinued operations and, as such, have been excluded from continuing operations and segment results for all periods presented. The sum of the individual earnings per share amounts from continuing operations and discontinued operations may not equal the total company earnings per share amounts due to rounding. The cash flows and comprehensive income related to the Performance Chemicals segment have not been segregated and are included in the Condensed Consolidated Statements of Cash Flows and Comprehensive Income, respectively, for all periods presented. Amounts related to the Performance Chemicals segment are consistently included or excluded from the Notes to the interim Consolidated Financial Statements based on the respective financial statement line item. See Note 2 for additional information.

The company revised accumulated other comprehensive loss at January 1, 2013 to adjust for currency translation of $97 and pension settlement charges of $54 that should have been recorded in prior years. The revision resulted in a $151 decrease in accumulated other comprehensive loss with a corresponding reduction in reinvested earnings. The currency translation was related to an adjustment to the exchange rates used by a foreign subsidiary in the translation of the financial statements to U.S. dollar (USD) in prior years. See further discussion of the pension settlement charges in Note 13. The impact of these adjustments is not material to the company’s current or previously issued financial statements.

The company’s cost structure is being impacted by the global, multi-year initiative to redesign its global organization and operating model to improve productivity and agility across all businesses and functions. Effective December 31, 2014, in order to better align to the transforming company’s organization and resulting cost structure, certain costs were reclassified from other operating charges to selling, general and administrative expenses. Prior year data have been reclassified to conform to current year presentation. Other operating charges primarily include, costs associated with the Performance Chemical separation, product claim charges and non-capitalizable costs associated with capital projects. Selling, general and administrative expense primarily includes selling and marketing expenses, commissions, functional costs, and business management expenses. Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead.

Foreign Currency Translation

The company's worldwide operations utilize the USD or local currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not clearly align with either category, factors are evaluated and a judgment is made to determine the functional currency.

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

7

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive loss in equity. Assets and liabilities denominated in other than the local currency are re-measured into the local currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed. As a result of the separation of its Performance Chemicals segment, coupled with the company’s ongoing redesign initiative, the functional currency at certain of the company’s foreign entities is being re-evaluated which, in some cases, has resulted in a change in the foreign entities’ functional currency.

Venezuelan Foreign Currency

Venezuela is considered a highly inflationary economy under GAAP and the USD is the functional currency for the company's subsidiaries in Venezuela. The official exchange rate continues to be set through the National Center for Foreign Commerce (CENCOEX, previously CADIVI). Based on its evaluation of the restrictions and limitations affecting the availability of specific exchange rate mechanisms, management concluded in the second quarter of 2014 that the Alternative Currency Exchange System (SICAD 2) auction process would be the most likely mechanism available. As a result, in the second quarter of 2014, the company changed from the official exchange rate to the SICAD 2 exchange rate, which resulted in a charge of $58 recorded within other income, net in the company's interim Consolidated Income Statements for the nine months ended September 30, 2014.

During the first quarter of 2015, the Venezuelan government enacted additional changes to the country’s foreign exchange systems including the introduction of the SIMADI (Foreign Exchange Marginal System) auction process. Management has concluded that the SIMADI auction process would be the most likely exchange mechanism available. As a result, effective in the first quarter of 2015, the company changed from the SICAD 2 to the SIMADI exchange rate, to re-measure its Bolivar Fuertes (VEF) denominated net monetary assets which resulted in a charge of $3 recorded within other income, net in the company's interim Consolidated Income Statements for the nine months ended September 30, 2015. The remaining net monetary assets and non-monetary assets are immaterial at September 30, 2015.

Recent Accounting Pronouncements

Accounting Pronouncements Implemented in 2015

In April 2014, the FASB issued authoritative guidance amending existing requirements for reporting discontinued operations.  Under the new guidance, discontinued operations reporting is limited to disposal transactions that represent strategic shifts having a major effect on operations and financial results. The amended guidance also enhances disclosures and requires assets and liabilities of a discontinued operation to be classified as such for all periods presented in the financial statements. Public entities will apply the amended guidance prospectively to all disposals occurring within annual periods beginning on or after December 15, 2014 and interim periods within those years. The company adopted this standard on January 1, 2015. Due to the change in requirements for reporting discontinued operations described above, presentation and disclosures of disposal transactions after adoption may be different than under previous standards.

New Accounting Pronouncements to be Implemented

In May 2015, the FASB issued ASU No. 2015-07, Fair Value Measurement (Topic 820), Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share or its Equivalent. This guidance removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient. The guidance also removes the requirement to make certain disclosures for all investments that are eligible to be measured at fair value using the net asset value per share practical expedient. Rather, those disclosures are limited to investments for which the entity has elected to measure the fair value using that practical expedient. The guidance is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. A reporting entity should apply the amendments retrospectively to all periods presented and early adoption is permissible. The company anticipates that this guidance will only impact disclosure and will not impact the company's financial position or results of operations.

8

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

In February 2015, the FASB issued ASU No. 2015-02 Consolidation (Topic 810), Amendments to the Consolidation Analysis. The amendments under the new guidance modify the evaluation of whether limited partnerships and similar legal entities are VIEs or voting interest entities and eliminate the presumption that a general partner should consolidate a limited partnership. The ASU is effective for public business entities for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. A reporting entity also may apply the amendments retrospectively. The company is currently evaluating the impact of adopting this guidance on its financial position and results of operations.

In May 2014, the FASB and the International Accounting Standards Board (IASB) jointly issued ASU No. 2014-9, Revenue from Contracts with Customers (Topic 606), which clarifies the principles for recognizing revenue and develops a common revenue standard for GAAP and International Financial Reporting Standards (IFRS). The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. In July 2015, the FASB approved a deferral of the ASU effective date from annual and interim periods beginning after December 15, 2016 to annual and interim periods beginning after December 15, 2017. The company is currently evaluating the impact of adopting this guidance on its financial position and results of operations.

9

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 2. Divestitures and Other Transactions

Performance Chemicals

On July 1, 2015 (the Distribution Date), DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of Chemours (the Separation). To effect the spin-off, DuPont distributed to its stockholders one share of Chemours common stock, par value $0.01 per share, for every five shares of DuPont common stock, par value $0.30 per share, (the Distribution) outstanding as of 5:00 p.m. June 23, 2015, the record date for the Distribution. In lieu of fractional shares of Chemours, stockholders of DuPont received cash, which generally was taxable. In connection with the  Separation, the company and Chemours entered into a Separation Agreement and a Tax Matters Agreement, discussed below, and certain ancillary agreements, including an employee matters agreement, agreements related to transition and site services,  and intellectual property cross licensing arrangements. In addition, the companies have entered into certain supply agreements.

Separation Agreement

The company and Chemours entered into a Separation Agreement that sets forth, among other things, the agreements between the company and Chemours regarding the principal transactions necessary to effect the Separation and also sets forth ancillary agreements that govern certain aspects of the company’s relationship with Chemours after the separation. Among other matters, the Separation Agreement and the ancillary agreements provide for the allocation between DuPont and Chemours of assets, employees, liabilities and obligations (including investments, property and employee benefits and tax-related assets and liabilities) attributable to periods prior to, at and after the completion of the Separation.

Pursuant to the Separation Agreement, Chemours indemnifies DuPont against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. The term of this indemnification is indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. At September 30, 2015, the indemnified assets are $100 within accounts and notes receivable, net and $400 within other assets offset by the corresponding liabilities of $100 within other accrued liabilities and $400 within other liabilities.

Tax Matters Agreement

The company and Chemours entered into a Tax Matters Agreement that governs the parties’ respective rights, responsibilities and obligations with respect to tax liabilities and benefits, tax attributes, the preparation and filing of tax returns, the control of audits and other tax proceedings and other matters regarding taxes. In general, under the agreement, the company is responsible for any U.S. federal, state and local taxes (and any related interest, penalties or audit adjustments) reportable on a consolidated, combined or unitary return that includes the company or any of its subsidiaries (and Chemours and/or any of its subsidiaries) for any periods or portions thereof ending on or prior to the date of the Separation and Chemours is responsible for any U.S. federal, state, local and foreign taxes (and any related interest, penalties or audit adjustments) that are imposed on Chemours and/or any of its subsidiaries for all tax periods, whether before or after the date of the distribution. Neither party’s obligations under the agreement are limited in amount or subject to any cap. Additionally, Chemours generally agrees to indemnify DuPont and its affiliates against any and all tax-related liabilities incurred by them relating to the distribution and certain other aspects of the separation to the extent caused by an acquisition of Chemours’ stock or assets or by certain other action undertaken by Chemours.

10

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

The results of operations of the Performance Chemicals segment are presented as discontinued operations as summarized below:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Net sales	$	—		$	1,606		$	2,810		$	4,788
Other income, net	—			(7		)	27			33
Total	—			1,599			2,837			4,821
Cost of goods sold	—			1,183			2,215			3,530
Other operating charges	59			122			369			300
Selling, general and administrative expenses	(277		)	114			(87		)	347
Research and development expense	—			28			40			86
Interest expense	—			—			32			—
Employee separation / asset related charges, net	—			—			59			19
Total	(218		)	1,447			2,628			4,282
Income from discontinued operations before taxes	218			152			209			539
Provision for income taxes	108			49			114			154
Income from discontinued operations after taxes	$	110		$	103		$	95		$	385

As a result of the separation, the company recorded an other long-term employee benefit plan curtailment gain of $274 and re-measured the associated plans as of July 1, 2015. The company also recorded a pension curtailment gain of $7 and re-measured the principal U.S. pension plan as of July 1, 2015. See Note 13 for further discussion.

During the three and nine months ended September 30, 2015 and the three and nine months ended September 30, 2014, the company incurred $68 and $289, and $61 and $112 of costs, respectively, in connection with the transaction primarily related to professional fees associated with preparation of regulatory filings and separation activities within finance, tax, legal, and information system functions. Income from discontinued operations during the three and nine months ended September 30, 2015, and the three and nine months ended September 30, 2014, includes $59 and $243, and $51 and $95 of these costs, respectively. Income from continuing operations during the three and nine months ended September 30, 2015, and the three and nine months ended September 30, 2014, includes $9 and $26, and $10 and $17 of these costs, respectively, recorded in other operating charges in the company's interim Consolidated Income Statements. Income from continuing operations during the nine months ended September 30, 2015 also included $20 of transaction costs incurred for a premium associated with the early retirement of DuPont debt. The company exchanged notes received from Chemours in May 2015 (as part of a dividend payment) for DuPont debt that it then retired. These costs were reported in interest expense in the company's interim Consolidated Income Statements.

Income from discontinued operations during the nine months ended September 30, 2015, included a restructuring charge of $59, consisting of severance and related benefit costs associated with the Performance Chemicals segment to achieve fixed cost and operational productivity improvements for Chemours post-spin.

11

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

The carrying amount of the major classes of assets and liabilities classified as assets and liabilities of discontinued operations at December 31, 2014 related to Performance Chemicals consisted of the following:

	December 31, 2014
Accounts and notes receivable, net	$	887
Inventories	1,054
Prepaid expenses	15
Deferred income taxes - current	53
Property, plant and equipment, net of accumulated depreciation	3,378
Goodwill	197
Other intangible assets	11
Investment in affiliates	124
Deferred income taxes - noncurrent	42
Other assets - noncurrent	466
Total assets of discontinued operations	$	6,227
Accounts payable	1,036
Income taxes	9
Other accrued liabilities	373
Other liabilities - noncurrent	616
Deferred income taxes - noncurrent	433
Total liabilities of discontinued operations	$	2,467

In connection with the spin-off, the company received a dividend from Chemours in May 2015 of $3,923 comprised of a cash distribution of $3,416 and a distribution in-kind of $507 of 7% senior unsecured notes due 2025 (Chemours Notes Received). Chemours financed the dividend payment through issuance of approximately $4,000 of debt, including the Chemours' Notes Received (Chemours' Debt). Net assets of $415 were transferred to Chemours on July 1, 2015, including the $4,000 of Chemours' Debt. In addition, approximately $468 of accumulated other comprehensive loss, net of income taxes, primarily related to pension and other long-term employee benefit plans, as well as cumulative translation adjustment was transferred to Chemours. This resulted in a $883 reduction to reinvested earnings. Cash, working capital and other accounts will be reconciled with Chemours and the net amount due to DuPont will be settled pursuant to the Separation Agreement.

The following table presents depreciation, amortization and purchases of property, plant and equipment of the discontinued operations related to Performance Chemicals:

	Nine Months Ended
	September 30,
	2015		2014
Depreciation	$	126	$	186
Amortization of intangible assets	2		2
Purchases of property, plant and equipment	235		350

Glass Laminating Solutions/Vinyls

In June 2014, the company sold Glass Laminating Solutions/Vinyls (GLS/Vinyls), a part of the Performance Materials segment, to Kuraray Co. Ltd. The sale resulted in a pre-tax gain of $391 ($273 net of tax). The gain was recorded in other income, net in the company's interim Consolidated Income Statements for the nine months ended September 30, 2014.

12

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 3. Employee Separation / Asset Related Charges, Net

2014 Restructuring Program

At September 30, 2015, total liabilities related to the 2014 restructuring program were $139. A complete discussion of restructuring initiatives is included in the company's 2014 Annual Report in Note 3, "Employee Separation / Asset Related Charges, Net."

Account balances and activity related to the 2014 restructuring program are summarized below:

	Employee Separation Costs			Other Non-Personnel Charges 1			Total
Balance at December 31, 2014	$	264		$	4		$	268
Payments	(117		)	(1		)	(118		)
Net translation adjustment	(9		)	—			(9		)
Other adjustments	(2		)	—			(2		)
Balance as of September 30, 2015	$	136		$	3		$	139

¹  Other non-personnel charges consist of contractual obligation costs.

During the nine months ended September 30, 2015, the company recorded adjustments to the estimated costs associated with the 2014 restructuring program in employee separation / asset related charges, net in the company's interim Consolidated Income Statements. This was primarily due to the identification of additional projects in certain segments, offset by lower than estimated individual severance costs and workforce reductions achieved through non-severance programs. The adjustments impacted segment results for the nine months ended September 30, 2015 as follows: Agriculture - $(4), Electronics & Communications - $11, Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Materials - $(2), Safety & Protection $1, and Other - $(3).

During the nine months ended September 30, 2014, a pre-tax charge of $244 was recorded in employee separation / asset related charges, net in the company's interim Consolidated Income Statements. The charge consisted of $150 employee separation costs, $3 of other non-personnel charges and $91 of asset shut down costs. The charge impacted segment results for year-to-date 2014 as follows: Agriculture - $47, Electronics & Communications - $68, Industrial Biosciences - $2, Nutrition & Health - $8, Performance Materials - $29 Safety & Protection - $31, Other - $2, as well as Corporate expenses - $57.

Cost Basis Investment Impairment

During the first quarter 2015, a $38 pre-tax impairment charge was recorded in employee separation / asset related charges, net within the Other segment. The majority relates to a cost basis investment in which the assessment resulted from the venture's revised operating plan reflecting underperformance of its European wheat based ethanol facility and deteriorating European ethanol market conditions. One of the primary investors communicated that they would not fund the revised operating plan of the investee. As a result, the carrying value of DuPont's 6 percent cost basis investment in this venture exceeds its fair value by $37, such that an impairment charge was recorded.

13

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 4.  Other Income, Net

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2015			2014		2015		2014
Royalty income	$	27		$	34	$	91	$	99
Interest income	33			33		98		103
Equity in earnings of affiliates, net	1			1		19		8
Net gain on sales of businesses and other assets	43			27		74		428
Net exchange (losses) gains1	(36		)	250		54		44
Miscellaneous income and expenses, net 2	30			19		216		67
Other income, net	$	98		$	364	$	552	$	749

¹ The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The net pre-tax exchange gains (losses) are recorded in other income, net and the related tax impact is recorded in provision for income taxes on the company's interim Consolidated Income Statements. Refer to Note 5 for discussion of the tax impacts related to this program. The $54 net exchange gain for the nine months ended September 30, 2015, includes a net $(35) pre-tax exchange loss associated with the devaluation of the Ukrainian hryvnia. The $44 net exchange gain for the nine months ended September 30, 2014, includes $(58), $(46) and $(14) exchange losses, associated with the devaluation of the Venezuela bolivar, Ukrainian hryvnia, and Argentinian peso, respectively.

²   Miscellaneous income and expenses, net, includes interest items, certain insurance recoveries and litigation settlements and other items.

Note 5.  Income Taxes

In the third quarter 2015, the company recorded a tax provision on continuing operations of $96, including $4 of tax benefit associated with the company’s policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations and gains or losses on foreign currency contracts. The company recorded pre-tax exchange losses in the third quarter 2015, including the re-measurement of the net monetary asset positions as well as the impacts of hedging, of $36. The third quarter 2015 tax provision also included a $17 tax benefit associated with a foreign tax court decision.

Year to date 2015, the company recorded a tax provision on continuing operations of $886, including $176 of tax expense primarily associated withthe company’s policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations and gains or losses on foreign currency contracts. The company recorded pre-tax exchange gains year-to-date 2015, including the re-measurement of the net monetary asset positions as well as the impacts of hedging, of $54.

In the third quarter 2014, the company recorded a tax provision on continuing operations of $303, including $258 of tax expense, primarily associated with the company's policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations and gains or losses on foreign currency contracts. The company recorded pre-tax exchange gains in the third quarter 2014, including the re-measurement of the net monetary asset positions as well as the impacts of hedging, of $250.

Year to date 2014, the company recorded a tax provision on continuing operations of $921, including $233 of tax expense, primarily associated with the company's policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations and gain or losses on foreign currency contracts. The company recorded pre-tax exchange gains year-to-date 2014, including the re-measurement of the net monetary asset positions as well as the impacts of hedging, of $44.

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company’s financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. It is reasonably possible that net reductions to the company’s global unrecognized tax benefits could be in the range of $225 to $250 within the next twelve months with the majority due to the settlement of uncertain tax positions with various tax authorities.

14

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 6.  Earnings Per Share of Common Stock

Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings per share calculations for the periods indicated:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Numerator:
Income from continuing operations after income taxes attributable to DuPont	$	131		$	330		$	2,117		$	2,558
Preferred dividends	(2		)	(2		)	(7		)	(7		)
Income from continuing operations after income taxes available to DuPont common stockholders	$	129		$	328		$	2,110		$	2,551
Income from discontinued operations after income taxes available to DuPont common stockholders	$	104		$	103		$	89		$	384
Net income available to common stockholders	$	233		$	431		$	2,199		$	2,935
Denominator:
Weighted-average number of common shares outstanding - Basic	887,275,000			910,764,000			899,883,000			917,589,000
Dilutive effect of the company’s employee compensation plans	4,011,000			6,997,000			5,639,000			7,057,000
Weighted-average number of common shares outstanding - Diluted	891,286,000			917,761,000			905,522,000			924,646,000

The following average number of stock options were antidilutive, and therefore not included in the dilutive earnings per share calculations:

	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2015	2014	2015	2014
Average number of stock options	8,510,000	7,000	4,622,000	4,000

The change in the average number of stock options that were antidilutive in the three and nine months ended September 30, 2015 compared to the same period last year was due to changes in the company's average stock price.

Note 7. Inventories

	September 30, 2015			December 31, 2014
Finished products	$	3,260		$	4,011
Semi-finished products	2,083			2,277
Raw materials, stores and supplies	749			739
	6,092			7,027
Adjustment of inventories to a last-in, first-out (LIFO) basis	(204		)	(240		)
Total	$	5,888		$	6,787

15

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 8.  Other Intangible Assets

The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 

	September 30, 2015							December 31, 2014
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (Definite-lived):
Customer lists	$	1,639	$	(514	)	$	1,125	$	1,699	$	(465	)	$	1,234
Patents	457		(211		)	246		474		(184		)	290
Purchased and licensed technology	1,131		(604		)	527		1,783		(1,069		)	714
Trademarks	26		(13		)	13		26		(12		)	14
Other 1	186		(72		)	114		202		(84		)	118
	3,439		(1,414		)	2,025		4,184		(1,814		)	2,370
Intangible assets not subject to amortization (Indefinite-lived):
In-process research and development	77		—			77		29		—			29
Microbial cell factories	306		—			306		306		—			306
Pioneer germplasm	1,050		—			1,050		1,064		—			1,064
Trademarks/tradenames	756		—			756		800		—			800
	2,189		—			2,189		2,199		—			2,199
Total	$	5,628	$	(1,414	)	$	4,214	$	6,383	$	(1,814	)	$	4,569

¹   Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.       

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $50 and $305 for the three and nine months ended September 30, 2015, respectively, and $48 and $292 for the three and nine months ended September 30, 2014, respectively. The estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 2015 and each of the next five years is approximately $51, $352, $217, $218, $205 and $188, respectively.

16

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 9.  Long-Term Borrowings

In connection with the spin-off, as previously discussed in Note 2, the company received a dividend from Chemours in May 2015 of $3,923 comprised of a cash distribution of $3,416 and a distribution in-kind of $507 of 7% senior unsecured notes due 2025.

In the second quarter of 2015, DuPont exchanged the Chemours Notes Received for $488 of company debt due in 2016 as follows: $152 of 1.95% notes, $277 of 2.75% notes, and $59 of 5.25% notes. The company paid a premium of $20, recorded in interest expense in the company's interim Consolidated Income Statements for the nine months ended September 30, 2015, in connection with the early retirement of the $488 of 2016 notes. This debt for debt exchange was considered an extinguishment.

Note 10.  Commitments and Contingent Liabilities

Guarantees

Indemnifications

In connection with acquisitions and divestitures as of September 30, 2015, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transaction. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited.

Obligations for Equity Affiliates & Others

The company has directly guaranteed various debt obligations under agreements with third parties related to equity affiliates, customers and suppliers. In connection with the separation, the company has directly guaranteed Chemours' purchase obligations under an agreement with a third party supplier. At September 30, 2015 and December 31, 2014, the company had directly guaranteed $375 and $513, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees. The company would be required to perform on these guarantees in the event of default by the guaranteed party.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

In certain cases, the company has recourse to assets held as collateral, as well as personal guarantees from customers and suppliers. Assuming liquidation, these assets are estimated to cover 41 percent of the $146 of guaranteed obligations of customers and suppliers. Set forth below are the company's guaranteed obligations at September 30, 2015:

	Short-Term		Long-Term		Total
Obligations for customers and suppliers1:
Bank borrowings (terms up to 6 years)	$	129	$	16	$	145
Leases on equipment and facilities (terms up to 3 years)	—		1		1
Obligations for equity affiliates2:
Bank borrowings (terms up to 1 year)	178		—		178
Obligations for Chemours3:
Chemours' purchase obligations (term up to 2 years)	40		11		51
Total	$	347	$	28	$	375

¹  Existing guarantees for customers and suppliers, as part of contractual agreements.

² Existing guarantees for equity affiliates' liquidity needs in normal operations.

³  Guarantee for Chemours' raw material purchase obligations under agreement with third party supplier.

Imprelis^® 

The company has received claims and lawsuits alleging that the use of Imprelis^® herbicide caused damage to certain trees. Sales of Imprelis^® were suspended in August 2011 and the product was last applied during the 2011 spring application season. The lawsuits seeking class action status were consolidated in multidistrict litigation in federal court in Philadelphia, Pennsylvania. In February 2014, the court entered the final order dismissing these lawsuits as a result of the class action settlement.

17

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

As part of the settlement, DuPont paid about $7 in plaintiffs' attorney fees and expenses. DuPont also provided a warranty, which expired on May 31, 2015, against new damage, if any, caused by the use of Imprelis^® on class members' properties. In the third quarter 2014, the company settled the majority of claims from class members that opted out of the class action settlement. About 30 opt-out actions are pending at September 30, 2015, a decrease of 10 from December 31, 2014.

DuPont recorded income of $150 and $185 for insurance recoveries, within other operating charges in the interim Consolidated Income Statements, for the three and nine months ended September 30, 2015, respectively. At September 30, 2015, DuPont had an accrual balance of $198 related to these claims which it continues to review as these claims are resolved.

Insurance recoveries are recognized when collection of payment is considered probable. The remaining coverage under the insurance program is $50 for costs and expenses. DuPont has submitted requests for payment related to its remaining coverage.

Litigation

The company is subject to various legal proceedings arising out of the normal course of its business including product liability, intellectual property, commercial, environmental and antitrust lawsuits. It is not possible to predict the outcome of these various proceedings. Although considerable uncertainty exists, management does not anticipate that the ultimate disposition of these matters will have a material adverse effect on the company's results of operations, consolidated financial position or liquidity.  However, the ultimate liabilities could be material to results of operations in the period recognized.  

PFOA 

DuPont used PFOA (collectively, perfluorooctanoic acids and its salts, including the ammonium salt), as a processing aid to manufacture some fluoropolymer resins at various sites around the world including its Washington Works plant in West Virginia. At September 30, 2015, DuPont has an accrual balance of $14 related to the PFOA matters discussed below. Pursuant to the Separation Agreement discussed in Note 2, the company is indemnified by Chemours for the PFOA matters discussed below. As a result, the company has recorded an indemnification asset of $14 corresponding to the accrual balance as of September 30, 2015.

The accrual includes charges related to DuPont's obligations under agreements with the U.S. Environmental Protection Agency and voluntary commitments to the New Jersey Department of Environmental Protection.  These obligations and voluntary commitments include surveying, sampling and testing drinking water in and around certain company sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national Provisional Health Advisory.

Drinking Water Actions

In August 2001, a class action, captioned Leach v DuPont, was filed in West Virginia state court alleging that residents living near the Washington Works facility had suffered, or may suffer, deleterious health effects from exposure to PFOA in drinking water.

DuPont and attorneys for the class reached a settlement in 2004 that binds about 80,000 residents. In 2005, DuPont paid the plaintiffs’ attorneys’ fees and expenses of $23 and made a payment of $70, which class counsel designated to fund a community health project.  The company funded a series of health studies which were completed in October 2012 by an independent science panel of experts (the C8 Science Panel). The studies were conducted in communities exposed to PFOA to evaluate available scientific evidence on whether any probable link exists, as defined in the settlement agreement, between exposure to PFOA and human disease.

The C8 Science Panel found probable links, as defined in the settlement agreement, between exposure to PFOA and pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol.

In May 2013, a panel of three independent medical doctors released its initial recommendations for screening and diagnostic testing of eligible class members. In September 2014, the medical panel recommended follow-up screening and diagnostic testing three years after initial testing, based on individual results. The medical panel has not communicated its anticipated schedule for completion of its protocol. The company is obligated to fund up to $235 for a medical monitoring program for eligible class members and, in addition, administrative costs associated with the program, including class counsel fees.  In January 2012, the company put $1 in an escrow account to fund medical monitoring as required by the settlement agreement.  The court appointed Director of Medical Monitoring has established the program to implement the medical panel's recommendations and the registration process, as well as eligibility screening, is ongoing. Diagnostic screening and testing has begun and associated payments to service providers are being disbursed from the escrow account.

18

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

In addition, under the settlement agreement, the company must continue to provide water treatment designed to reduce the level of PFOA in water to six area water districts, including the Little Hocking Water Association (LHWA), and private well users.

Class members may pursue personal injury claims against DuPont only for those human diseases for which the C8 Science Panel determined a probable link exists. At September 30, 2015 and June 30, 2015, there were approximately 3,500 lawsuits pending in various federal and state courts in Ohio and West Virginia. In accordance with a stipulation reached in the third quarter 2014 and other court procedures, these lawsuits have been or will be served and consolidated in multi-district litigation in Ohio federal court (MDL). Based on information currently available to the company the majority of the lawsuits allege personal injury claims associated with high cholesterol and thyroid disease from exposure to PFOA in drinking water.  At September 30, 2015, 37 of the pending lawsuits allege wrongful death. In 2014, six plaintiffs from the MDL were selected for individual trial. On October 7, 2015, in the first individual trial involving a plaintiff who alleged that exposure to C8 had caused the plaintiff's kidney cancer, the jury awarded $1.6 in compensatory damages. DuPont expects to appeal the decision. The second trial is scheduled to begin in March 2016. DuPont denies the allegations in these lawsuits and is defending itself vigorously.

Additional Actions

An Ohio action brought by the LHWA is ongoing. In addition to general claims of PFOA contamination of drinking water, the action claims “imminent and substantial endangerment to health and or the environment” under the Resource Conservation and Recovery Act (RCRA). In the second quarter 2014, DuPont filed a motion for summary judgment and LHWA moved for partial summary judgment. In the first quarter of 2015, the court granted in part and denied in part both parties’ motions. As a result, the litigation process is continuing with respect to certain of the plaintiffs’ claims and trial has been set for January 2016.

PFOA Summary

While it is probable that the company will incur liabilities related to funding the medical monitoring program, such liabilities cannot be reasonably estimated due to uncertainties surrounding the level of participation by eligible class members and the scope of testing. DuPont believes that it is reasonably possible that it could incur additional liabilities related to the other PFOA matters discussed above; however, a range of such liabilities, if any, cannot be reasonably estimated at this time, due to the uniqueness of the individual MDL plaintiff's claims and the company's defenses to those claims both as to potential liability and damages on an individual claims basis, among other factors. As noted above, the company is indemnified by Chemours for these PFOA matters.

Environmental

The company is also subject to contingencies pursuant to environmental laws and regulations that in the future may require the company to take further action to correct the effects on the environment of prior disposal practices or releases of chemical or petroleum substances by the company or other parties. The company accrues for environmental remediation activities consistent with the policy as described in the company's 2014 Annual Report in Note 1, “Summary of Significant Accounting Policies.” Much of this liability results from the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA, often referred to as Superfund), Resource Conservation and Recovery Act (RCRA) and similar state and global laws. These laws require the company to undertake certain investigative, remediation and restoration activities at sites where the company conducts or once conducted operations or at sites where company-generated waste was disposed. The accrual also includes estimated costs related to a number of sites identified by the company for which it is probable that environmental remediation will be required, but which are not currently the subject of enforcement activities.

Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, diverse regulatory agencies and enforcement policies, as well as the presence or absence of potentially responsible parties. At September 30, 2015, the Condensed Consolidated Balance Sheet included a liability of $505, relating to these matters and, in management's opinion, is appropriate based on existing facts and circumstances. The average time frame over which the accrued or presently unrecognized amounts may be paid, based on past history, is estimated to be 15-20 years. Considerable uncertainty exists with respect to these costs and, under adverse changes in circumstances, the potential liability may range up to $1,100 above the amount accrued as of September 30, 2015. Pursuant to the Separation Agreement discussed in Note 2, the company is indemnified by Chemours for certain environmental matters, included in the liability of $505, that have an estimated liability of $299 as of September 30, 2015 and a potential exposure that ranges up to approximately $630 above the amount accrued. As such, the company has recorded an indemnification asset of $299 corresponding to the company’s accrual balance related to these matters at September 30, 2015.

19

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 11.  Stockholders’Equity

Share Repurchase Program

2015 Share Buyback Plan

In the first quarter 2015, DuPont announced its intention to buy back shares of about $4,000 using the distribution proceeds received from Chemours. In connection with the completion of the spin-off of Chemours, the Board of Directors authorized the use of the distribution proceeds to buy back shares of the company's common stock as follows: $2,000 to be purchased and retired by December 31, 2015 with the remainder to be purchased and retired by December 31, 2016. In August 2015, the company entered into an accelerated share repurchase (ASR) agreement. Under the terms of the August 2015 ASR agreement, the company paid $2,000 to the financial institution and received and retired an initial delivery of 28.8 million shares, which represent 80 percent of the $2,000 notional amount of the agreement. The purchase price per share and final number of shares retired will be determined using the volume-weighted price of the company's stock over the term of the ASR agreement. The August 2015 ASR will be completed in the fourth quarter 2015.

2014 Share Buyback Plan

In January 2014, the company's Board of Directors authorized a $5,000 share buyback plan that replaced the 2011 plan. During the nine months ended September 30, 2015, the company purchased and retired 4.6 million shares in the open market for a total cost of $353, which offset the dilution from employee compensation plans in the first and second quarter of 2015. As of September 30, 2015, the company has purchased 34.7 million shares at a total cost of $2,353 under the plan. There is no required completion date for the remaining stock purchases.

Noncontrolling Interest

In September 2015, the company obtained a controlling interest in a joint venture included in the Performance Materials segment. Accordingly, the company consolidated the entity at September 30, 2015 and recorded the fair value of the noncontrolling interest in the amount of $157 in the Condensed Consolidated Balance Sheet.

20

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Other Comprehensive Income (Loss)

A summary of the changes in other comprehensive income (loss) for the three and nine months ended September 30, 2015 and 2014 is provided as follows:

	Three Months Ended									Three Months Ended									Affected Line Item in Consolidated Income Statements
	September 30, 2015									September 30, 2014
	Pre-Tax			Tax			After-Tax			Pre-Tax			Tax			After-Tax
Cumulative translation adjustment	$	(125	)	$	—		$	(125	)	$	(428	)	$	—		$	(428	)
Net revaluation and clearance of cash flow hedges to earnings:
Additions and revaluations of derivatives designated as cash flow hedges	(22		)	9			(13		)	(3		)	2			(1		)	See (1) below
Clearance of hedge results to earnings:
Foreign currency contracts	—			—			—			(2		)	1			(1		)	Net sales
Net revaluation and clearance of cash flow hedges to earnings	(22		)	9			(13		)	(5		)	3			(2		)
Pension benefit plans:
Net gain (loss)(3)	634			(228		)	406			(5		)	1			(4		)	See (1) below
Prior service cost	—			—			—			(1		)	—			(1		)	See (1) below
Effect of foreign exchange rates	54			(16		)	38			—			—			—			See (1) below
Reclassifications to net income:
Amortization of prior service (benefit) cost	(3		)	1			(2		)	1			—			1			See (2) below
Amortization of loss	172			(61		)	111			151			(52		)	99			See (2) below
Curtailment gain	(7		)	3			(4		)	—			—			—			See (2) below
Settlement loss	44			(16		)	28			2			(1		)	1			See (2) below
Pension benefit plans, net	894			(317		)	577			148			(52		)	96
Other benefit plans:
Net loss(3)	(73		)	27			(46		)	(33		)	10			(23		)	See (1) below
Prior service benefit	—			—			—			50			(1		)	49			See (1) below
Effect of foreign exchange rates	(1		)	1			—			—			—			—			See (1) below
Reclassifications to net income:
Amortization of prior service benefit	(39		)	13			(26		)	(54		)	18			(36		)	See (2) below
Amortization of loss	20			(7		)	13			15			(6		)	9			See (2) below
Curtailment gain	(274		)	98			(176		)	—			—			—			See (2) below
Other benefit plans, net	(367		)	132			(235		)	(22		)	21			(1		)
Other comprehensive income (loss)	$	380		$	(176	)	$	204		$	(307	)	$	(28	)	$	(335	)

21

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

	Nine Months Ended									Nine Months Ended									Affected Line Item in Consolidated Income Statements
	September 30, 2015									September 30, 2014
	Pre-Tax			Tax			After-Tax			Pre-Tax			Tax			After-Tax
Cumulative translation adjustment(4)	$	(1,405	)	$	—		$	(1,405	)	$	(559	)	$	—		$	(559	)
Net revaluation and clearance of cash flow hedges to earnings:
Additions and revaluations of derivatives designated as cash flow hedges	(36		)	12			(24		)	23			(8		)	15			See (1) below
Clearance of hedge results to earnings:
Foreign currency contracts	(10		)	4			(6		)	—			—			—			Net sales
Commodity contracts	22			(9		)	13			29			(11		)	18			Cost of goods sold
Net revaluation and clearance of cash flow hedges to earnings	(24		)	7			(17		)	52			(19		)	33
Pension benefit plans:
Net gain (loss)(3)	628			(226		)	402			(107		)	34			(73		)	See (1) below
Prior service cost	—			—			—			(1		)	—			(1		)	See (1) below
Effect of foreign exchange rates	92			(25		)	67			—			—			—			See (1) below
Reclassifications to net income:
Amortization of prior service (benefit) cost	(6		)	2			(4		)	2			—			2			See (2) below
Amortization of loss	591			(210		)	381			450			(155		)	295			See (2) below
Curtailment (gain) loss	(7		)	3			(4		)	4			(1		)	3			See (2) below
Settlement loss	53			(19		)	34			4			(1		)	3			See (2) below
Pension benefit plans, net	1,351			(475		)	876			352			(123		)	229
Other benefit plans:
Net loss(3)	(73		)	27			(46		)	(33		)	10			(23		)	See (1) below
Prior service benefit	—			—			—			50			(1		)	49			See (1) below
Effect of foreign exchange rates	(1		)	1			—			—			—			—			See (1) below
Reclassifications to net income:
Amortization of prior service benefit	(143		)	50			(93		)	(160		)	56			(104		)	See (2) below
Amortization of loss	58			(20		)	38			43			(15		)	28			See (2) below
Curtailment gain	(274		)	98			(176		)	—			—			—			See (2) below
Other benefit plans, net	(433		)	156			(277		)	(100		)	50			(50		)
Other comprehensive loss	$	(511	)	$	(312	)	$	(823	)	$	(255	)	$	(92	)	$	(347	)

¹  These amounts represent changes in accumulated other comprehensive loss excluding changes due to reclassifying amounts to the interim Consolidated Income Statements.

²  These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other long-term employee benefit plans. See Note 13 for additional information.

³  See Note 13 for discussion of the re-measurement of the principal U.S. pension plan and other long-term employee benefit plans as a result of the Performance Chemicals separation.

⁴  The increase in currency translation adjustment losses over prior year for the nine months ended September 30, 2015 is driven by the strengthening USD against primarily the Euro and Brazilian real.  The change in both periods is also due to changes in certain foreign entity's functional currency as described in Note 1.

22

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

The changes and after-tax balances of components comprising accumulated other comprehensive loss are summarized below:

	Cumulative Translation Adjustment			Net Revaluation and Clearance of Cash Flow Hedges to Earnings			Pension Benefit Plans			Other Benefit Plans			Unrealized Gain on Securities			Total
2015
Balance January 1, 2015	$	(919	)	$	(6	)	$	(7,895	)	$	262		$	2		$	(8,556	)
Other comprehensive (loss) income before reclassifications	(1,405		)	(24		)	469			(46		)	—			(1,006		)
Amounts reclassified from accumulated other comprehensive loss	—			7			407			(231		)	—			183
Spin-off of Chemours	191			—			278			—			(1		)	468
Balance September 30, 2015	$	(2,133	)	$	(23	)	$	(6,741	)	$	(15	)	$	1		$	(8,911	)

	Cumulative Translation Adjustment			Net Revaluation and Clearance of Cash Flow Hedges to Earnings			Pension Benefit Plans			Other Benefit Plans			Unrealized Gain on Securities		Total
2014
Balance January 1, 2014	$	(43	)	$	(48	)	$	(5,695	)	$	494		$	2	$	(5,290	)
Other comprehensive (loss) income before reclassifications	(559		)	15			(74		)	26			—		(592		)
Amounts reclassified from accumulated other comprehensive loss	—			18			302			(76		)	—		244
Balance September 30, 2014	$	(602	)	$	(15	)	$	(5,467	)	$	444		$	2	$	(5,638	)

Note 12. Financial Instruments

Cash Equivalents

The fair value of cash equivalents approximates its stated value.  The estimated fair value of the company's cash equivalents was determined using level 1 and level 2 inputs within the fair value hierarchy, as described in the company's 2014 Annual Report in Note 1,“Summary of Significant Accounting Policies.”  Level 1 measurements are based on observable net asset values and level 2 measurements are based on current interest rates for similar investments with comparable credit risk and time to maturity.  The company held $0 and $1,436 of money market funds (level 1 measurements) as of September 30, 2015 and December 31, 2014, respectively.  The company held $1,680 and $3,293 of other cash equivalents (level 2 measurements) as of September 30, 2015 and December 31, 2014, respectively.     

Marketable Securities

Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investment. Investments classified as available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive loss. The company held $381 and $124 of held-to-maturity and $25 and $0 of available-for-sale securities as of September 30, 2015 and December 31, 2014, respectively.

Debt

The estimated fair value of the company's total debt, including interest rate financial instruments, was determined using level 2 inputs within the fair value hierarchy, as described in the company's 2014 Annual Report in Note 1,“Summary of Significant Accounting Policies.”Based on quoted market prices for the same or similar issues or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's debt was approximately$10,430and$11,394as ofSeptember 30, 2015andDecember 31, 2014, respectively.

23

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Derivative Instruments

Objectives and Strategies for Holding Derivative Instruments

In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency, interest rate and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any nonderivatives as hedging instruments.

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company's derivative assets and liabilities are reported on a gross basis in the Condensed Consolidated Balance Sheets. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The notional amounts of the company's derivative instruments were as follows:

	September 30, 2015		December 31, 2014
Derivatives designated as hedging instruments:
Interest rate swaps	$	—	$	1,000
Foreign currency contracts	10		434
Commodity contracts	78		388
Derivatives not designated as hedging instruments:
Foreign currency contracts	7,819		10,586
Commodity contracts	15		166

Foreign Currency Risk

The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments and cash flows.

The company routinely uses forward exchange and option contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, net of related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. The objective of the hedge program is to reduce earnings and cash flow volatility related to changes in foreign currency exchange rates.

Commodity Price Risk

Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn, soybeans and soybean meal. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Cash Flow Hedges

Foreign Currency Contracts

The company uses foreign currency exchange instruments such as forwards and options to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. In addition, the company occasionally uses forward exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated transactions such as capital expenditures.

24

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Commodity Contracts

The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two-year period. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring. The following table summarizes the after-tax effect of cash flow hedges on accumulated other comprehensive loss for the three and nine months ended September 30, 2015 and 2014:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Beginning balance	$	(10	)	$	(13	)	$	(6	)	$	(48	)
Additions and revaluations of derivatives designated as cash flow hedges	(13		)	(1		)	(24		)	15
Clearance of hedge results to earnings	—			(1		)	7			18
Ending balance	$	(23	)	$	(15	)	$	(23	)	$	(15	)

At September 30, 2015, an after-tax net loss of $9 is expected to be reclassified from accumulated other comprehensive loss into earnings over the next 12 months.

Derivatives not Designated in Hedging Relationships

Foreign Currency Contracts

The company routinely uses forward exchange and options contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues.

Commodity Contracts

The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn, soybeans and soybean meal.

25

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Fair Values of Derivative Instruments

The table below presents the fair values of the company's derivative assets and liabilities within the fair value hierarchy, as described in the company's 2014 Annual Report in Note 1, “Summary of Significant Accounting Policies.”

		Fair Value Using Level 2 Inputs
	Balance Sheet Location	September 30, 2015		December 31, 2014
Asset derivatives:
Derivatives designated as hedging instruments:
Interest rate swaps1	Accounts and notes receivable, net	$	—	$	1
Foreign currency contracts	Accounts and notes receivable, net	—		10
		—		11
Derivatives not designated as hedging instruments:
Foreign currency contracts2	Accounts and notes receivable, net	132		254
Total asset derivatives3		$	132	$	265
Cash collateral1,2	Other accrued liabilities	$	20	$	47
Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	$	—	$	10
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	63		62
Commodity contracts	Other accrued liabilities	1		1
		64		63
Total liability derivatives3		$	64	$	73

¹  Cash collateral held as of September 30, 2015 and December 31, 2014 represents $0 and $6, respectively, related to interest rate swap derivatives designated as hedging instruments.

²  Cash collateral held as of September 30, 2015 and December 31, 2014 represents $20 and $41, respectively, related to foreign currency derivatives not designated as hedging instruments.

³  The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $51 at September 30, 2015 and $67 at December 31, 2014.

26

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Effect of Derivative Instruments

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion)						Amount of Gain (Loss) Recognized in Income2
Three Months Ended September 30,	2015			2014			2015			2014			Income Statement Classification
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps	$	—		$	—		$	—		$	(7	)	Interest expense
Cash flow hedges:
Foreign currency contracts	—			20			—			2			Net sales
Commodity contracts	(22		)	(23		)	—			—			Cost of goods sold
	(22		)	(3		)	—			(5		)
Derivatives not designated as hedging instruments:
Foreign currency contracts	—			—			174			403			Other income, net3
Commodity contracts	—			—			(2		)	4			Cost of goods sold
	—			—			172			407
Total derivatives	$	(22	)	$	(3	)	$	172		$	402

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion)					Amount of Gain (Loss) Recognized in Income2
Nine Months Ended September 30,	2015			2014		2015			2014			Income Statement Classification
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps	$	—		$	—	$	(1	)	$	(20	)	Interest expense
Cash flow hedges:
Foreign currency contracts	(1		)	19		10			—			Net sales
Commodity contracts	(35		)	4		(22		)	(29		)	Cost of goods sold
	(36		)	23		(13		)	(49		)
Derivatives not designated as hedging instruments:
Foreign currency contracts	—			—		435			287			Other income, net3
Foreign currency contracts	—			—		(3		)	—			Net sales
Commodity contracts	—			—		3			(21		)	Cost of goods sold
	—			—		435			266
Total derivatives	$	(36	)	$	23	$	422		$	217

¹   OCI is defined as other comprehensive income (loss).

²   For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. For the three and nine months ended September 30, 2015 and 2014, there was no material ineffectiveness with regard to the company's cash flow hedges.

³   Gain (loss) recognized in other income, net, was partially offset by the related gain (loss) on the foreign currency-denominated monetary assets and liabilities of the company's operations, which were $(210) and $(153) for the three months ended September 30, 2015 and 2014, respectively, and $(381) and $(243) for the nine months ended September 30, 2015 and 2014, respectively. See Note 4 for additional information.

27

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 13. Long-Term Employee Benefits

In connection with the completed separation of its Performance Chemicals segment on July 1, 2015 (See Note 2), the company entered into an Employee Matters Agreement with Chemours which provides that employees of Chemours no longer participate in benefit plans sponsored or maintained by the company as of the separation date. Upon separation, the company pension and other long-term employee benefit plans transferred assets and obligations to the Chemours plans resulting in a net decrease in the underfunded status of the sponsored pension and other long-term employee benefit plans of $21. Additionally, as a result of the transfer of unrecognized losses to Chemours, deferred income tax liabilities and accumulated other comprehensive loss, net of tax, decreased $88 and $278, respectively.

Pension Plans

As a result of the separation, the company recorded a pension curtailment gain of $7 and re-measured the principal U.S. pension plan as of July 1, 2015. In connection with the re-measurement, the company updated the discount rate assumed at December 31, 2014, from 4.10 percent to 4.50 percent. The re-measurement decreased the underfunded status of the pension plan by $634 with a corresponding reduction to net loss within other comprehensive income (loss) for the three and nine months ended September 30, 2015.

In determining the U.S. pension plan 2015 net periodic benefit costs, the company updated the expected return on plan assets assumption from 8.75 percent to 8.50 percent.

The company recorded a charge of $32 ($21 after-tax) during the three and nine months ended September 30, 2015, which related to settlements that occurred in prior periods. In addition, accumulated other comprehensive loss at January 1, 2013 has been revised to adjust for $54, after-tax, for settlement charges that should have been recorded in previous periods with a corresponding reduction in reinvested earnings. The settlement charges were related to the company’s Pension Restoration Plan which provides for lump sum benefit payments to certain eligible retirees. The company recognizes pension settlements when lump sum payments exceed the sum of service and interest cost components of net periodic pension cost of the plan for the year. The impact of these adjustments is not material to the company’s current or previously issued financial statements.

The following sets forth the components of the company’s net periodic benefit cost for pensions:  

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Service cost	$	50		$	61		$	179		$	181
Interest cost	270			290			815			875
Expected return on plan assets	(375		)	(405		)	(1,180		)	(1,211		)
Amortization of loss	172			151			591			450
Amortization of prior service (benefit) cost	(3		)	1			(6		)	2
Curtailment (gain) loss	(7		)	—			(7		)	4
Settlement loss	44			2			53			4
Net periodic benefit cost - Total	$	151		$	100		$	445		$	305
Less: Discontinued operations	(7		)	9			(5		)	31
Net periodic benefit cost - Continuing operations	$	158		$	91		$	450		$	274

Other Long-Term Employee Benefit Plans

As a result of the separation noted above, the company recorded an other long-term employee benefit plans curtailment gain of $274 and re-measured the associated plans as of July 1, 2015. In connection with the re-measurement, the company updated the plans' demographics and the discount rate assumed at December 31, 2014, from 3.95 percent to 4.30 percent. The re-measurement resulted in a net increase of $73 to the company's other long-term employee benefit obligation with a corresponding increase to net loss within other comprehensive income (loss) for the three and nine months ended September 30, 2015.

28

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

The following sets forth the components of the company’s net periodic benefit cost for other long-term employee benefits:  

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Service cost	$	3		$	4		$	12		$	13
Interest cost	28			30			83			91
Amortization of loss	20			15			58			43
Amortization of prior service benefit	(39		)	(54		)	(143		)	(160		)
Curtailment gain	(274		)	—			(274		)	—
Net periodic benefit cost- Total	$	(262	)	$	(5	)	$	(264	)	$	(13	)
Less: Discontinued operations	(274		)	1			(272		)	3
Net periodic benefit cost - Continuing operations	$	12		$	(6	)	$	8		$	(16	)

29

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Note 14.  Segment Information

Segment pre-tax operating income (loss) (PTOI) is defined as income (loss) from continuing operations before income taxes excluding non-operating pension and other postretirement employee benefit costs, exchange gains (losses), corporate expenses and interest. Effective July 1, 2015, certain corporate expenses will now be included in segment PTOI.  Reclassifications of prior year data have been made to conform to current year classifications. 

Three Months Ended September 30,	Agriculture1				Electronics & Communications		Industrial Biosciences		Nutrition & Health		Performance Materials			Safety & Protection		Other			Total
2015
Net sales	$	1,093			$	532	$	305	$	810	$	1,302		$	831	$	—		$	4,873
PTOI	(63		)	5	104		52		102		317			156		(88		)	580
2014
Net sales	$	1,563			$	620	$	314	$	899	$	1,531		$	976	$	2		$	5,905
PTOI	(56		)		90		42		99		366		4	195		(50		)	686

Nine Months Ended September 30,	Agriculture1			Electronics & Communications			Industrial Biosciences			Nutrition & Health			Performance Materials			Safety & Protection			Other				Total
2015
Net sales	$	8,248		$	1,577		$	870		$	2,449		$	4,021		$	2,663		$	3			$	19,831
PTOI	1,878		2,5	283		2	147		2	284		2	933		2	635		2,6	(215		)	2,7	3,945
2014
Net sales	$	9,564		$	1,810		$	925		$	2,686		$	4,618		$	2,950		$	4			$	22,557
PTOI	2,171		3	176		3	146		3	282		3	1,303		3,4	536		3	(166		)	3	4,448

¹  As of September 30, 2015, Agriculture net assets were $10,162, an increase of $3,467 from $6,695 at December 31, 2014. The increase was primarily due to higher trade receivables related to normal seasonality in the sales and cash collections cycle.

²  Included $(2) net adjustment to the estimated costs associated with the 2014 restructuring program, recorded in employee separation / asset related charges, net. These adjustments were primarily due to the identification of additional projects in certain segments, offset by lower than estimated individual severance costs and workforce reductions achieved through non-severance programs. The adjustments impacted segment results for the nine months ended September 30, 2015 as follows: Agriculture - $(4) , Electronics & Communications - $11, Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Materials - $(2), and Safety & Protection $1, and Other - $(3). See Note 3 for additional information.

³  Included a $(187) restructuring charge recorded in employee separation / asset related charges, net. The pre-tax charges by segment are: Agriculture -$(47) , Electronics & Communications -$(68) , Industrial Biosciences - $(2) , Nutrition & Health -$(8) , Performance Materials - $(29) , Safety & Protection - $(31), and Other - $(2). See Note 3 for additional information.

⁴  Included a gain of $391 recorded in other income, net associated with the sale of GLS/Vinyls. See Note 2 for additional information.

⁵  Included $147 and $182 of net insurance recoveries recorded in other operating charges for the three and nine months ended September 30, 2015, for recovery of costs for customer claims related to the use of the Imprelis^® herbicide. See Note 10 for additional information.

⁶  Included a gain of $112, net of legal expenses, recorded in other income, net related to the company’s settlement of a legal claim.

⁷  Included a $(37) pre-tax impairment charge recorded in employee separation / asset related charges, net for a cost basis investment. See Note 3 for additional information.

30

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in millions, except per share)

Reconciliation to Consolidated Income Statements 

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Total segment PTOI	$	580		$	686		$	3,945		$	4,448
Non-operating pension and other postretirement employee benefit costs	(115		)	(32		)	(288		)	(96		)
Net exchange (losses) gains1	(36		)	250			54			44
Corporate expenses2	(120		)	(177		)	(439		)	(617		)
Interest expense3	(82		)	(93		)	(260		)	(290		)
Income from continuing operations before income taxes	$	227		$	634		$	3,012		$	3,489

¹  Included a charge of $(40) associated with remeasuring the company's Ukrainian hryvnia net monetary assets in the nine months ended September 30, 2015, as well as a charge of $(58) associated with remeasuring the company's Venezuelan net monetary assets from the official exchange rate to the SICAD II exchange system in the nine months ended September 30, 2014, which were recorded in other income, net in the company's interim Consolidated Income Statements. See Note 4 for additional information.

²  Included transaction costs associated with the separation of the Performance Chemicals segment of $(9) and $(10) in the three months ended September 30, 2015 and 2014, respectively, and $(26) and $(17) in the nine months ended September 30, 2015 and 2014, respectively, which were recorded in other operating charges in the company's interim Consolidated Income Statements.

³  Included transaction costs of $(20) in the nine months ended September 30, 2015, associated with the early retirement of debt exchanged for the notes received from Chemours in May 2015.

31

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary Statements About Forward-Looking Statements

This report contains forward-looking statements which may be identified by their use of words like “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “projects,” “estimates” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, segment outlooks and financial results, are forward-looking statements.

Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company's control. Some of the important factors that could cause the company's actual results to differ materially from those projected in any such forward-looking statements are:

• Fluctuations in energy and raw material prices;

• Failure to develop and market new products and optimally manage product life cycles;

• Outcome of significant litigation and environmental matters, including those related to divested businesses;

• Failure to appropriately manage process safety and product stewardship issues;

• Effect of changes in tax, environmental and other laws and regulations or political conditions in the United States of America (U.S.) and other countries in which the company operates;

• Conditions in the global economy and global capital markets, including economic factors, such as inflation, deflation, fluctuations in currency rates, interest rates and commodity prices;

• Ability to appropriately respond to market acceptance, government rules, regulations and policies affecting products based on biotechnology;

• Impact of business disruptions, including supply disruptions, and security threats, regardless of cause, including acts of sabotage, cyber-attacks, terrorism or war, weather events and natural disasters;

• Ability to discover, develop and protect new technologies and enforce the company's intellectual property rights;

• Successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses; and

• Timely realization of the expected benefits from the separation of Performance Chemicals.

For some of the important factors that could cause the company's actual results to differ materially from those projected in any such forward-looking statements, see the Risk Factors discussion set forth under Part I, Item 1A of the company's 2014 Annual Report.

32

Recent Developments

Separation of Performance Chemicals

On July 1, 2015 (the Distribution Date), DuPont completed the separation of its Performance Chemicals segment though the spin-off of all of the issued and outstanding stock of The Chemours Company (Chemours). The financial position and results of operations of the Performance Chemicals segment are presented as discontinued operations and, as such, have been excluded from continuing operations and segment results for all periods presented.

Redesign Initiative

In June 2014, DuPont announced its global, multi-year initiative to redesign its global organization and operating model to reduce costs and improve productivity and agility across all businesses and functions. DuPont commenced a restructuring plan to realign and rebalance staff function support, enhance operational efficiency, and to reduce residual costs associated with the separation of its Performance Chemicals segment. The company continues to make significant progress in this effort with incremental cost savings of $0.10 per share and $0.30 per share in the three and nine months ended September 30, 2015, respectively. For full year 2015, the company expects to deliver incremental cost savings of approximately $0.40 year over year. In October 2015, the company announced that it is accelerating, by one year, its operational redesign cost saving actions and as a result, expects to achieve $1.3 billion of savings on a run rate basis by the end of 2016. In addition, the company announced its commitment to achieving additional cost savings as part of its operational redesign and is targeting approximately $1.6 billion on a run rate basis by the end of 2017. The company anticipates that it will incur a charge in the fourth quarter of 2015 as plans related to the additional cost savings are developed.

33

Results of Operations

Overview

The following is a summary of the results of continuing operations for the three months ended September 30, 2015:

• Results were negatively impacted by macro challenges including currency, industry wide challenges in Agriculture markets, particularly in Brazil, and continued weakness in emerging markets and oil and gas markets affecting Safety & Protection partially offset by continued positive effects of the operational redesign and cost reductions in the quarter, including performance-based compensation.

• Net Sales were $4.9 billion, down 17 percent from $5.9 billion in the same period last year, principally reflecting an 8 percent negative currency impact and 7 percent lower volume.

• Total segment pre-tax operating income (PTOI) was $580 million versus $686 million last year, down 15 percent due to negative currency impacts of $187 million and lower volume, partly offset by insurance recoveries, productivity improvements and lower costs for raw materials, energy and freight. Growth in Electronics & Communications and Industrial Biosciences was more than offset by declines in Agriculture, Performance Materials and Safety & Protection.

• Income from continuing operations after taxes was $131 million versus $331 million in the prior year, principally reflecting lower segment PTOI and higher non-operating pension and OPEB costs.

• Cost savings from the strategic redesign of the company’s operating model contributed an incremental $0.10 per share.

The following is a summary of the results of continuing operations for the nine months ended September 30, 2015:

• Net Sales were $19.8 billion down 12 percent from $22.6 billion in the prior year, principally reflecting 7 percent negative currency impacts and 3 percent lower volume.

• Total segment PTOI was $3.9 billion versus $4.4 billion in the prior year, down 11 percent due to negative currency impacts of $613 million, the absence of a prior-year gain on the sale of GLS/Vinyls and lower volume, partly offset by productivity improvements, insurance recoveries, and lower costs for raw materials, energy and freight.

• Income from continuing operations after taxes was $2.1 billion versus $2.6 billion in the prior year, principally reflecting lower segment PTOI and higher non-operating pension and OPEB costs, partially offset by lower corporate expenses.

• Cost savings from the strategic redesign of the company’s operating model contributed an incremental $0.30 per share.

Net Sales

Net sales for the three months ended September 30, 2015 were $4.9 billion versus $5.9 billion in the prior year, a 17 percent decline, attributable to an 8 percent negative impact from weaker currencies, particularly the Brazilian real and Euro; 7 percent lower volume; 1 percent lower local prices and 1 percent due to absence of sales from divested businesses. Lower volume reflects a 17 percent decline in Agriculture, primarily driven by lower seed volume and reduced demand for insect control products in Latin America. Net sales in developing markets were $2.0 billion, down 22 percent, reflecting a 12 percent negative currency impact, largely due to weaker currencies in Eastern Europe and Latin America, 9 percent lower volume due to lower Agriculture sales in Latin America and EMEA, and 12 percent combined lower volume in the Electronics & Communications and Safety & Protection segments in Asia Pacific. Developing markets include China, India and countries located in Latin America, Eastern and Central Europe, Middle East, Africa and Southeast Asia.

The tables below shows a regional breakdown of net sales based on location of customers and percentage variances from the prior year: 

34

	Three Months Ended September 30, 2015				Percent Change Due to:
	Net Sales ($ Billions)		Percent Change vs. 2014		Local Price and Product Mix		Currency		Volume		Portfolio and Other
Worldwide	$	4.9	(17	)	(1	)	(8	)	(7	)	(1	)
U.S. & Canada	1.6		(9	)	(5	)	—		(3	)	(1	)
Europe, Middle East & Africa (EMEA)	1.2		(19	)	1		(14	)	(4	)	(2	)
Asia Pacific	1.3		(14	)	(2	)	(4	)	(6	)	(2	)
Latin America	0.8		(33	)	1		(18	)	(16	)	—

Net sales for the nine months ended September 30, 2015 were $19.8 billion, down 12 percent versus $22.6 billion in the prior year. Lower sales are attributable to a 7 percent negative currency impact, 3 percent lower volume, and a 2 percent negative impact from the absence of sales from divested businesses. Volume reflects declines in Agriculture and Electronics & Communications, partly offset with increases in Performance Materials and Industrial Biosciences. Agriculture local selling prices were increased 2 percent, partially offsetting an 8 percent negative currency impact. Local prices in combined other segments were 2 percent lower, largely reflecting lower ethylene prices and pass through of lower precious metals prices. Total company sales in developing markets were $6.1 billion, down 16 percent versus $7.3 billion in the prior year, reflecting a 9 percent negative currency impact, lower volume, and the absence of sales from divested businesses.

	Nine Months Ended September 30, 2015				Percent Change Due to:
	Net Sales ($ Billions)		Percent Change vs. 2014		Local Price and Product Mix		Currency		Volume		Portfolio and Other
Worldwide	$	19.8	(12	)	—		(7	)	(3	)	(2	)
U.S. & Canada	8.9		(6	)	(2	)	—		(2	)	(2	)
Europe, Middle East & Africa (EMEA)	4.8		(18	)	2		(16	)	(2	)	(2	)
Asia Pacific	4.2		(10	)	(1	)	(3	)	(3	)	(3	)
Latin America	1.9		(26	)	1		(13	)	(13	)	(1	)

Other Income, Net

Other income, net, totaled $98 million for the three months ended September 30, 2015, a decrease of $266 million compared to $364 million in the prior year primarily due to decrease in pre-tax net exchange gain (loss) of $286 million, partially offset by an increase in gains on sales of businesses and other assets. The decrease in pre-tax net exchange gains was driven by lower gains on foreign currency exchange contracts. See Notes 4 and 12 to the interim Consolidated Financial Statements for further discussion of the company's policy of hedging the foreign currency-denominated monetary assets and liabilities.  

For the nine months ended September 30, 2015, other income, net, was $552 million compared to $749 million in the prior year, a decrease of $197 million primarily due to the absence of the $391 million gain related to the sale of GLS/Vinyls within the Performance Materials segment, partially offset by $112 million of income for a litigation claim settled in the second quarter of 2015.

Additional information related to the company's other income, net, is included in Note 4 to the interim Consolidated Financial Statements.

Cost of Goods Sold (COGS)

COGS totaled $3.1 billion for the third quarter 2015 versus $3.7 billion in the prior year, a 17 percent decrease principally due to lower volume, the currency impact of a stronger dollar, lower costs for raw materials, energy and freight, and productivity improvements. COGS as a percent of sales was 63 percent, the same as prior year.

COGS for the nine months ended September 30, 2015 was $11.7 billion versus $13.4 billion in the prior year, a 12 percent decrease principally due to the currency impact of a stronger dollar, lower sales, and lower costs for raw materials, energy, and freight. COGS as a percent of sales was unchanged from prior year at 59 percent as the benefit of productivity improvements offset the negative impact of currency which decreased sales by 7 percent and COGS by 4 percent.

35

Other Operating Charges

Other operating charges were $91 million in the third quarter 2015, versus $201 million in the prior year. Year-to-date other operating charges totaled $413 million versus $609 million in the prior year. The decrease in both periods was primarily due to insurance recoveries associated with the Imprelis^® matter.

Selling, General and Administrative Expenses (SG&A)

SG&A totaled $1.0 billion for the third quarter 2015 versus $1.2 billion in the prior year. Year-to-date SG&A totaled $3.5 billion versus $3.8 billion in the prior year. The decrease in both periods was primarily due to the strengthening of the U.S. dollar versus global currencies, cost savings from the company's operational redesign initiative, and lower selling and commission expense mainly in Agriculture. Partially offsetting the declines was an increase in pension and other postretirement employee benefit (OPEB) costs in the current year. SG&A was approximately 21 percent and 20 percent of net sales for the third quarter 2015 and 2014, respectively. SG&A was approximately 18 percent and 17 percent of net sales for the nine months ended in 2015 and 2014, respectively. The increase as a percentage of net sales in both periods was primarily driven by higher pension and OPEB costs in the current year.

Research and Development Expense (R&D)

R&D totaled $441 million and $486 million for the third quarter 2015 and 2014, respectively. Year-to-date R&D totaled $1.4 billion and $1.5 billion for the nine months ended September 30, 2015 and 2014, respectively. The decrease in both periods was primarily due to the impact of currency and lower spending. R&D was approximately 9 percent and 8 percent of net sales for the third quarter 2015 and 2014, respectively. R&D was approximately 7 percent of net sales for the nine months ended September 30, 2015 and 2014.

Interest Expense

Interest expense totaled $82 million in the third quarter 2015, compared to $93 million in 2014. For the nine months ended September 30, 2015, interest expense was $260 million versus $290 million in the prior year. The decrease in both periods was due to lower borrowings.

Employee Separation / Asset Related Charges, Net

For the nine months ended September 30, 2015, employee separation / asset related charges, net were $40 million, compared to $244 million in 2014. The nine months ended September 30, 2015 included $38 million in the first quarter related to cost investment impairments and $2 million in the second quarter related to adjustments to the 2014 restructuring program. The nine months ended September 30, 2014 includes a charge of $244 million recorded for the 2014 restructuring program.

See Note 3 to the interim Consolidated Financial Statements for additional information.

Provision for Income Taxes on Continuing Operations

The company's effective tax rate for the third quarter 2015 was 42.3 percent as compared to 47.8 percent in 2014. The lower effective tax rate in 2015 versus 2014 reflects the favorable tax impact of higher exchange losses recognized for the third quarter of 2015 on the re-measurement of the net monetary asset positions. The favorable impact of a foreign tax court decision also contributed to the decrease in the effective tax rate. These impacts were partially offset by the tax impact of insurance recoveries associated with the Imprelis^® matter as well as unfavorable geographic mix of earnings.

The company’s effective tax rate for the nine months ended September 30, 2015 was 29.4 percent as compared to 26.4 percent in 2014. The higher effective tax rate in 2015 versus 2014 reflects unfavorable geographic mix of earnings and the impact of a state tax rate change associated with the separation of Chemours. These impacts were partially offset by the favorable tax impact of higher exchange losses recognized for the third quarter of 2015 on the re-measurement of the net monetary asset positions which are not always tax deductible in their local jurisdictions.

See Note 5 to the interim Consolidated Financial Statements for additional information.

Outlook

In October 2015, the company revised its 2015 outlook downward due to continued strengthening of the U.S. dollar versus currencies in emerging markets, particularly the Brazilian real, further weakening of agricultural markets, primarily in Brazil, and continued weakness in emerging markets.

Recent Accounting Pronouncements

See Note 1 to the interim Consolidated Financial Statements for a description of recent accounting pronouncements.

36

Segment Reviews

Summarized below are comments on individual segment net sales and PTOI for the three and nine month period ended September 30, 2015 compared with the same period in 2014. Segment PTOI is defined as income (loss) from continuing operations before income taxes excluding non-operating pension and other postretirement employee benefit costs, exchange gains (losses), corporate expenses and interest. Effective July 1, 2015, certain corporate expenses will now be included in segment PTOI.  Reclassifications of prior year data have been made to conform to current year classifications. All references to prices are based on local price unless otherwise specified. A reconciliation of segment PTOI to income before income taxes for the three and nine month periods ended September 30, 2015 and 2014 is included in Note 14 to the interim Consolidated Financial Statements. See Note 3 to the interim Consolidated Financial Statements for information related to the 2014 restructuring plan.

Segment PTOI includes certain items which management believes are significant to understanding the segment results discussed below. See Note 14 to the interim Consolidated Financial Statements. These items are excluded from the Agriculture segment outlook below which discusses management’s current expectations for fourth quarter 2015 segment net sales and PTOI compared to fourth quarter 2014.

The following table summarizes third quarter and year-to-date 2015 segment net sales and related variances versus prior year:

	Three Months Ended
	September 30, 2015				Percentage Change Due to:
	Segment Net Sales ($ Billions)		Percent Change vs. 2014		Local Price and Product Mix		Currency		Volume		Portfolio and Other
Agriculture	$	1.1	(30	)	3		(15	)	(17	)	(1	)
Electronics & Communications	0.5		(14	)	(5	)	(2	)	(7	)	—
Industrial Biosciences	0.3		(3	)	(4	)	(6	)	7		—
Nutrition & Health	0.8		(10	)	—		(9	)	—		(1	)
Performance Materials	1.3		(15	)	(5	)	(6	)	(3	)	(1	)
Safety & Protection	0.8		(15	)	(1	)	(4	)	(6	)	(4	)

	Nine Months Ended
	September 30, 2015				Percentage Change Due to:
	Segment Net Sales ($ Billions)		Percent Change vs. 2014		Local Price and Product Mix		Currency		Volume		Portfolio and Other
Agriculture	$	8.2	(14	)	2		(8	)	(7	)	(1	)
Electronics & Communications	1.6		(13	)	(5	)	(2	)	(6	)	—
Industrial Biosciences	0.9		(6	)	(4	)	(6	)	4		—
Nutrition & Health	2.4		(9	)	—		(9	)	1		(1	)
Performance Materials	4.0		(13	)	(4	)	(6	)	2		(5	)
Safety & Protection	2.7		(10	)	—		(5	)	—		(5	)

Agriculture - Third quarter 2015 segment net sales of $1,093 million decreased $470 million, or 30 percent, as demand for seed and crop protection products, primarily in Brazil, further weakened in the third quarter impacted by macroeconomic and competitive pressures. The volume decline of 17 percent and the negative impact of currency of $232 million were partially offset by higher local crop protection prices. Decreased volumes are driven by lower corn seed volumes as growers are expected to reduce hybrid corn planted area in Brazil, lower soybean seed volumes in Brazil and North America where adverse weather for late season planting lowered area expectations and reduced demand for insect control products in Brazil reflecting low expected insect pressure. Insect control volumes were also impacted by the shutdown of the LaPorte manufacturing facility in Texas.

37

Third quarter 2015 PTOI seasonal loss of $63 million was $7 million larger, or 13 percent, on lower volumes, a $108 million negative currency impact and an approximately $40 million negative impact from the shutdown of the LaPorte manufacturing facility, partially offset by net insurance recoveries of $147 million for recovery of costs for customer claims related to the use of the Imprelis^® herbicide, increases in local price, cost reductions and continued productivity. Third quarter 2015 PTOI included $27 million for gains on the sales of assets and a $21 million benefit related to an adjustment for prior periods’ cost of goods sold. The impact of the adjustment was not material to current or prior periods.

Year-to-date segment net sales of $8,248 million decreased $1,316 million, or 14 percent, on the negative impact of currency of $760 million and lower volumes, partially offset by pricing actions in Europe and Africa to mitigate the impact of a stronger U.S. dollar and improved mix of Pioneer's new corn hybrids and soybean varieties in the U.S. Decreased volumes are due to reductions in global corn planted area and reduced soybean sales primarily due to soybean market share loss in North America.

PTOI of $1,878 million decreased $293 million, or 13 percent, on $399 million negative currency impact, lower volumes and an approximately $90 million negative impact of the shutdown of the LaPorte manufacturing facility partially offset by increases in local prices, cost reductions and continued productivity, net insurance recoveries of $182 million for recovery of costs for customer claims related to the use of the Imprelis^® herbicide and the absence of $47 million associated with the 2014 restructuring program in second quarter 2014. Year-to-date PTOI included charges of $4 million associated with the 2014 restructuring program. See Note 10 to the interim Consolidated Financial Statements for more information related to the Imprelis^® matter.

Outlook Fourth quarter 2015 sales are expected to be down low-teens percent due to the negative impact of currency, lower crop protection volumes in Brazil and the continued impact of the shutdown of the LaPorte manufacturing facility, partially offset by local pricing gains. Fourth quarter 2015 PTOI is expected to be a loss of about $100 million due to the significant impact from currency, lower crop protection volumes and the prior year impacts from performance based compensation adjustments and $36 million in gains from the sale of businesses, partially offset by continued productivity and cost reductions.

Electronics & Communications - Third quarter 2015 segment net sales of $532 million decreased $88 million, or 14 percent, due to competitive pressures impacting sales of Solamet^® paste, lower pricing from the pass-through of lower metals prices and the negative impact of currency partially offset by volume growth in Tedlar^® film in photovoltaics and products for the consumer electronics market. PTOI of $104 million increased $14 million, or 16 percent, as cost reductions and continued productivity more than offset lower sales.

Year-to-date segment net sales of $1,577 million decreased $233 million, or 13 percent, due to competitive pressures impacting sales of Solamet^® paste, lower pricing from the pass-through of lower metals prices and the negative impact of currency partially offset by volume growth in Tedlar^® film in photovoltaics and products for the consumer electronics market. PTOI of $283 million increased $107 million, or 61 percent, driven by cost reductions and continued productivity, and the absence of $68 million associated with the 2014 restructuring program in the prior year, partially offset by the above mentioned competitive pressures and negative impact of currency. Year-to-date PTOI included an $11 million benefit associated with the 2014 restructuring program.

Industrial Biosciences - Third quarter 2015 segment net sales of $305 million decreased $9 million, or 3 percent, as volume growth across the business was more than offset by the negative impact of currency of $18 million and lower pricing, primarily for biomaterials. Volume growth was driven primarily by home and personal care and food markets. PTOI of $52 million increased $10 million, or 24 percent, as volume growth, cost reductions and continued productivity were partially offset by lower pricing and the negative impact of currency.

Year-to-date segment net sales of $870 million decreased $55 million, or 6 percent, due to the negative impact of currency of $54 million, lower prices and lower demand for biomaterials, partially offset by volume growth in enzymes, principally for home and personal care, food markets and animal nutrition. PTOI of $147 million increased $1 million, or 1 percent, as lower pricing and the negative impact of currency offset enzyme demand, cost reductions and continued productivity. Year-to-date 2015 and 2014 PTOI included charges of $1 million and $2 million, respectively, associated with the 2014 restructuring program.

Nutrition & Health - Third quarter 2015 segment net sales of $810 million decreased $89 million, or 10 percent, primarily driven by the negative impact of currency of $83 million. Volume growth in probiotics, ingredient systems and texturants was offset by lower volumes due to competitive challenges in specialty proteins. PTOI of $102 million increased $3 million, or 3 percent, as cost reduction and continued productivity were partially offset by the negative impact of currency of $17 million.

38

Year-to-date segment net sales of $2,449 million decreased $237 million, or 9 percent, driven by the negative impact of currency of $235 million. Volume growth in probiotics, texturants, cultures and ingredient systems was partially offset by lower volumes in specialty proteins. PTOI of $284 million increased $2 million, or 1 percent driven by volume, cost reductions and continued productivity, partially offset by the negative impact of currency of $42 million. Year-to-date 2015 and 2014 PTOI included charges of $4 million and $8 million, respectively, associated with the 2014 restructuring program.

Performance Materials - Third quarter 2015 segment net sales of $1,302 million decreased $229 million, or 15 percent, driven by the negative impact of currency of $89 million, lower price and volume for ethylene, auto build weakness in Asia Pacific resulting in reduced demand for auto polymers, and the portfolio changes from the sale of a majority owned interest in a joint venture. PTOI of $317 million decreased $49 million or 13 percent, driven by the negative impact of currency of $47 million, lower volume and price for ethylene partially offset by cost reductions and continued productivity. Third quarter 2015 PTOI included a $16 million net benefit from a joint venture while prior year PTOI included a $23 million gain on sale of a majority owned interest in a joint venture.

Year-to-date 2015 segment net sales of $4,021 million decreased $597 million, or 13 percent, driven by the negative impact of currency of $269 million, the portfolio changes from the sale of Glass Laminating Solutions/Vinyls (GLS/Vinyls), and lower ethylene pricing. Partially offsetting the declines are increased ethylene volumes due to the prior year scheduled outage at the Orange Texas ethylene unit. PTOI of $933 million decreased $370 million or 28 percent, driven by the absence of the $391 million pre-tax gain on the sale of GLS/Vinyls in prior year and the negative impact of currency of $113 million, partially offset by cost reductions, continued productivity and lower product costs. Year-to-date 2015 and 2014 PTOI included a charge of $2 million and $29 million, respectively, associated with the 2014 restructuring plan.

Safety & Protection - Third quarter 2015 segment net sales of $831 million decreased $145 million, or 15 percent, due to lower volume, the portfolio impact of the Sontara^® divestiture and the negative impact of currency of $40 million. Volume growth for Tyvek^® protective material, including medical packaging, was more than offset by lower demand for Sustainable Solution offerings, Nomex^® thermal-resistant fiber particularly from the oil and gas industry, and Kevlar^® high-strength material due to military spending delays. PTOI of $156 million decreased $39 million, or 20 percent, driven by lower sales, higher unit costs associated with the slower-than-expected recovery from the outage in the first quarter at the Chambers Works facility in New Jersey and the negative impact of currency of $13 million, partially offset by cost reductions and continued productivity.

Year-to-date 2015 segment net sales of $2,663 million decreased $287 million, or 10 percent, due to the portfolio impact of the Sontara^® divestiture and the negative impact of currency of $124 million. PTOI of $635 million increased $99 million, or 18 percent, driven by a pre-tax gain of $112 million, net of legal expenses, recorded in other income, net related to the company’s settlement of a legal claim, cost reductions and continued productivity, and the absence of a $31 million charge associated with the 2014 restructuring program in the prior year. This was partially offset by the negative impact of currency of $46 million, lower sales, and higher unit costs associated with the outage in the first quarter at the Chambers Works facility. Year-to-date 2015 PTOI included a $1 million benefit associated with the 2014 restructuring program.

39

Liquidity & Capital Resources

Information related to the company's liquidity and capital resources can be found in the company's 2014 Annual Report, Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital Resources. Discussion below provides the updates to this information for the nine months ended September 30, 2015.

(Dollars in millions)	September 30, 2015		December 31, 2014
Cash, cash equivalents and marketable securities	$	3,730	$	7,034
Total debt	9,936		10,655

The company's cash, cash equivalents and marketable securities at September 30, 2015 and December 31, 2014 are $3.7 billion and $7.0 billion, respectively. The $3.3 billion decrease was primarily due to share repurchases, dividend payments, purchases of property, plant and equipment and the company's seasonal working capital needs, partially offset with proceeds from the Chemours distribution. In connection with the separation, the company received dividend proceeds from Chemours in May 2015 of $3,923 million comprised of a cash distribution of $3,416 million and a distribution in-kind of $507 million in the form of senior unsecured notes maturing in 2025 with a fixed interest rate of 7%. The company exchanged the notes received from Chemours for $488 million of DuPont debt due in 2016.

Total debt as of September 30, 2015 was $9.9 billion, a $0.7 billion decrease from $10.7 billion as of December 31, 2014. The decrease in total debt is primarily due to repayments of $1.4 billion of maturing debt, the early retirement of $488 million notes due in 2016, partially offset by the issuance of commercial paper. The company paid a premium of $20 million in connection with the early retirement.

The company's credit ratings impact its access to the debt capital markets and cost of capital. The company remains committed to a strong financial position and a strong investment-grade rating. The company's long-term and short-term credit ratings are as follows:

	Long-Term	Short-Term	Outlook
Standard and Poor's	A-	A-2	Negative
Moody's Investors Service	A3	P-2	Stable
Fitch Ratings	A	F1	Stable

In May 2015, Moody's Investors Service (Moody's) downgraded the company's long-term rating to A3 from A2, and the short-term rating to P-2 from P-1. In October 2015, Standard and Poor's Ratings Services (Standard and Poor's) downgraded the company's long-term rating to A- from A, and the short-term rating to A-2 from A-1. The company expects the impact of the downgrades to be immaterial to its liquidity position. While the downgrades may result in reduced market capacity for commercial paper, the company's liquidity needs can continue to be met through a variety of alternative sources, including cash provided by operating activities, cash and cash equivalents, marketable securities, commercial paper, syndicated credit lines, bilateral credit lines, equity and long-term debt markets and asset sales.

Summary of Cash Flows 

Cash used for operating activities was $1.8 billion for the nine months ended September 30, 2015, essentially unchanged compared with the nine months ended September 30, 2014. The decline in net income was offset by various working capital benefits.

Cash used for investing activities was $1.0 billion for the nine months ended September 30, 2015 compared to $0.7 billion for the same period last year. The $0.3 billion increase in cash used for investing activities was primarily due to the absence of proceeds from the sale of GLS/Vinyls, partially offset by an increase in cash settlements from foreign currency contract settlements.

Cash used for financing activities was $0.4 billion for the nine months ended September 30, 2015 compared to $2.2 billion of cash for the same period last year. The $1.8 billion decrease in cash used for financing activities was primarily due to the distribution of Chemours borrowings to the company as part of the separation, partially offset by a reduction in short term borrowings, and an increase in the repurchase of common stock.

Dividends paid to shareholders during the nine months ended September 30, 2015 totaled $1.2 billion. In October 2015, the Board of Directors declared a fourth quarter common stock dividend of $0.38 per share. The company has paid quarterly consecutive dividends since the company’s first dividend in the fourth quarter 1904.

40

In January 2014, the company's Board of Directors authorized a $5 billion share buyback plan. During the nine months ended September, 30, 2015, the company purchased and retired 4.6 million shares in the open market which offset the dilution from employee compensation plans in the first and second quarter 2015. As of September 30, 2015, the company has purchased 34.7 million shares at a total cost of $2.4 billion under the plan. There is no required completion date for the remaining stock purchases.

In the first quarter 2015, DuPont announced its intention to buy back shares of about $4 billion using the distribution proceeds received from Chemours. In connection with the completion of the spin-off of Chemours, the Board of Directors authorized the use of the distribution proceeds to buy back shares of the company's common stock as follows: $2 billion to be purchased and retired by December 31, 2015 with the remainder to be purchased and retired by December 31, 2016. In August 2015, the company entered into an accelerated share repurchase (ASR) agreement. Under the terms of the August 2015 ASR agreement, the company paid $2 billion to the financial institution and received and retired an initial delivery of 28.8 million shares, which represents 80 percent of the $2 billion notional amount of the agreement. The purchase price per share and final number of shares retired will be determined using the volume-weighted price of the company's stock over the term of the ASR agreement. The August 2015 ASR will be completed in the fourth quarter 2015.

See Part II, Item 2 and Note 11 to the interim Consolidated Financial Statements for additional information.

Guarantees and Off-Balance Sheet Arrangements

For detailed information related to Guarantees, Indemnifications, and Obligations for Equity Affiliates and Others, see the company's 2014 Annual Report, Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Off- Balance Sheet Arrangements, and Note 10 to the interim Consolidated Financial Statements.

41

Contractual Obligations

Information related to the company's contractual obligations at December 31, 2014 can be found in the company's 2014 Annual Report, Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, Off-Balance Sheet Arrangements. The company's long-term debt obligations at September 30, 2015 decreased by $1.9 billion versus prior year-end primarily due to $1.4 billion of debt principal maturities. As a result of the spin-off of Chemours on July 1, 2015, the company’s raw material obligations decreased by approximately $1.5 billion at September 30, 2015. In addition, Chemours indemnified DuPont against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. At September 30, 2015, the indemnified assets were $500 million which offset the corresponding liabilities of $500 million. See Note 2 to the interim Consolidated Financial Statements for additional information in relation to the indemnification.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See Note 12, “Financial Instruments”, to the interim Consolidated Financial Statements. See also Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk, of the company's 2014 Annual Report for information on the company's utilization of financial instruments and an analysis of the sensitivity of these instruments.

42

Item 4.CONTROLS AND PROCEDURES

a)        Evaluation of Disclosure Controls and Procedures

The company maintains a system of disclosure controls and procedures to give reasonable assurance that information required to be disclosed in the company's reports filed or submitted under the Securities Exchange Act of 1934 (Exchange Act) is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. These controls and procedures also give reasonable assurance that information required to be disclosed in such reports is accumulated and communicated to management to allow timely decisions regarding required disclosures.

As of September 30, 2015, the company's Interim Chief Executive Officer (CEO) and Chief Financial Officer (CFO), together with management, conducted an evaluation of the effectiveness of the company's disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation, the CEO and CFO concluded that these disclosure controls and procedures are effective.

b)Changes in Internal Control over Financial Reporting

There has been no change in the company's internal control over financial reporting that occurred during the quarter ended September 30, 2015 that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.

43

PART II.  OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

The company is subject to various litigation matters, including, but not limited to, product liability, patent infringement, antitrust claims, and claims for third party property damage or personal injury stemming from alleged environmental torts. Information regarding certain of these matters is set forth below and in Note 10 to the interim Consolidated Financial Statements.

Imprelis^® Herbicide Claims Process

Information related to this matter is included in Note 10 to the interim Consolidated Financial Statements under the heading Imprelis^®.

PFOA: Environmental and Litigation Proceedings

For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms. Information related to this matter is included in Note 10 to the interim Consolidated Financial Statements under the heading PFOA.

LaPorte Plant, LaPorte, Texas

The U.S. Environmental Protection Agency (EPA) conducted a multimedia inspection at the LaPorte facility in January 2008. DuPont, EPA and the Department of Justice (DOJ) began discussions in the Fall 2011 relating to the management of certain materials in the facility's waste water treatment system, hazardous waste management, flare and air emissions. These negotiations continue.

LaPorte Plant, LaPorte, Texas - Crop Protection

On November 15, 2014 there was a release of methyl mercaptan at the company’s LaPorte facility.  The release occurred at the site’s Crop Protection unit resulting in four employee fatalities inside the unit. DuPont is continuing its investigation into the incident. Several governmental agencies also are conducting their own investigations. DuPont is cooperating with these agency reviews. In May, 2015, the Occupational Safety & Health Administration (OSHA) cited the company for eight serious and one repeat violation with an associated penalty of $99,000. The company is contesting OSHA’s findings.

LaPorte Plant, LaPorte, Texas - OSHA Process Safety Management (PSM) Audit

In 2015, OSHA conducted a PSM audit of the Crop Protection and Fluoroproducts units at the LaPorte Plant. In July, 2015, OSHA cited the company for three willful, one repeat and four serious PSM violations and placed the company in its Severe Violator Enforcement Program. OSHA has proposed a penalty of $273,000. The company is contesting OSHA’s findings.

Sabine Plant, Orange, Texas

In June 2012, DuPont began discussions with DOJ and EPA related to a multimedia inspection that EPA conducted at the Sabine facility in March 2009. The discussions involve the management of materials in the facility's waste water treatment system, hazardous waste management, flare and air emissions.

Yerkes Plant, Buffalo, New York

In March 2015, DuPont began discussions with the EPA related to alleged violations at the Yerkes facility of a Risk Management Plan (RMP) and General Duty Clause under the Clean Air Act (CAA). The allegations stem from a 2010 incident at the facility during which a welding contractor ignited residual vapors in an empty storage vessel. The EPA and the company reached a settlement under which DuPont will pay a fine of $724,000 and undertake a Supplemental Environmental Project benefiting the local fire department.

Item 1A. RISK FACTORS

There have been no material changes in the company's risk factors discussed in Part I, Item 1A, Risk Factors, in the company's 2014 Annual Report.

44

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity

In January 2014, the company's Board of Directors authorized a $5 billion share buyback plan. There is no required completion date for purchases under this plan.

In the first quarter 2015, DuPont announced its intention to buy back shares of about $4 billion using the distribution proceeds received from Chemours. In connection with the completion of the spin-off of Chemours, the Board of Directors authorized the use of the distribution proceeds to buy back shares of the company's common stock as follows: $2 billion to be purchased and retired by December 31, 2015 with the remainder to be purchased and retired by December 31, 2016. In August 2015, the company entered into an accelerated share repurchase (ASR) agreement. Under the terms of the August 2015 ASR agreement, the company paid $2 billion to the financial institution and received and retired an initial delivery of 28.8 million shares, which represents 80 percent of the $2 billion notional amount of the ASR agreement. The August 2015 ASR will be completed in the fourth quarter 2015.

See Part I, Item 2 on page 41 of this report and Note 11 to the interim Consolidated Financial Statements for additional information.

The following table summarizes information with respect to the company's purchase of its common stock during the three months ended September 30, 2015:

Month	Total Number of Shares Purchased	Average Price Paid per Share	Total Number of Shares Purchased as Part of Publicly Announced Programs	Approximate Value of Shares that May Yet Be Purchased Under the Programs(1) (Dollars in millions)
August:
ASR(2)	28,782,155	See (2) Below	28,782,155
Total	28,782,155		28,782,155	$	4,647

¹  Represents approximate value of shares that may yet be purchased under the 2014 and 2015 plans.

²  Includes the 80% initial share delivery under the August ASR agreement described above. The purchase price per share and final number of shares retired will be determined using the volume-weighted price of the company's stock over the term of the ASR agreement.

Item 5.OTHER INFORMATION

Effective October 22, 2015, the company’s Office of the Chief Executive was dissolved and in conjunction therewith, the company amended its Bylaws to delete Article IV, entitled “Office of the Chief Executive,” in its entirety and to strike the references to the Office of the Chief Executive and in each instance replacing it with reference to the Chief Executive Officer in Sections 1, 3, 4, 5, 6, 7, 8, 9, 10 and 12 of Article V entitled “Officers.”

Item 6. EXHIBITS

Exhibits: The list of exhibits in the Exhibit Index to this report is incorporated herein by reference.

45

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

E. I. DU PONT DE NEMOURS AND COMPANY
(Registrant)
Date:	October 27, 2015
By:	/s/ Nicholas C. Fanandakis
	Nicholas C. Fanandakis
	Executive Vice President and
	Chief Financial Officer
	(As Duly Authorized Officer and
	Principal Financial and Accounting Officer)

46

EXHIBIT INDEX

Exhibit Number	Description
3.1	Company’s Restated Certificate of Incorporation (incorporated by reference to Exhibit 99.2 to the company’s Current Report on Form 8-K (Commission file number 1-815) dated June 1, 2015).
3.2	Company’s Bylaws, as last amended effective October 22, 2015.
4	The company agrees to provide the Commission, on request, copies of instruments defining the rights of holders of long-term debt of the company and its subsidiaries.
10.1*	The DuPont Stock Accumulation and Deferred Compensation Plan for Directors, as last amended effective January 1, 2009 (incorporated by reference to Exhibit 10.1 to the company's Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2013).
10.2*	Company’s Supplemental Retirement Income Plan, as last amended effective June 4, 1996 (incorporated by reference to Exhibit 10.2 to the company’s Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2011).
10.3*	Company’s Pension Restoration Plan, as last amended effective June 29, 2015 (incorporated by reference to Exhibit 10.3 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2015).
10.4*	Company’s Rules for Lump Sum Payments, as last amended effective May 15, 2014 (incorporated by reference to Exhibit 10.4 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2015).
10.5*	Company’s Stock Performance Plan, as last amended effective January 25, 2007 (incorporated by reference to Exhibit 10.5 to the company’s Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2011).
10.6*	Company’s Equity and Incentive Plan, as amended October 23, 2014 (incorporated by reference to Exhibit 10.6 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended September 30, 2014).
10.7*	Form of Award Terms under the company’s Equity and Incentive Plan (incorporated by reference to Exhibit 10.7 to the company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2013).
10.8*	Company’s Retirement Savings Restoration Plan, as last amended effective May 15, 2014. (incorporated by reference to Exhibit 10.8 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2014).
10.9*	Company’s Retirement Income Plan for Directors, as last amended January 2011 (incorporated by reference to Exhibit 10.9 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2012).
10.10*	Company's Senior Executive Severance Plan, adopted on August 12, 2013 (incorporated by reference to Exhibit 10.11 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended September 30, 2013). The company agrees to furnish supplementally a copy of any omitted schedules to the Commission upon request.

47

Exhibit Number	Description
10.11*	Supplemental Deferral Terms for Deferred Long Term Incentive Awards and Deferred Variable Compensation Awards (incorporated by reference to Exhibit 10.12 to the company's Annual Report on Form 10-K (Commission file number 1-815) for the year ended December 31, 2013).
10.12*	Form of 2014 Award Terms under the Company's Equity and Incentive Plan (incorporated by reference to Exhibit 10.13 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2014).
10.13*	Company’s Management Deferred Compensation Plan, as last amended effective April 15, 2014 (incorporated by reference to Exhibit 10.13 to the company's Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2014).
10.14*	Consulting Agreement dated October 22, 2014, by and between E.I. du Pont de Nemours and Company and Thomas M. Connelly (incorporated by reference to Exhibit 10.4 to the company's Quarterly Report on 10-Q (Commission file number 1-815) for the period ended September 30, 2014).
10.15*	Separation Agreement dated October 5, 2015, by and between E.I. du Pont de Nemours and Company and Ellen J. Kullman (incorporate by reference to Exhibit 10.1 to the company's Current Report on Form 8-K (Commission file number 1-815) dated October 5, 2015).
10.16*	Form of 2015 Award Terms under the Company's Equity and Incentive Plan (incorporated by reference to Exhibit 10.14 to the company's Quarterly Report on 10-Q (Commission file number 1-815) for the period ended March 31, 2015).
10.17**	Separation Agreement by and between the Company and The Chemours Company (incorporated by reference to reference to Exhibit 2.1 to the company’s Current Report on Form 8-K (Commission file number 1-815) dated July 8, 2015).
10.18	Tax Matters Agreement by and between the Company and The Chemours Company (incorporated by reference to reference to Exhibit 2.2 to the company’s Current Report on Form 8-K (Commission file number 1-815) dated July 8, 2015).
12	Computation of Ratio of Earnings to Fixed Charges.
18.1	Preferability Letter of Independent Registered Public Accounting Firm (incorporated by reference to Exhibit 18.1 to the company's Quarterly Report on Form 10-Q for the period ended September 30, 2014).
31.1	Rule 13a-14(a)/15d-14(a) Certification of the company’s Principal Executive Officer.
31.2	Rule 13a-14(a)/15d-14(a) Certification of the company’s Principal Financial Officer.
32.1	Section 1350 Certification of the company’s Principal Executive Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
32.2	Section 1350 Certification of the company’s Principal Financial Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document

48

101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

______________________________________

*Management contract or compensatory plan or arrangement.

**DuPont hereby undertakes to furnish supplementally a copy of any omitted schedule or exhibit to such agreement to the U.S. Securities and Exchange Commission upon request.

49

EX-3.2

BYLAWS

OF

E. I. DU PONT DE NEMOURS AND COMPANY

Incorporated Under The Laws of Delaware

AS REVISED EFFECTIVE

OCTOBER 22, 2015

BYLAWS

Page

ARTICLE I.

MEETING OF STOCKHOLDERS:

Section 1.	Annual	4
Section 2.	Special	4
Section 3.	Notice	5
Section 4.	Quorum	5
Section 5.	Organization; Adjournment	5
Section 6.	Voting	5
Section 7.	Inspectors	6
Section 8.	Advance Notice of Stockholder Nominations and Proposals	6
Section 9.	Stockholder Action by Written Consent	10

ARTICLE II.

BOARD OF DIRECTORS:

Section 1.	Number	10
Section 2.	Term	10
Section 3.	Increase of Number	10
Section 4.	Resignation	10
Section 5.	Vacancies	10
Section 6.	Regular Meetings	10
Section 7.	Special Meetings	10
Section 8.	Quorum	11
Section 9.	Place of Meeting, Etc.	11
Section 10.	Interested Directors; Quorum	11

ARTICLE III.

COMMITTEES OF THE BOARD:

Section 1.	Committees	12
Section 2.	Procedure	12
Section 3.	Reports to the Board	13
Section 4.	Audit Committee	13
Section 5.	Environmental Policy Committee	13
Section 6.	Compensation Committee	13
Section 7.	Corporate Governance Committee	13
Section 8.	Science and Technology Committee	13

Page

ARTICLE lV.

OFFICERS:

Section 1.	Officers	14
Section 2.	Chair of the Board	14
Section 3.	Chief Executive Officer	14
Section 4.	Executive Vice Presidents	14
Section 5.	Vice Presidents	15
Section 6.	Chief Financial Officer	15
Section 7.	Treasurer	15
Section 8.	Assistant Treasurer	15
Section 9.	Controller	15
Section 10.	Assistant Controller	15
Section 11.	Secretary	15
Section 12.	Assistant Secretary	15
Section 13.	Removal	16
Section 14.	Resignation	16
Section 15.	Vacancies	16

ARTICLE V.

MISCELLANEOUS:

Section 1.	Indemnification of Directors or Officers	16
Section 2.	Certificate for Shares	17
Section 3.	Transfer of Shares	17
Section 4.	Regulations	17
Section 5.	Record Date of Stockholders	17
Section 6.	Corporate Seal	18
Section 7.	Forum for Adjudication of Certain Disputes	18

ARTICLE VI.

AMENDMENTS 18

BYLAWS

OF

E. I. DU PONT DE NEMOURS AND COMPANY

ARTICLE I.

MEETING OF STOCKHOLDERS

SECTION 1. Annual. Meetings of the stockholders for the purpose of electing Directors, and transacting such other proper business as may be brought before the meeting, shall be held annually at such date, time and place, within or without the State of Delaware as may be designated by the Board of Directors (“Board”).

SECTION 2. Special. Special meetings of the stockholders may be called by the Board and shall be called by the Secretary at the request in writing of the holders of record of at least twenty-five percent of the outstanding stock of the Company entitled to vote. A request to the Secretary shall be signed by each stockholder, or a duly authorized agent of such stockholder, requesting the special meeting and shall set forth, for each stockholder requesting the meeting, the information required to be in a stockholder’s notice pursuant to Section 8(b), Section 8(c) or Section 8(e) of this Article I, as applicable.

The special meeting shall be held not more than ninety (90) days after a proper request to call the special meeting is received by the Secretary. Notwithstanding the foregoing, a special meeting requested by stockholders shall not be held if (1) the business proposed to be brought before the special meeting by stockholders is not a proper subject for stockholder action under applicable law or (2) the Board has called or calls for an annual meeting of stockholders to be held within ninety (90) days after the Secretary receives the request for the special meeting and the Board determines in good faith that the business of such annual meeting includes (among any other matters properly brought before the annual meeting) the business specified in the request. A stockholder may revoke a request for a special meeting at any time by written revocation delivered to the Secretary, and if, following such revocation, there are un-revoked requests from stockholders holding in the aggregate less than the requisite number of shares entitling the stockholders to request the calling of a special meeting, the Board, in its discretion, may cancel the special meeting.

Business transacted at all special meetings shall be limited to the matters stated in the Company’s notice of special meeting. Business transacted at a special meeting requested by stockholders shall be limited to the matters described in the request for the special meeting; provided, however, that nothing herein shall prohibit the Board from submitting additional matters to stockholders at any such special meeting.

Special meetings shall be held within or without the State of Delaware, as the Board shall designate.

SECTION 3. Notice. Written notice of each meeting of stockholders, stating the place, date and hour of the meeting, and the purpose or purposes thereof, shall be mailed not less than ten nor more than sixty days before the date of such meeting to each stockholder entitled to vote thereat.

SECTION 4. Quorum. Unless otherwise provided by statute, the holders of shares of stock entitled to cast a majority of votes at a meeting, present either in person or by proxy, shall constitute a quorum at such meeting.

Absence of a quorum of the holders of Common Stock or Preferred Stock at any meeting or adjournment thereof, at which under the Certificate of Incorporation the holders of Preferred Stock have the right to elect any Directors, shall not prevent the election of Directors by the other class of stockholders entitled to elect Directors as a class if the necessary quorum of stockholders of such other class shall be present in person or by proxy.

SECTION 5. Organization; Adjournment. The Chair of the Board (“Chair”) shall preside at meetings of stockholders. The Secretary of the Company shall act as Secretary of all meetings of the stockholders, but in the absence of the Secretary the presiding officer may appoint a Secretary of the meeting. The order of business for such meetings shall be determined by the Chair. The Chair shall have the power to adjourn any meeting of the stockholders from time to time to reconvene at the same or some other place, and notice need not be given of any such adjourned meeting if the time and place thereof are announced at the meeting at which the adjournment is taken.

SECTION 6. Voting. Each stockholder entitled to vote at any meeting shall be entitled to one vote for each share held of record, in person, by written proxy or by any permissible means of electronic transmission, provided that such electronic transmission must either contain, or be submitted with, information from which it can be determined that it was authorized by the stockholder. Upon the demand of any stockholder, such stockholder shall be entitled to vote by ballot. Except as otherwise provided by law or by the Certificate of Incorporation:

(a) each director shall be elected by the vote of a majority of the votes cast with respect to that director’s election; provided, however, that directors shall be elected by a plurality of the votes cast at any meeting of the stockholders for which the Secretary of the Company receives a notice in accordance with these Bylaws that a stockholder has nominated a person for election to the Board at any time prior to any meeting of stockholders or at such meeting. For purposes of this Section 6, a majority of the votes cast shall mean that the number of votes cast “for” a director’s election exceeds the number of votes cast “against” that director’s election.

Abstentions and broker non-votes are not counted as votes cast either “for” or “against” a director’s election; and

(b) whenever any corporate action other than the election of directors is to be taken, it shall be decided by a plurality of the votes cast, except as otherwise required by statute. Abstentions and broker non-votes are not counted as votes cast.

SECTION 7. Inspector(s). At each meeting of the stockholders the Inspector(s) shall, among other things, ascertain the number of shares outstanding and the voting power of each; determined the shares represented at the meeting and the validity of proxies and ballots; count all votes and ballots; and certify their determination of the number of shares represented and their count of all votes and ballots. If three or more Inspectors are appointed, a majority of those appointed shall have power to make a decision. Each such Inspector shall be appointed by the Board before the meeting, or in default thereof, by the presiding officer at the meeting, and shall be sworn to the faithful performance of their duties. If any Inspector previously appointed shall fail to attend or refuse or be unable to serve, a substitute shall be appointed by the presiding officer.

SECTION 8. Advance Notice of Stockholder Nominations and Proposals.

(a) Timely Notice. At a meeting of the stockholders, only such nominations of persons for the election of directors and such other business shall be conducted as shall have been properly brought before the meeting. To be properly brought before an annual meeting, nominations or such other business must be: (i) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board or any committee thereof, (ii) otherwise properly brought before the meeting by or at the direction of the Board or any committee thereof, or (iii) otherwise properly brought before an annual meeting by a stockholder who: (A) is a stockholder of record of the Company at the time such notice of meeting is delivered and at the time the notice required hereunder is delivered to the Secretary; (B) is entitled to vote at the meeting; and (C) complies with the notice procedures and disclosure requirements set forth in this Section 8. In addition, any proposal of business (other than the nomination of persons for election to the Board) must be a proper matter for stockholder action. For business (including, but not limited to, director nominations) to be properly brought before an annual meeting by a stockholder, the stockholder or stockholders of record intending to propose the business (the "Proposing Stockholder") must have given timely notice thereof pursuant to this Section 8(a) or Section 8(c) below, as applicable, in writing to the Secretary of the Company even if such matter is already the subject of any notice to the stockholders or Public Disclosure from the Board. To be timely, a Proposing Stockholder's notice must be delivered to or mailed and received at the principal executive offices of the Company: (x) not later than the close of business on the 90th day, nor earlier than the close of

business on the 120th day in advance of the anniversary of the previous year's annual meeting if such meeting is to be held on a day that is within 30 days before or after the anniversary of the previous year's annual meeting; and (y) with respect to any other annual meeting of stockholders, the close of business on the tenth (10th) day following the date of Public Disclosure of the date of such meeting. In no event shall any adjournment or postponement of an annual meeting, or the Public Disclosure thereof, commence a new notice time period (or extend any notice time period).

(b)    Stockholder Nominations. For the nomination of any person or persons for election to the Board whether at an annual meeting or a properly called special meeting of stockholders, a Proposing Stockholder's notice to the Secretary of the Company shall set forth (i) the name, age, business address and residence address of each nominee proposed in such notice, (ii) the principal occupation or employment of each such nominee, (iii) (A) the number of shares of capital stock of the Company which are owned of record and beneficially by each such nominee and any affiliates or associates of such nominee (if any) and (B) a description of any agreement, arrangement or understanding of the type described in clause (vi)(D) of this section, but as it relates to each such nominee rather than the Proposing Stockholder, (iv) (A) if any such nominee is a party to any compensatory, payment or other financial agreement, arrangement or understanding with any person or entity other than the Company, or has received any compensation or other payment from any person or entity other than the Company, in each case in connection with candidacy or service as a director of the Company, a detailed description of such agreement, arrangement or understanding and its terms or of any such compensation received and (B) such other information concerning each such nominee as would be required to be disclosed in a proxy statement soliciting proxies for the election of such nominee as a director in an election contest (even if an election contest is not involved) or that is otherwise required to be disclosed, under Section 14(a) of the Exchange Act and the rules and regulations promulgated thereunder, (v) the consent of the nominee to being named in the proxy statement as a nominee and to serving as a director if elected and a representation by the nominee to the effect that, if elected, the nominee will agree to and abide by all policies of the Board as may be in place at any time and from time to time, and (vi) as to the Proposing Stockholder: (A) the name and address of the Proposing Stockholder as they appear on the Company's books and of the beneficial owner, if any, on whose behalf the nomination is being made, (B) the class and number of shares of the Company which are owned by the Proposing Stockholder (beneficially and of record) and owned by the beneficial owner, if any, on whose behalf the nomination is being made, as of the date of the Proposing Stockholder's notice, (C) a description of any agreement, arrangement or understanding with respect to such nomination between or among the Proposing Stockholder and any of its affiliates or associates, and any others (including their names) acting in concert with any of the foregoing, (D) a description of any agreement, arrangement or understanding (including any derivative or short positions, profit interests, options, hedging transactions, and borrowed or loaned shares) that has been entered into as of the date of the Proposing Stockholder's notice by, or on behalf of, the Proposing Stockholder or any of its affiliates or

associates, the effect or intent of which is to mitigate loss to, manage risk or benefit of share price changes for, or increase or decrease the voting power of the Proposing Stockholder or any of its affiliates or associates with respect to shares of stock of the Company, (E) a representation that the Proposing Stockholder is a holder of record of shares of the Company entitled to vote at the meeting and intends to appear in person or by proxy at the meeting to nominate the person or persons specified in the notice, (F) a representation whether the Proposing Stockholder intends to deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Company's outstanding capital stock required to approve the election of the nominee and/or otherwise to solicit proxies from stockholders in support of such election and (G) and, with respect to (B), (C) and (D) above, a representation that the Proposing Stockholder will promptly notify the Company in writing of the same as of the record date for the meeting promptly following the later of the record date or the date notice of the record date is first publicly disclosed. The Company may require any proposed nominee to furnish such other information as it may reasonably require to determine the eligibility of such proposed nominee to serve as an independent director of the Company or that could be material to a reasonable stockholder's understanding of the independence, or lack thereof, of such nominee.

(c)    Other Stockholder Proposals. For all business other than director nominations, a Proposing Stockholder's notice to the Secretary of the Company shall set forth as to each matter the Proposing Stockholder proposes to bring before the annual meeting or properly called special meeting, as the case may be: (i) a brief description of the business desired to be brought before the meeting and the reasons for conducting such business at the meeting, (ii) any other information relating to such stockholder and beneficial owner, if any, on whose behalf the proposal is being made, required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for the proposal and pursuant to and in accordance with Section 14(a) of the Exchange Act and the rules and regulations promulgated thereunder, (iii) a description of all agreements, arrangements, or understandings between or among such Proposing Stockholder, or any affiliates or associates of such Proposing Stockholder, and any other person or persons (including their names) in connection with the proposal of such business and any material interest of such Proposing Stockholder or any affiliates or associates of such Proposing Stockholder, in such business, including any anticipated benefit therefrom to such Proposing Stockholder, or any affiliates or associates of such Proposing Stockholder and (iv) the information required by Section 8(b)(vi) above.

(d)    Proxy Rules. The foregoing notice requirements of Section 8(c) shall be deemed satisfied by a stockholder with respect to inclusion in the proxy statement referenced below of a proposal with respect to business other than a nomination if the stockholder has notified the Company of his, her or its intention to present such proposal at an annual meeting in compliance with Rule 14(a)-8 of the Exchange Act and such stockholder's proposal has been included in a proxy statement that has been prepared by the Company to solicit proxies for such annual meeting.

(e)    Special Meetings of Stockholders. Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting pursuant to the Company's notice of meeting. Nominations of persons for election to the Board may be made at a special meeting of stockholders at which directors are to be elected pursuant to the Company's notice of meeting (x) by or at the direction of the Board or any committee thereof (or stockholders pursuant to Section 2 above) or (y) provided that the Board (or stockholders pursuant to Section 2 above) has determined that directors shall be elected at such meeting, by any stockholder of the Company who is a stockholder of record at the time the notice provided for in this Section 8 is delivered to the Secretary of the Company, who is entitled to vote at the meeting and upon such election and who complies with the notice procedures set forth in this Section 8. In the event the Company calls a special meeting of stockholders for the purpose of electing one or more directors to the Board, any such stockholder entitled to vote in such election of directors may nominate a person or persons (as the case may be) for election to such position(s) as specified in the Company’s notice of meeting, if the stockholder's notice required by this Section 8 shall be delivered to the Secretary at the principal executive offices of the Company not later than the close of business on the tenth (10th) day following the day on which notice of the date of the Special Meeting was mailed or Public Disclosure of the date of the Special Meeting was made, whichever first occurs. In no event shall any adjournment or postponement of a special meeting, or the Public Disclosure thereof, commence a new time period (or extend any notice time period).

(f)    Effect of Noncompliance. Notwithstanding anything in these By- laws to the contrary: (i) no nominations shall be made or business shall be conducted at any annual meeting or special meeting except in accordance with the procedures set forth in this Section 8, and (ii) unless otherwise required by law, if a Proposing Stockholder intending to propose business or make nominations at an annual meeting or special meeting pursuant to this Section 8 does not provide the information required under this Section 8 to the Company in accordance with the applicable timing requirements set forth in these Bylaws, or the Proposing Stockholder (or a qualified representative of the Proposing Stockholder) does not appear at the meeting to present the proposed business or nominations, such business or nominations shall not be considered, notwithstanding that proxies in respect of such business or nominations may have been received by the Company.

(g)    For purposes of this Section 8:

"Exchange Act" the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

"Public Disclosure" a disclosure made in a press release reported by the Dow Jones News Services, The Associated Press or a comparable national news service or in a document filed by the Company with the Securities and Exchange Commission pursuant to Section 13, 14 or 15(d) of the Exchange Act.

SECTION 9. Stockholder Action by Written Consent. Any stockholder of record seeking to have the stockholders authorize or take corporate action by written consent shall, by written notice to the Secretary, request the Board to fix a record date. The Board shall have the right, within ten (10) days after the date on which such a request is received, to adopt a resolution fixing the record date, which date shall be not more than ten (10) days after the date upon which the resolution fixing the record date is adopted by the Board. If no record date has been fixed by the Board, such record date shall be determined as set forth in Section 213(b) of the General Corporation Law of Delaware.

ARTICLE II. BOARD OF DIRECTORS

SECTION 1. Number. The business and affairs of the Company shall be under the direction of the Board. The number of Directors, which shall not be less than ten, shall be determined from time to time by the vote of two-thirds of the whole Board.

SECTION 2. Term. Each Director shall hold office until the next annual election of Directors and until the Director’s successor is elected and qualified.

SECTION 3. Increase of Number. In case of any increase in the number of Directors between Annual Meetings of Stockholders, each additional Director shall be elected by the vote of two-thirds of the whole Board.

SECTION 4. Resignation. A director may resign at any time by giving written notice to the Chair or the Secretary. The acceptance thereof shall not be necessary to make it effective; and such resignation shall take effect at the time specified therein or, in the absence of such specification, it shall take effect upon the receipt thereof.

SECTION 5. Vacancies. In case of any vacancy in the Board for any cause, the remaining Directors, by vote of majority of the whole board, may elect a successor to hold office for the unexpired term of the Director whose place is vacant.

SECTION 6. Regular Meetings. Regular meetings of the Board shall be held at such times as the Board may designate. A notice of each regular meeting shall not be required.

SECTION 7. Special Meetings. Special meetings of the Board shall be held whenever called by the direction of the Chair, Lead Director or a majority of the Directors.

The Secretary shall give notice of such special meetings by mailing the same at least two days before the meeting, or by telegraphing the same at least one day before the meeting to each Director; but such notice may be waived by any Director. Unless otherwise indicated in the notice thereof, any and all business may be transacted at a special meeting. At any meeting at which every Director shall be present, any business may be transacted, irrespective of notice.

SECTION 8. Quorum. One-third of the Board shall constitute a quorum. If there be less than a quorum present at any meeting, a majority of those present may adjourn the meeting from time to time.

Except as otherwise provided by law, the Certificate of Incorporation, or by these Bylaws, the affirmative vote of a majority of the Directors present at any meeting at which there is quorum shall be necessary for the passage of any resolution.

SECTION 9. Place of Meeting, Etc. The Directors shall hold the meetings, and may have an office or offices in such place or places within or outside the State of Delaware as the Board from time to time may determine.

SECTION 10. Interested Directors; Quorum

1) No contract or other transaction between the Company and one or more of its Directors, or between the Company and any other corporation, partnership, association, or other organization in which one or more of the Directors of the Company is a Director or officer, or has a financial interest, shall be void or voidable, because the Director is present at or participates in the meeting of the Board or committee thereof which authorizes the contract or transaction, or solely because such Director’s vote is counted for such purpose, if:

a) the material facts as to such Director’s relationship or interest and as to the contract or transaction are disclosed or are known to the Board or the committee, and the Board or committee in good faith authorizes the contract or transaction by the affirmative votes of a majority of the disinterested Directors, even though the disinterested Directors be less than a quorum; or

b) the material facts as to such Director’s relationship or interest and as to the contract or transaction are disclosed or are known to the stockholders entitled to vote thereon, and the contract or transaction is specifically approved in good faith by vote of the stockholders; or

c) the contract or transaction is fair as to the Company as of the time it is authorized, approved or ratified, by the Board, a committee thereof, or the stockholders; and

2) Common or interested Directors may be counted in determining the presence of a quorum at a meeting of the Board or of a committee which authorizes the contract or transaction.

ARTICLE III.

COMMITTEES OF THE BOARD

SECTION 1. Committees. The Board shall by the affirmative vote of a majority of the whole Board, elect from the Directors an Audit Committee, an Environmental Policy Committee, a Compensation Committee, a Corporate Governance Committee and a Science and Technology Committee, and may, by resolution passed by a majority of the whole Board, designate one or more additional committees, each committee to consist of one or more Directors. The Board shall designate for each of these committees a Chairman, and, if desired, a Vice Chairman, who shall continue as such during the pleasure of the Board. The number of members of each committee shall be determined from time to time by the Board.

SECTION 2. Procedure. Each Committee shall fix its own rules of procedure and shall meet where and as provided by such rules. A majority of a committee shall constitute a quorum. In the absence or disqualification of a member of any committee, the members of such committee present at any meeting, and not disqualified from voting, whether or not they constitute a quorum, may unanimously appoint another member of the Board to act at the meeting in the place of any such absent or disqualified member.

SECTION 3. Reports To The Board. Each Committee shall keep regular minutes of its proceedings and shall periodically report to the Board summaries of the Committee’s significant completed actions and such other matters as requested by the Board.

SECTION 4. Audit Committee. The Audit Committee shall employ an independent registered public accounting firm, subject to stockholder ratification at each annual meeting, review the adequacy of internal controls and the accounting principles employed in financial reporting, and shall have such power and perform such duties as may be assigned to it from time to time by the Board. None of the Members of the Audit Committee shall be an officer or employee of the Company or its subsidiaries.

SECTION 5. Environmental Policy Committee. The Environmental Policy Committee shall review the Company’s environmental policies and practices and shall have such powers and perform such duties as may be assigned to it from time to time by the Board.

SECTION 6. Compensation Committee. The Compensation Committee shall have the power and authority vested in it by the Compensation Plans of the Company and shall have such powers and perform such duties as may be assigned to it from time to time by the Board. None of the members of the Compensation Committee shall be an officer or employee of the Company or its subsidiaries.

SECTION 7. Corporate Governance Committee. The Corporate Governance Committee shall recommend to the Board nominees for election as directors of the Company. The Committee shall also have responsibility for reviewing and making recommendations to the Board related to matters on corporate governance and shall have such powers and perform such duties as may be assigned to it from time to time by the Board. None of the members of the Corporate Governance Committee shall be an officer or employee of the Company or its subsidiaries.

SECTION 8. Science and Technology Committee. The Science and Technology Committee shall monitor the state of science and technology capabilities within the Company and oversee the development of key technologies essential to the long-term success of the Company. The Committee    shall also review the evolution of science and technology external to the Company for potential application within the Company.

ARTICLE lV. OFFICERS

SECTION 1. Officers. The Board shall appoint at least the following officers of the Company: a Chair of the Board, a Chief Executive Officer, one or more Executive Vice Presidents, a Chief Financial Officer, a Treasurer and a Secretary.

The Board and the Chief Executive Officer, may appoint such other officers as they deem necessary, who shall have such authority and shall perform such duties as may be prescribed, respectively, by the Board or the Chief Executive Officer.

SECTION 2. Chair of the Board. The Chair of the Board shall preside at all meetings of the stockholders and of the Board. The Chair may sign and execute all authorized bonds, contracts or other obligations, in the name of the Company, and with the Treasurer may sign all certificates of the shares in the capital stock of the Company.

SECTION 3. Chief Executive Officer. The office of Chief Executive Officer will normally be vested in the Chair, provided however, that the office of Chief Executive Officer may be established independent of the Chair at the discretion of the Board. The Chief Executive Officer, subject to the Board, shall have general charge of the business and affairs of the Company.

SECTION 4. Executive Vice Presidents. Each Executive Vice President shall have such powers and perform such duties as may be assigned to such Executive Vice President by the Board or the Chief Executive Officer.

SECTION 5. Vice Presidents. The Board or the Chief Executive Officer may appoint one or more Vice Presidents. Each Vice President shall have such title, powers and duties as may be assigned to such Vice President by the Board or the Chief Executive Officer.

SECTION 6. Chief Financial Officer. The Chief Financial Officer shall be the principal financial officer of the Company and shall have such powers and perform such duties as may be assigned to such Chief Financial Officer by the Board or the Chief Executive Officer.

SECTION 7. Treasurer. Under the general direction of the Chief Financial Officer, the Treasurer shall have such powers and perform such duties as may be assigned to such Treasurer by the Board or the Chief Executive Officer.

SECTION 8. Assistant Treasurer. The Board or the Chief Executive Officer may appoint one or more Assistant Treasurers. Each Assistant Treasurer shall have such powers and shall perform such duties as may be assigned to such Assistant Treasurer by the Board or the Chief Executive Officer.

SECTION 9. Controller. The Board may appoint a Controller. Under the general direction of the Chief Financial Officer, the Controller shall have such powers and perform such duties as may be assigned to such Controller by the Board or the Chief Executive Officer.

SECTION 10. Assistant Controller. The Board or the Chief Executive Officer may appoint one or more Assistant Controllers. Each Assistant Controller shall have such powers and shall perform such duties as may be assigned to such Assistant Controller by the Board or the Chief Executive Officer.

SECTION 11. Secretary. The Secretary shall keep the minutes of all the meetings of the Board and the minutes of all the meetings of the stockholders; the Secretary shall attend to the giving and serving of all notices of meetings as required by law or these Bylaws; the Secretary shall affix the seal of the Company to any instruments when so required; and the Secretary shall in general perform all the corporate duties incident to the office of Secretary, subject to the control of the Board or the Chair, and such other duties as may be assigned to the Secretary by the Board or the Chair.

SECTION 12. Assistant Secretary. The Board or the Chief Executive Officer may appoint one or more Assistant Secretaries. Each Assistant Secretary shall have such powers and shall perform such duties as may be assigned to such Assistant Secretary by the Board or the Chair; and such Assistant Secretary shall affix the seal of the Company to any instruments when so required.

SECTION 13. Removal. All officers may be removed or suspended at any time by the vote of the majority of the whole Board. All officers, agents and employees, other than officers elected or appointed by the Board, may be suspended or removed by the committee or by the officer appointing them.

SECTION 14. Resignation. Any officer may resign at any time by giving written notice to the Chair or the Secretary. Unless otherwise stated in such notice of resignation, the acceptance thereof shall not be necessary to make it effective; and such resignation shall take effect at the time specified therein or, in the absence of such specification, it shall take effect upon the receipt thereof.

SECTION 15. Vacancies. A vacancy in any office shall be filled in the same manner as provided for election or appointment to such office.

ARTICLE V.

MISCELLANEOUS

SECTION 1. Indemnification of Directors or Officers. Each person who is or was a Director or officer of the Company (including the heirs, executors, administrators or estate of such person) shall be indemnified by the Company as of right to the full extent permitted by the General Corporation Law of Delaware against any liability, cost or expense asserted against such Director or officer and incurred by such Director or officer by reason of the fact that such person is or was a Director or officer. The right to indemnification conferred by this Section shall include the right to be paid by the Company the expenses incurred in defending in any action, suit or proceeding in advance of its final disposition, subject to the receipt by the Company of such undertakings as might be required of an indemnitee by the General Corporation Law of Delaware.

In any action by an indemnitee to enforce a right to indemnification hereunder or by the Company to recover advances made hereunder, the burden of proving that the indemnitee is not entitled to be indemnified shall be on the Company. In such an action, neither the failure of the Company (including its Board, independent legal counsel or stockholders) to have made a determination that indemnification is proper, nor a determination by the Company that indemnification is improper, shall create a presumption that the indemnitee is not entitled to be indemnified or, in the case of such an action brought by the indemnitee, be a defense thereto. If successful in whole or in part in such an action, an indemnitee shall be entitled to be paid also the expense of prosecuting or defending same. The Company may, but shall not be obligated to, maintain insurance at its expense, to protect itself and any such person against any such liability, cost or expense.

SECTION 2. Certificate for Shares. The shares of the capital stock of the Company shall be represented by certificates unless the Company provides by appropriate action that some or all of any or all classes or series of the Company’s stock shall be uncertificated. Notwithstanding the Company’s taking such action, to the extent required by law, every holder of stock represented by certificates and, upon request, every holder of uncertificated shares, shall be entitled to a certificate representing the number of shares in the Company owned by such stockholder in such form, not inconsistent with the Certificate of Incorporation, as shall be prescribed by the Board. Certificates representing shares of the capital stock of the Company shall be signed by the Chair or an Executive Vice President and the Treasurer, Secretary or an Assistant Secretary. Any or all signatures on the certificate, including those of the Transfer Agent and Registrar, may be facsimile.

The name of the person owning the shares represented thereby, with the number of such shares and the date of issue, shall be entered on the Company’s books.

All certificates surrendered to the Company shall be cancelled, and no new certificates shall be issued until the former certificate for the same number of shares of the same class shall have been surrendered and cancelled, except that the Board may determine, from time to time, the conditions and provisions on which new certificates may be used in substitution of any certificates that may have been lost, stolen or destroyed.

SECTION 3. Transfer of Shares. Shares in the capital stock of the Company shall be transferred by the record holder thereof, in person, or by any such person’s attorney upon surrender and cancellation of certificates for a like number of shares.

SECTION 4. Regulations. The Board also may make rules and regulations concerning the issue, transfer and registration of certificates for shares of the capital stock of the Company.

The Board may appoint one or more transfer agents and one or more registrars of transfers, and may require all stock certificates to bear the signature of a transfer agent and a registrar of transfer.

SECTION 5. Record Date of Stockholders. The Board may fix in advance a date, not exceeding sixty days preceding the date of any meeting of stockholders, or the date for the payment of any dividend or other distribution, or the date for the allotment of rights, or the date when any change or conversion or exchange of capital stock shall go into effect, as a record date for the determination of the stockholders entitled to notice of, and to vote at, any such meeting, or entitled to receive payment of any such dividend or other distribution,

or to any such allotment of rights, or to exercise the rights in respect of any such change, conversion or exchange of capital stock, and in such case only such stockholders as shall be stockholders of record on the date so fixed shall be entitled to such notice of, and to vote at, such meeting, or to receive any such dividend or other distribution, or to receive such allotment of rights, or to exercise such rights, as the case may be, notwithstanding any transfer of any stock on the books of the Company after such record date fixed as aforesaid.

SECTION 6. Corporate Seal. The seal of the Company shall be circular in form, containing the words “E. I. DU PONT DE NEMOURS AND CO.” and “DELAWARE” on the circumference, surrounding the words “FOUNDED” and “SEAL,” and the date “1802.”

The seal shall be in the custody of the Secretary. A duplicate of the seal may be kept and used by the Chief Financial Officer, any Vice President – DuPont Finance, the Treasurer, or by any Assistant Secretary or Assistant Treasurer.

SECTION 7. Forum for Adjudication of Certain Disputes. Unless the Company consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Company’s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the General Corporation Law of Delaware, or (iv) any action asserting a claim governed by the internal affairs doctrine. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Company shall be deemed to have notice of and consented to the provisions of this Section 7 of Article VI. Failure to enforce the foregoing provisions would cause the Company irreparable harm and the Company shall be entitled to equitable relief, including injunction and specific performance, to enforce the foregoing provisions.

ARTICLE VI.

AMENDMENTS

The Board shall have the power to adopt, amend and repeal the Bylaws of the Company, by a vote of the majority of the whole Board, at any regular or special meeting of the Board, provided that notice of intention to adopt, amend or repeal the Bylaws in whole or in part shall have been given at the next preceding meeting, or, without any such notice, by the vote of two-thirds of the whole Board.

EX-12

Exhibit 12

E.  I.  DU  PONT  DE  NEMOURS  AND  COMPANY

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(Dollars in millions)

	Nine Months Ended September 30,
	2015			2014
Income from continuing operations before income taxes	$	3,012		$	3,489
Adjustment for companies accounted for by the    equity method	6			60
Less: Capitalized interest	(55		)	(36		)
Add: Amortization of capitalized interest	25			27
	2,988			3,540
Fixed charges:
Interest and debt expense	292			290
Capitalized interest	55			36
Rental expense representative of interest factor	62			60
	409			386
Total adjusted earnings available for payment of     fixed charges	$	3,397		$	3,926
Number of times fixed charges earned	8.3			10.2

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Edward D. Breen, certify that:

1. I have reviewed this report on Form 10-Q for the period ended September 30, 2015 of E. I. du Pont de Nemours and Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	October 27, 2015
By:	/s/ Edward D. Breen
	Edward D. Breen
	Interim Chair of the Board and
	Interim Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Nicholas C. Fanandakis, certify that:

1. I have reviewed this report on Form 10-Q for the period ended September 30, 2015 of E. I. du Pont de Nemours and Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	October 27, 2015
By:	/s/ Nicholas C. Fanandakis
	Nicholas C. Fanandakis
	Executive Vice President and
	Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of CEO Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of E. I. du Pont de Nemours and Company (the “Company”) on Form 10-Q for the period ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Edward D. Breen, as Interim Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Edward D. Breen

Edward D. Breen

Interim Chief Executive Officer

October 27, 2015

EX-32.2

Exhibit 32.2

Certification of CFO Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of E. I. du Pont de Nemours and Company (the “Company”) on Form 10-Q for the period ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Nicholas C. Fanandakis, as Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Nicholas C. Fanandakis

Nicholas C. Fanandakis

Chief Financial Officer

October 27, 2015

XML

Employee Separation / Asset Related Charges, Net (2014 Restructuring Program schedule) (Details) - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, accrual adjustment		$ (2)
Restructuring charges			$ 187
2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve		139		$ 268
Restructuring reserve, payments		(118)
Restructuring reserve, net translation adjustment		(9)
Restructuring reserve, other accrual adjustment		(2)
Restructuring charges			244
Employee Severance [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve		136		264
Restructuring reserve, payments		(117)
Restructuring reserve, net translation adjustment		(9)
Restructuring reserve, other accrual adjustment		(2)
Restructuring charges			150
Other Non-Personnel Charges [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	[1]	3		$ 4
Restructuring reserve, payments	[1]	(1)
Restructuring reserve, net translation adjustment	[1]	0
Restructuring reserve, other accrual adjustment	[1]	0
Restructuring charges	[1]		3
Asset Shut Down Charges [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges			91
Agriculture [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, accrual adjustment		(4)
Restructuring charges			47
Electronics & Communications [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, accrual adjustment		11
Restructuring charges			68
Industrial Biosciences [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, accrual adjustment		(1)
Restructuring charges			2
Nutrition & Health [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, accrual adjustment		(4)
Restructuring charges			8
Performance Materials [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, accrual adjustment		(2)
Restructuring charges			29
Safety & Protection [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, accrual adjustment		1
Restructuring charges			31
Other Segment [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, accrual adjustment		$ (3)
Restructuring charges			2
Corporate Expenses [Member] | 2014 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges			$ 57

[1] Other non-personnel charges consist of contractual obligation costs.

XML

Stockholders' Equity (Noncontrolling Interest) (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 215	$ 58
Performance Materials [Member]
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 157

XML

Long-Term Borrowings (Narrative) (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	May. 31, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Jun. 30, 2015	May. 12, 2015
Debt Instrument [Line Items]
Dividend received from Chemours	$ 3,923
Cash distribution received from Chemours	$ 3,416
Separation related transaction costs		$ 68	$ 61	$ 289	$ 112
Senior notes due 2016 [Member]
Debt Instrument [Line Items]
Senior notes						$ 488
1.95% notes due 2016 [Member]
Debt Instrument [Line Items]
Senior notes						$ 152
Debt instrument, interest rate, stated percentage						1.95%
2.75% notes due 2016 [Member]
Debt Instrument [Line Items]
Senior notes						$ 277
Debt instrument, interest rate, stated percentage						2.75%
5.25% notes due 2016 [Member]
Debt Instrument [Line Items]
Senior notes						$ 59
Debt instrument, interest rate, stated percentage						5.25%
Chemours Notes Received [Member] | 7% notes due 2025 [Member]
Debt Instrument [Line Items]
Senior notes							$ 507
Debt instrument, interest rate, stated percentage							7.00%
Loss on extinguishment of debt [Member]
Debt Instrument [Line Items]
Separation related transaction costs				$ 20

XML

Stockholders' Equity (Schedule of Other Comprehensive Income) (Details) - USD ($) $ in Millions		3 Months Ended			9 Months Ended
		Sep. 30, 2015		Sep. 30, 2014	Sep. 30, 2015		Sep. 30, 2014
Components of Other Comprehensive Income (Loss) [Line Items]
Cumulative translation adjustment, pre-tax		$ (125)		$ (428)	$ (1,405)	[1]	$ (559)	[1]
Cumulative translation adjustment, tax		0		0	0		0
Cumulative translation adjustment, after-tax		(125)		(428)	(1,405)	[1]	(559)	[1]
Additions and revaluations of derivatives designated as cash flow hedges, pre-tax	[2]	(22)		(3)	(36)		23
Additions and revaluations of derivatives designated as cash flow hedges, tax		9		2	12		(8)
Additions and revaluations of derivatives designated as cash flow hedges, after-tax		(13)		(1)	(24)		15
Clearance of hedge results to earnings, pre-tax		0		(2)	12		29
Net revaluation and clearance of cash flow hedges to earnings, pre-tax		(22)		(5)	(24)		52
Net revaluation and clearance of cash flow hedges to earnings, tax		9		3	7		(19)
Net revaluation and clearance of cash flow hedges to earnings, after-tax		(13)		(2)	(17)		33
Other comprehensive income (loss), before tax		380		(307)	(511)		(255)
Income tax expense related to items of other comprehensive income		(176)		(28)	(312)		(92)
Other comprehensive income (loss), net of tax		204		(335)	(823)		(347)
Net sales [Member] | Foreign Currency Contract [Member]
Components of Other Comprehensive Income (Loss) [Line Items]
Clearance of hedge results to earnings, pre-tax		0		(2)	(10)		0
Clearance of hedge results to earnings, tax		0		1	4		0
Clearance of hedge results to earnings, after-tax		0		(1)	(6)		0
Cost of goods sold [Member] | Commodity Contract [Member]
Components of Other Comprehensive Income (Loss) [Line Items]
Clearance of hedge results to earnings, pre-tax					22		29
Clearance of hedge results to earnings, tax					(9)		(11)
Clearance of hedge results to earnings, after-tax					13		18
Pension Plans [Member]
Components of Other Comprehensive Income (Loss) [Line Items]
Net gain (loss), pre-tax	[2]	634	[3]	(5)	628	[3]	(107)
Net gain (loss), tax		(228)		1	(226)		34
Net gain (loss), after-tax		406		(4)	402		(73)
Prior service benefit (cost)	[2]	0		(1)	0		(1)
Prior service benefit (cost), tax		0		0	0		0
Prior service benefit (cost), after tax		0		(1)	0		(1)
Effect of foreign exchange rates, pre-tax	[2]	54		0	92		0
Effect of foreign exchange rates, tax		(16)		0	(25)		0
Effect of foreign exchange rates, after-tax		38		0	67		0
Amortization of prior service (benefit) cost, pre-tax	[4]	(3)		1	(6)		2
Amortization of prior service (benefit) cost, tax		1		0	2		0
Amortization of prior service (benefit) cost, after tax		(2)		1	(4)		2
Amortization of loss, pre-tax	[4]	172		151	591		450
Amortization of loss, tax		(61)		(52)	(210)		(155)
Amortization of loss, after tax		111		99	381		295
Curtailment (gain) loss, pre-tax	[4]	(7)		0	(7)		4
Curtailment (gain) loss, tax		3		0	3		(1)
Curtailment (gain) loss, after-tax		(4)		0	(4)		3
Settlement loss, pre-tax	[4]	44		2	53		4
Settlement loss, tax		(16)		(1)	(19)		(1)
Settlement loss, after tax		28		1	34		3
Benefit plans, net, pre-tax		894		148	1,351		352
Benefit plans, net, tax		(317)		(52)	(475)		(123)
Benefit plans, net, after-tax		577		96	876		229
Other Long-Term Employee Benefit Plans [Member]
Components of Other Comprehensive Income (Loss) [Line Items]
Net gain (loss), pre-tax	[2]	(73)	[3]	(33)	(73)	[3]	(33)
Net gain (loss), tax		27		10	27		10
Net gain (loss), after-tax		(46)		(23)	(46)		(23)
Prior service benefit (cost)	[2]	0		50	0		50
Prior service benefit (cost), tax		0		(1)	0		(1)
Prior service benefit (cost), after tax		0		49	0		49
Effect of foreign exchange rates, pre-tax	[2]	(1)		0	(1)		0
Effect of foreign exchange rates, tax		1		0	1		0
Effect of foreign exchange rates, after-tax		0		0	0		0
Amortization of prior service (benefit) cost, pre-tax	[4]	(39)		(54)	(143)		(160)
Amortization of prior service (benefit) cost, tax		13		18	50		56
Amortization of prior service (benefit) cost, after tax		(26)		(36)	(93)		(104)
Amortization of loss, pre-tax	[4]	20		15	58		43
Amortization of loss, tax		(7)		(6)	(20)		(15)
Amortization of loss, after tax		13		9	38		28
Curtailment (gain) loss, pre-tax	[4]	(274)		0	(274)		0
Curtailment (gain) loss, tax		98		0	98		0
Curtailment (gain) loss, after-tax		(176)		0	(176)		0
Benefit plans, net, pre-tax		(367)		(22)	(433)		(100)
Benefit plans, net, tax		132		21	156		50
Benefit plans, net, after-tax		$ (235)		$ (1)	$ (277)		$ (50)

[1] The increase in currency translation adjustment losses over prior year for the nine months ended September 30, 2015 is driven by the strengthening USD against primarily the Euro and Brazilian real. The change in both periods is also due to changes in certain foreign entity's functional currency as described in Note 1.

[2] These amounts represent changes in accumulated other comprehensive loss excluding changes due to reclassifying amounts to the interim Consolidated Income Statements.

[3] See Note 13 for discussion of the re-measurement of the principal U.S. pension plan and other long-term employee benefit plans as a result of the Performance Chemicals separation.

[4] These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other long-term employee benefit plans. See Note 13 for additional information.

XML

Other Intangible Assets (Schedule of Other Intangible Assets) (Details) - USD ($) $ in Millions		Sep. 30, 2015	Dec. 31, 2014
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Definite-lived Intangible Assets, Gross		$ 3,439	$ 4,184
Definite-lived Intangible Assets, Accumulated Amortization		(1,414)	(1,814)
Definite-lived Intangible Assets, Net		2,025	2,370
Indefinite-lived Intangible Assets		2,189	2,199
Total Intangible Assets, Gross		5,628	6,383
Total Intangible Assets, Accumulated Amortization		(1,414)	(1,814)
Intangible Assets Net Excluding Goodwill		4,214	4,569
In Process Research and Development [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets		77	29
Microbial Cell Factories [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets		306	306
Pioneer Germplasm [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets		1,050	1,064
Trademarks/Tradenames [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets		756	800
Customer Lists [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Definite-lived Intangible Assets, Gross		1,639	1,699
Definite-lived Intangible Assets, Accumulated Amortization		(514)	(465)
Definite-lived Intangible Assets, Net		1,125	1,234
Patents [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Definite-lived Intangible Assets, Gross		457	474
Definite-lived Intangible Assets, Accumulated Amortization		(211)	(184)
Definite-lived Intangible Assets, Net		246	290
Purchased and Licensed Technology [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Definite-lived Intangible Assets, Gross		1,131	1,783
Definite-lived Intangible Assets, Accumulated Amortization		(604)	(1,069)
Definite-lived Intangible Assets, Net		527	714
Trademarks [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Definite-lived Intangible Assets, Gross		26	26
Definite-lived Intangible Assets, Accumulated Amortization		(13)	(12)
Definite-lived Intangible Assets, Net		13	14
Other [Member]
Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]
Definite-lived Intangible Assets, Gross	[1]	186	202
Definite-lived Intangible Assets, Accumulated Amortization	[1]	(72)	(84)
Definite-lived Intangible Assets, Net	[1]	$ 114	$ 118

[1] Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.

XML

Summary of Significant Accounting Policies Basis of Presentation (Details) $ in Millions	Jan. 01, 2013 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated other comprehensive loss revision for CTA	$ 97
Revision impact	$ 151

XML

Financial Instruments (Cash Equivalents) (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014
Fair Value, Inputs, Level 1 [Member]
Fair value of cash equivalents	$ 0	$ 1,436
Fair Value, Inputs, Level 2 [Member]
Fair value of cash equivalents	$ 1,680	$ 3,293

XML

Earnings Per Share of Common Stock (Tables)

9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Earnings Per Share of Common Stock Reconciliation Table

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Numerator:
Income from continuing operations after income taxes attributable to DuPont	$	131		$	330		$	2,117		$	2,558
Preferred dividends	(2		)	(2		)	(7		)	(7		)
Income from continuing operations after income taxes available to DuPont common stockholders	$	129		$	328		$	2,110		$	2,551
Income from discontinued operations after income taxes available to DuPont common stockholders	$	104		$	103		$	89		$	384
Net income available to common stockholders	$	233		$	431		$	2,199		$	2,935
Denominator:
Weighted-average number of common shares outstanding - Basic	887,275,000			910,764,000			899,883,000			917,589,000
Dilutive effect of the company’s employee compensation plans	4,011,000			6,997,000			5,639,000			7,057,000
Weighted-average number of common shares outstanding - Diluted	891,286,000			917,761,000			905,522,000			924,646,000

Average Number of Antidilutive Stock Options

	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2015	2014	2015	2014
Average number of stock options	8,510,000	7,000	4,622,000	4,000

XML

Commitments and Contingent Liabilities (Imprelis) (Narrative) (Details) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2015 USD ($) actions	Sep. 30, 2015 USD ($) actions	Dec. 31, 2013 USD ($)
Product Claims [Line Items]
Insurance program limits	$ 50	$ 50
Imprelis [Member]
Product Claims [Line Items]
Plaintiffs' attorney fees to pay per proposed settlement			$ 7
Claims filed and pending | actions	30	30
Loss Contingency, number of claims settled		10
Insurance recoveries for litigation	$ 150	$ 185
Accrual balance	$ 198	$ 198

XML

Provision for Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015		Sep. 30, 2014
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Provision for income taxes on continuing operations	$ 96	$ 303	$ 886		$ 921
Tax (benefit) expense associated with the company's policy of hedging the foreign currency-denominated monetary assets and liabilities	(4)	258	176		233
Net exchange (losses) gains	(36)	250	54	[1]	44	[1]
Tax benefit associated with a foreign tax court decision	(17)
Minimum [Member]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Range estimate of reasonably possible net reduction in unrecognized tax benefits	225		225
Maximum [Member]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Range estimate of reasonably possible net reduction in unrecognized tax benefits	250		250
Provision for income taxes [Member]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Net exchange (losses) gains	$ (36)	$ 250	$ 54		$ 44

[1] Included a charge of $(40) associated with remeasuring the company's Ukrainian hryvnia net monetary assets in the nine months ended September 30, 2015, as well as a charge of $(58) associated with remeasuring the company's Venezuelan net monetary assets from the official exchange rate to the SICAD II exchange system in the nine months ended September 30, 2014, which were recorded in other income, net in the company's interim Consolidated Income Statements. See Note 4 for additional information.

XML

Divestitures and Other Transactions Divestitures and Other Transactions (Schedule of assets and liabilities of discontinued operation) (Details) - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total assets of discontinued operations	$ 0	$ 6,227
Total liabilities of discontinued operations	$ 0	2,467
Performance Chemicals [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Accounts and notes receivable, net		887
Inventories		1,054
Prepaid expenses		15
Deferred income taxes - current		53
Property, plant and equipment, net of accumulated depreciation		3,378
Goodwill		197
Other intangible assets		11
Investment in affiliates		124
Deferred income taxes - noncurrent		42
Other assets - noncurrent		466
Total assets of discontinued operations		6,227
Accounts payable		1,036
Income taxes		9
Other accrued liabilities		373
Other liabilities - noncurrent		616
Deferred income taxes - noncurrent		433
Total liabilities of discontinued operations		$ 2,467

XML

Commitments and Contingent Liabilities Commitments and Contingent Liabilities (Environmental) (Narrative) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2015 USD ($) yr
Environmental Remediation [Line Items]
Accrual for environmental remediation activities	$ 505
Potential environmental liability in excess of accrued amount	$ 1,100
Minimum [Member]
Environmental Remediation [Line Items]
Average time frame of disbursements of environmental site remediation | yr	15
Maximum [Member]
Environmental Remediation [Line Items]
Average time frame of disbursements of environmental site remediation | yr	20
Chemours [Member]
Environmental Remediation [Line Items]
Accrual for environmental remediation activities	$ 299
Potential environmental liability in excess of accrued amount	630
Indemnification assets	$ 299

XML

Segment Information (Reconciliation to Consolidated Income Statements) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015		Sep. 30, 2014
Segment Information
Total segment PTOI		$ 580	$ 686	$ 3,945		$ 4,448
Non operating pension and other post retirement employee benefit costs		(115)	(32)	(288)		(96)
Net exchange (losses) gains		(36)	250	54	[1]	44	[1]
Corporate expenses	[2]	(120)	(177)	(439)		(617)
Interest expense		(82)	(93)	(260)	[3]	(290)
Income from continuing operations before income taxes		227	634	3,012		3,489
Separation related transaction costs		(68)	(61)	(289)		(112)
Corporate Expenses [Member]
Segment Information
Separation related transaction costs		$ (9)	$ (10)	(26)		(17)
Corporate Expenses [Member] | Loss on extinguishment of debt [Member]
Segment Information
Separation related transaction costs				(20)
Foreign currency loss due to devaluation of Ukrainian hryvnia [Member]
Segment Information
Net exchange (losses) gains				$ (40)
Foreign currency loss due to devaluation of Venezuelan Bolivar [Member]
Segment Information
Net exchange (losses) gains						$ (58)

[1] Included a charge of $(40) associated with remeasuring the company's Ukrainian hryvnia net monetary assets in the nine months ended September 30, 2015, as well as a charge of $(58) associated with remeasuring the company's Venezuelan net monetary assets from the official exchange rate to the SICAD II exchange system in the nine months ended September 30, 2014, which were recorded in other income, net in the company's interim Consolidated Income Statements. See Note 4 for additional information.

[2] Included transaction costs associated with the separation of the Performance Chemicals segment of $(9) and $(10) in the three months ended September 30, 2015 and 2014, respectively, and $(26) and $(17) in the nine months ended September 30, 2015 and 2014, respectively, which were recorded in other operating charges in the company's interim Consolidated Income Statements.

[3] Included transaction costs of $(20) in the nine months ended September 30, 2015, associated with the early retirement of debt exchanged for the notes received from Chemours in May 2015.

XML

Financial Instruments (Effect of Cash Flows Hedges on Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Derivative [Line Items]
Portion of ending balance of gain (loss) expected to be reclassified into earnings over the next twelve months, after-tax	$ (9)
Cash Flow Hedging [Member]
Derivative [Line Items]
Beginning balance, after-tax	(10)	$ (13)	$ (6)	$ (48)
Additions and revaluations of derivatives designated as cash flow hedges, after-tax	(13)	(1)	(24)	15
Clearance of hedge results to earnings, after-tax	0	(1)	7	18
Ending balance, after-tax	$ (23)	$ (15)	$ (23)	$ (15)

XML

Other Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Other Intangible Assets
Aggregate pre-tax amortization expense			$ 307	$ 294
Continuing Operations [Member]
Other Intangible Assets
Aggregate pre-tax amortization expense	$ 50	$ 48	305	$ 292
Pre-tax amortization expense, 2015	51		51
Pre-tax amortization expense, 2016	352		352
Pre-tax amortization expense, 2017	217		217
Pre-tax amortization expense, 2018	218		218
Pre-tax amortization expense, 2019	205		205
Pre-tax amortization expense, 2020	$ 188		$ 188

XML

Employee Separation / Asset Related Charges, Net

9 Months Ended

Sep. 30, 2015

Restructuring Charges [Abstract]

Employee Separation / Asset Related Charges, Net

Employee Separation / Asset Related Charges, Net

2014 Restructuring Program

At September 30, 2015, total liabilities related to the 2014 restructuring program were $139. A complete discussion of restructuring initiatives is included in the company's 2014 Annual Report in Note 3, "Employee Separation / Asset Related Charges, Net."

Account balances and activity related to the 2014 restructuring program are summarized below:

	Employee Separation Costs			Other Non-Personnel Charges 1			Total
Balance at December 31, 2014	$	264		$	4		$	268
Payments	(117		)	(1		)	(118		)
Net translation adjustment	(9		)	—			(9		)
Other adjustments	(2		)	—			(2		)
Balance as of September 30, 2015	$	136		$	3		$	139

¹  Other non-personnel charges consist of contractual obligation costs.

During the nine months ended September 30, 2015, the company recorded adjustments to the estimated costs associated with the 2014 restructuring program in employee separation / asset related charges, net in the company's interim Consolidated Income Statements. This was primarily due to the identification of additional projects in certain segments, offset by lower than estimated individual severance costs and workforce reductions achieved through non-severance programs. The adjustments impacted segment results for the nine months ended September 30, 2015 as follows: Agriculture - $(4), Electronics & Communications - $11, Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Materials - $(2), Safety & Protection $1, and Other - $(3).

During the nine months ended September 30, 2014, a pre-tax charge of $244 was recorded in employee separation / asset related charges, net in the company's interim Consolidated Income Statements. The charge consisted of $150 employee separation costs, $3 of other non-personnel charges and $91 of asset shut down costs. The charge impacted segment results for year-to-date 2014 as follows: Agriculture - $47, Electronics & Communications - $68, Industrial Biosciences - $2, Nutrition & Health - $8, Performance Materials - $29 Safety & Protection - $31, Other - $2, as well as Corporate expenses - $57.

Cost Basis Investment Impairment

During the first quarter 2015, a $38 pre-tax impairment charge was recorded in employee separation / asset related charges, net within the Other segment. The majority relates to a cost basis investment in which the assessment resulted from the venture's revised operating plan reflecting underperformance of its European wheat based ethanol facility and deteriorating European ethanol market conditions. One of the primary investors communicated that they would not fund the revised operating plan of the investee. As a result, the carrying value of DuPont's 6 percent cost basis investment in this venture exceeds its fair value by $37, such that an impairment charge was recorded.

XML

Financial Instruments (Schedule of the Fair Value of Derivative Instruments) (Details) - USD ($) $ in Millions		Sep. 30, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets and liabilities subject to master netting arrangement		$ 51	$ 67
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset derivatives	[1]	132	265
Liability derivatives	[1]	64	73
Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset derivatives		0	11
Not Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability derivatives		64	63
Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash collateral		0	6
Foreign Currency Contract [Member] | Not Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash collateral		20	41
Accounts and Notes Receivable [Member] | Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset derivatives	[2]	0	1
Accounts and Notes Receivable [Member] | Foreign Currency Contract [Member] | Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset derivatives		0	10
Accounts and Notes Receivable [Member] | Foreign Currency Contract [Member] | Not Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset derivatives	[3]	132	254
Other accrued liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash collateral	[2],[3]	20	47
Other accrued liabilities [Member] | Foreign Currency Contract [Member] | Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability derivatives		0	10
Other accrued liabilities [Member] | Foreign Currency Contract [Member] | Not Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability derivatives		63	62
Other accrued liabilities [Member] | Commodity Contract [Member] | Not Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability derivatives		$ 1	$ 1

[1] The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $51 at September 30, 2015 and $67 at December 31, 2014.

[2] Cash collateral held as of September 30, 2015 and December 31, 2014 represents $0 and $6, respectively, related to interest rate swap derivatives designated as hedging instruments.

[3] Cash collateral held as of September 30, 2015 and December 31, 2014 represents $20 and $41, respectively, related to foreign currency derivatives not designated as hedging instruments.

XML

Earnings Per Share of Common Stock (Earnings Per Share of Common Stock Reconciliation) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Earnings Per Share [Abstract]
Income from continuing operations after income taxes attributable to DuPont	$ 131	$ 330	$ 2,117	$ 2,558
Preferred dividends	(2)	(2)	(7)	(7)
Income from continuing operations after income taxes available to DuPont common stockholders	129	328	2,110	2,551
Income from discontinued operations after income taxes available to DuPont common stockholders	104	103	89	384
Net income available to common stockholders	$ 233	$ 431	$ 2,199	$ 2,935
Weighted-average number of common shares outstanding - Basic	887,275,000	910,764,000	899,883,000	917,589,000
Dilutive effect of the company's employee compensation plans	4,011,000	6,997,000	5,639,000	7,057,000
Weighted average number of common shares outstanding - Diluted	891,286,000	917,761,000	905,522,000	924,646,000

XML

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2015

Stockholders' Equity Note [Abstract]

Schedule of Comprehensive Income (Loss)

	Three Months Ended									Three Months Ended									Affected Line Item in Consolidated Income Statements
	September 30, 2015									September 30, 2014
	Pre-Tax			Tax			After-Tax			Pre-Tax			Tax			After-Tax
Cumulative translation adjustment	$	(125	)	$	—		$	(125	)	$	(428	)	$	—		$	(428	)
Net revaluation and clearance of cash flow hedges to earnings:
Additions and revaluations of derivatives designated as cash flow hedges	(22		)	9			(13		)	(3		)	2			(1		)	See (1) below
Clearance of hedge results to earnings:
Foreign currency contracts	—			—			—			(2		)	1			(1		)	Net sales
Net revaluation and clearance of cash flow hedges to earnings	(22		)	9			(13		)	(5		)	3			(2		)
Pension benefit plans:
Net gain (loss)(3)	634			(228		)	406			(5		)	1			(4		)	See (1) below
Prior service cost	—			—			—			(1		)	—			(1		)	See (1) below
Effect of foreign exchange rates	54			(16		)	38			—			—			—			See (1) below
Reclassifications to net income:
Amortization of prior service (benefit) cost	(3		)	1			(2		)	1			—			1			See (2) below
Amortization of loss	172			(61		)	111			151			(52		)	99			See (2) below
Curtailment gain	(7		)	3			(4		)	—			—			—			See (2) below
Settlement loss	44			(16		)	28			2			(1		)	1			See (2) below
Pension benefit plans, net	894			(317		)	577			148			(52		)	96
Other benefit plans:
Net loss(3)	(73		)	27			(46		)	(33		)	10			(23		)	See (1) below
Prior service benefit	—			—			—			50			(1		)	49			See (1) below
Effect of foreign exchange rates	(1		)	1			—			—			—			—			See (1) below
Reclassifications to net income:
Amortization of prior service benefit	(39		)	13			(26		)	(54		)	18			(36		)	See (2) below
Amortization of loss	20			(7		)	13			15			(6		)	9			See (2) below
Curtailment gain	(274		)	98			(176		)	—			—			—			See (2) below
Other benefit plans, net	(367		)	132			(235		)	(22		)	21			(1		)
Other comprehensive income (loss)	$	380		$	(176	)	$	204		$	(307	)	$	(28	)	$	(335	)

	Nine Months Ended									Nine Months Ended									Affected Line Item in Consolidated Income Statements
	September 30, 2015									September 30, 2014
	Pre-Tax			Tax			After-Tax			Pre-Tax			Tax			After-Tax
Cumulative translation adjustment(4)	$	(1,405	)	$	—		$	(1,405	)	$	(559	)	$	—		$	(559	)
Net revaluation and clearance of cash flow hedges to earnings:
Additions and revaluations of derivatives designated as cash flow hedges	(36		)	12			(24		)	23			(8		)	15			See (1) below
Clearance of hedge results to earnings:
Foreign currency contracts	(10		)	4			(6		)	—			—			—			Net sales
Commodity contracts	22			(9		)	13			29			(11		)	18			Cost of goods sold
Net revaluation and clearance of cash flow hedges to earnings	(24		)	7			(17		)	52			(19		)	33
Pension benefit plans:
Net gain (loss)(3)	628			(226		)	402			(107		)	34			(73		)	See (1) below
Prior service cost	—			—			—			(1		)	—			(1		)	See (1) below
Effect of foreign exchange rates	92			(25		)	67			—			—			—			See (1) below
Reclassifications to net income:
Amortization of prior service (benefit) cost	(6		)	2			(4		)	2			—			2			See (2) below
Amortization of loss	591			(210		)	381			450			(155		)	295			See (2) below
Curtailment (gain) loss	(7		)	3			(4		)	4			(1		)	3			See (2) below
Settlement loss	53			(19		)	34			4			(1		)	3			See (2) below
Pension benefit plans, net	1,351			(475		)	876			352			(123		)	229
Other benefit plans:
Net loss(3)	(73		)	27			(46		)	(33		)	10			(23		)	See (1) below
Prior service benefit	—			—			—			50			(1		)	49			See (1) below
Effect of foreign exchange rates	(1		)	1			—			—			—			—			See (1) below
Reclassifications to net income:
Amortization of prior service benefit	(143		)	50			(93		)	(160		)	56			(104		)	See (2) below
Amortization of loss	58			(20		)	38			43			(15		)	28			See (2) below
Curtailment gain	(274		)	98			(176		)	—			—			—			See (2) below
Other benefit plans, net	(433		)	156			(277		)	(100		)	50			(50		)
Other comprehensive loss	$	(511	)	$	(312	)	$	(823	)	$	(255	)	$	(92	)	$	(347	)

¹  These amounts represent changes in accumulated other comprehensive loss excluding changes due to reclassifying amounts to the interim Consolidated Income Statements.

²  These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other long-term employee benefit plans. See Note 13 for additional information.

³  See Note 13 for discussion of the re-measurement of the principal U.S. pension plan and other long-term employee benefit plans as a result of the Performance Chemicals separation.

⁴  The increase in currency translation adjustment losses over prior year for the nine months ended September 30, 2015 is driven by the strengthening USD against primarily the Euro and Brazilian real.  The change in both periods is also due to changes in certain foreign entity's functional currency as described in Note 1.

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

	Cumulative Translation Adjustment			Net Revaluation and Clearance of Cash Flow Hedges to Earnings			Pension Benefit Plans			Other Benefit Plans			Unrealized Gain on Securities			Total
2015
Balance January 1, 2015	$	(919	)	$	(6	)	$	(7,895	)	$	262		$	2		$	(8,556	)
Other comprehensive (loss) income before reclassifications	(1,405		)	(24		)	469			(46		)	—			(1,006		)
Amounts reclassified from accumulated other comprehensive loss	—			7			407			(231		)	—			183
Spin-off of Chemours	191			—			278			—			(1		)	468
Balance September 30, 2015	$	(2,133	)	$	(23	)	$	(6,741	)	$	(15	)	$	1		$	(8,911	)

	Cumulative Translation Adjustment			Net Revaluation and Clearance of Cash Flow Hedges to Earnings			Pension Benefit Plans			Other Benefit Plans			Unrealized Gain on Securities		Total
2014
Balance January 1, 2014	$	(43	)	$	(48	)	$	(5,695	)	$	494		$	2	$	(5,290	)
Other comprehensive (loss) income before reclassifications	(559		)	15			(74		)	26			—		(592		)
Amounts reclassified from accumulated other comprehensive loss	—			18			302			(76		)	—		244
Balance September 30, 2014	$	(602	)	$	(15	)	$	(5,467	)	$	444		$	2	$	(5,638	)

XML

Commitments and Contingent Liabilities (Tables)

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Schedule of Guaranteed Obligations

	Short-Term		Long-Term		Total
Obligations for customers and suppliers1:
Bank borrowings (terms up to 6 years)	$	129	$	16	$	145
Leases on equipment and facilities (terms up to 3 years)	—		1		1
Obligations for equity affiliates2:
Bank borrowings (terms up to 1 year)	178		—		178
Obligations for Chemours3:
Chemours' purchase obligations (term up to 2 years)	40		11		51
Total	$	347	$	28	$	375

¹  Existing guarantees for customers and suppliers, as part of contractual agreements.

² Existing guarantees for equity affiliates' liquidity needs in normal operations.

³  Guarantee for Chemours' raw material purchase obligations under agreement with third party supplier.

XML

Stockholder's Equity (Schedule of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Components of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss, beginning balance	$ (8,556)	$ (5,290)
Other comprehensive loss before reclassifications	(1,006)	(592)
Amounts reclassified from accumulated other comprehensive loss	183	244
Spin-off of Chemours	468
Accumulated other comprehensive loss, ending balance	(8,911)	(5,638)
Cumulative Translation Adjustment [Member]
Components of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss, beginning balance	(919)	(43)
Other comprehensive loss, before reclassifications, CTA	(1,405)	(559)
Amounts reclassified from accumulated other comprehensive loss	0	0
Spin-off of Chemours	191
Accumulated other comprehensive loss, ending balance	(2,133)	(602)
Net Revaluation and Clearance of Cash Flow Hedges to Earnings
Components of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss, beginning balance	(6)	(48)
Other comprehensive (loss) income, before reclassifications, cash flow hedges	(24)	15
Amounts reclassified from accumulated other comprehensive loss, cash flow hedges	7	18
Spin-off of Chemours	0
Accumulated other comprehensive loss, ending balance	(23)	(15)
Pension Plans [Member]
Components of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss, beginning balance	(7,895)	(5,695)
Other comprehensive income (loss), before reclassifications, pension and other benefit plans	469	(74)
Amounts reclassified from accumulated other comprehensive loss, pension and other benefit plans	407	302
Spin-off of Chemours	278
Accumulated other comprehensive loss, ending balance	(6,741)	(5,467)
Other Long-Term Employee Benefit Plans [Member]
Components of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss, beginning balance	262	494
Other comprehensive income (loss), before reclassifications, pension and other benefit plans	(46)	26
Amounts reclassified from accumulated other comprehensive loss, pension and other benefit plans	(231)	(76)
Spin-off of Chemours	0
Accumulated other comprehensive loss, ending balance	(15)	444
Unrealized Gain on Securities
Components of Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss, beginning balance	2	2
Other comprehensive income (loss), before reclassifications, securities	0	0
Amounts reclassified from accumulated other comprehensive loss, securities	0	0
Spin-off of Chemours	(1)
Accumulated other comprehensive loss, ending balance	$ 1	$ 2

XML

Earnings Per Share of Common Stock Earnings Per Share of Common Stock (Schedule of Average Number of Antidilutive Stock Options) (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Average number of stock options	8,510,000	7,000	4,622,000	4,000

XML

Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2015

Financial Instruments Disclosure [Abstract]

Schedule of Notional Amounts of Outstanding Derivative Positions

	September 30, 2015		December 31, 2014
Derivatives designated as hedging instruments:
Interest rate swaps	$	—	$	1,000
Foreign currency contracts	10		434
Commodity contracts	78		388
Derivatives not designated as hedging instruments:
Foreign currency contracts	7,819		10,586
Commodity contracts	15		166

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Beginning balance	$	(10	)	$	(13	)	$	(6	)	$	(48	)
Additions and revaluations of derivatives designated as cash flow hedges	(13		)	(1		)	(24		)	15
Clearance of hedge results to earnings	—			(1		)	7			18
Ending balance	$	(23	)	$	(15	)	$	(23	)	$	(15	)

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

		Fair Value Using Level 2 Inputs
	Balance Sheet Location	September 30, 2015		December 31, 2014
Asset derivatives:
Derivatives designated as hedging instruments:
Interest rate swaps1	Accounts and notes receivable, net	$	—	$	1
Foreign currency contracts	Accounts and notes receivable, net	—		10
		—		11
Derivatives not designated as hedging instruments:
Foreign currency contracts2	Accounts and notes receivable, net	132		254
Total asset derivatives3		$	132	$	265
Cash collateral1,2	Other accrued liabilities	$	20	$	47
Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	$	—	$	10
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	63		62
Commodity contracts	Other accrued liabilities	1		1
		64		63
Total liability derivatives3		$	64	$	73

¹  Cash collateral held as of September 30, 2015 and December 31, 2014 represents $0 and $6, respectively, related to interest rate swap derivatives designated as hedging instruments.

²  Cash collateral held as of September 30, 2015 and December 31, 2014 represents $20 and $41, respectively, related to foreign currency derivatives not designated as hedging instruments.

³  The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $51 at September 30, 2015 and $67 at December 31, 2014.

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion)						Amount of Gain (Loss) Recognized in Income2
Three Months Ended September 30,	2015			2014			2015			2014			Income Statement Classification
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps	$	—		$	—		$	—		$	(7	)	Interest expense
Cash flow hedges:
Foreign currency contracts	—			20			—			2			Net sales
Commodity contracts	(22		)	(23		)	—			—			Cost of goods sold
	(22		)	(3		)	—			(5		)
Derivatives not designated as hedging instruments:
Foreign currency contracts	—			—			174			403			Other income, net3
Commodity contracts	—			—			(2		)	4			Cost of goods sold
	—			—			172			407
Total derivatives	$	(22	)	$	(3	)	$	172		$	402

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion)					Amount of Gain (Loss) Recognized in Income2
Nine Months Ended September 30,	2015			2014		2015			2014			Income Statement Classification
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps	$	—		$	—	$	(1	)	$	(20	)	Interest expense
Cash flow hedges:
Foreign currency contracts	(1		)	19		10			—			Net sales
Commodity contracts	(35		)	4		(22		)	(29		)	Cost of goods sold
	(36		)	23		(13		)	(49		)
Derivatives not designated as hedging instruments:
Foreign currency contracts	—			—		435			287			Other income, net3
Foreign currency contracts	—			—		(3		)	—			Net sales
Commodity contracts	—			—		3			(21		)	Cost of goods sold
	—			—		435			266
Total derivatives	$	(36	)	$	23	$	422		$	217

¹   OCI is defined as other comprehensive income (loss).

²   For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. For the three and nine months ended September 30, 2015 and 2014, there was no material ineffectiveness with regard to the company's cash flow hedges.

³   Gain (loss) recognized in other income, net, was partially offset by the related gain (loss) on the foreign currency-denominated monetary assets and liabilities of the company's operations, which were $(210) and $(153) for the three months ended September 30, 2015 and 2014, respectively, and $(381) and $(243) for the nine months ended September 30, 2015 and 2014, respectively. See Note 4 for additional information.

XML

Long-Term Employee Benefits (Tables)

9 Months Ended

Sep. 30, 2015

General Discussion of Pension and Other Postretirement Benefits [Abstract]

Schedules of Net Periodic Benefit Cost

The following sets forth the components of the company’s net periodic benefit cost for pensions:  

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Service cost	$	50		$	61		$	179		$	181
Interest cost	270			290			815			875
Expected return on plan assets	(375		)	(405		)	(1,180		)	(1,211		)
Amortization of loss	172			151			591			450
Amortization of prior service (benefit) cost	(3		)	1			(6		)	2
Curtailment (gain) loss	(7		)	—			(7		)	4
Settlement loss	44			2			53			4
Net periodic benefit cost - Total	$	151		$	100		$	445		$	305
Less: Discontinued operations	(7		)	9			(5		)	31
Net periodic benefit cost - Continuing operations	$	158		$	91		$	450		$	274

The following sets forth the components of the company’s net periodic benefit cost for other long-term employee benefits:  

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Service cost	$	3		$	4		$	12		$	13
Interest cost	28			30			83			91
Amortization of loss	20			15			58			43
Amortization of prior service benefit	(39		)	(54		)	(143		)	(160		)
Curtailment gain	(274		)	—			(274		)	—
Net periodic benefit cost- Total	$	(262	)	$	(5	)	$	(264	)	$	(13	)
Less: Discontinued operations	(274		)	1			(272		)	3
Net periodic benefit cost - Continuing operations	$	12		$	(6	)	$	8		$	(16	)

XML

Divestitures and Other Transactions

9 Months Ended

Sep. 30, 2015

Discontinued Operations and Disposal Groups [Abstract]

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

Divestitures and Other Transactions

Performance Chemicals

On July 1, 2015 (the Distribution Date), DuPont completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of Chemours (the Separation). To effect the spin-off, DuPont distributed to its stockholders one share of Chemours common stock, par value $0.01 per share, for every five shares of DuPont common stock, par value $0.30 per share, (the Distribution) outstanding as of 5:00 p.m. June 23, 2015, the record date for the Distribution. In lieu of fractional shares of Chemours, stockholders of DuPont received cash, which generally was taxable. In connection with the  Separation, the company and Chemours entered into a Separation Agreement and a Tax Matters Agreement, discussed below, and certain ancillary agreements, including an employee matters agreement, agreements related to transition and site services,  and intellectual property cross licensing arrangements. In addition, the companies have entered into certain supply agreements.

Separation Agreement

The company and Chemours entered into a Separation Agreement that sets forth, among other things, the agreements between the company and Chemours regarding the principal transactions necessary to effect the Separation and also sets forth ancillary agreements that govern certain aspects of the company’s relationship with Chemours after the separation. Among other matters, the Separation Agreement and the ancillary agreements provide for the allocation between DuPont and Chemours of assets, employees, liabilities and obligations (including investments, property and employee benefits and tax-related assets and liabilities) attributable to periods prior to, at and after the completion of the Separation.

Pursuant to the Separation Agreement, Chemours indemnifies DuPont against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. The term of this indemnification is indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. At September 30, 2015, the indemnified assets are $100 within accounts and notes receivable, net and $400 within other assets offset by the corresponding liabilities of $100 within other accrued liabilities and $400 within other liabilities.

Tax Matters Agreement

The company and Chemours entered into a Tax Matters Agreement that governs the parties’ respective rights, responsibilities and obligations with respect to tax liabilities and benefits, tax attributes, the preparation and filing of tax returns, the control of audits and other tax proceedings and other matters regarding taxes. In general, under the agreement, the company is responsible for any U.S. federal, state and local taxes (and any related interest, penalties or audit adjustments) reportable on a consolidated, combined or unitary return that includes the company or any of its subsidiaries (and Chemours and/or any of its subsidiaries) for any periods or portions thereof ending on or prior to the date of the Separation and Chemours is responsible for any U.S. federal, state, local and foreign taxes (and any related interest, penalties or audit adjustments) that are imposed on Chemours and/or any of its subsidiaries for all tax periods, whether before or after the date of the distribution. Neither party’s obligations under the agreement are limited in amount or subject to any cap. Additionally, Chemours generally agrees to indemnify DuPont and its affiliates against any and all tax-related liabilities incurred by them relating to the distribution and certain other aspects of the separation to the extent caused by an acquisition of Chemours’ stock or assets or by certain other action undertaken by Chemours.

The results of operations of the Performance Chemicals segment are presented as discontinued operations as summarized below:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Net sales	$	—		$	1,606		$	2,810		$	4,788
Other income, net	—			(7		)	27			33
Total	—			1,599			2,837			4,821
Cost of goods sold	—			1,183			2,215			3,530
Other operating charges	59			122			369			300
Selling, general and administrative expenses	(277		)	114			(87		)	347
Research and development expense	—			28			40			86
Interest expense	—			—			32			—
Employee separation / asset related charges, net	—			—			59			19
Total	(218		)	1,447			2,628			4,282
Income from discontinued operations before taxes	218			152			209			539
Provision for income taxes	108			49			114			154
Income from discontinued operations after taxes	$	110		$	103		$	95		$	385

As a result of the separation, the company recorded an other long-term employee benefit plan curtailment gain of $274 and re-measured the associated plans as of July 1, 2015. The company also recorded a pension curtailment gain of $7 and re-measured the principal U.S. pension plan as of July 1, 2015. See Note 13 for further discussion.

During the three and nine months ended September 30, 2015 and the three and nine months ended September 30, 2014, the company incurred $68 and $289, and $61 and $112 of costs, respectively, in connection with the transaction primarily related to professional fees associated with preparation of regulatory filings and separation activities within finance, tax, legal, and information system functions. Income from discontinued operations during the three and nine months ended September 30, 2015, and the three and nine months ended September 30, 2014, includes $59 and $243, and $51 and $95 of these costs, respectively. Income from continuing operations during the three and nine months ended September 30, 2015, and the three and nine months ended September 30, 2014, includes $9 and $26, and $10 and $17 of these costs, respectively, recorded in other operating charges in the company's interim Consolidated Income Statements. Income from continuing operations during the nine months ended September 30, 2015 also included $20 of transaction costs incurred for a premium associated with the early retirement of DuPont debt. The company exchanged notes received from Chemours in May 2015 (as part of a dividend payment) for DuPont debt that it then retired. These costs were reported in interest expense in the company's interim Consolidated Income Statements.

Income from discontinued operations during the nine months ended September 30, 2015, included a restructuring charge of $59, consisting of severance and related benefit costs associated with the Performance Chemicals segment to achieve fixed cost and operational productivity improvements for Chemours post-spin.

The carrying amount of the major classes of assets and liabilities classified as assets and liabilities of discontinued operations at December 31, 2014 related to Performance Chemicals consisted of the following:

	December 31, 2014
Accounts and notes receivable, net	$	887
Inventories	1,054
Prepaid expenses	15
Deferred income taxes - current	53
Property, plant and equipment, net of accumulated depreciation	3,378
Goodwill	197
Other intangible assets	11
Investment in affiliates	124
Deferred income taxes - noncurrent	42
Other assets - noncurrent	466
Total assets of discontinued operations	$	6,227
Accounts payable	1,036
Income taxes	9
Other accrued liabilities	373
Other liabilities - noncurrent	616
Deferred income taxes - noncurrent	433
Total liabilities of discontinued operations	$	2,467

In connection with the spin-off, the company received a dividend from Chemours in May 2015 of $3,923 comprised of a cash distribution of $3,416 and a distribution in-kind of $507 of 7% senior unsecured notes due 2025 (Chemours Notes Received). Chemours financed the dividend payment through issuance of approximately $4,000 of debt, including the Chemours' Notes Received (Chemours' Debt). Net assets of $415 were transferred to Chemours on July 1, 2015, including the $4,000 of Chemours' Debt. In addition, approximately $468 of accumulated other comprehensive loss, net of income taxes, primarily related to pension and other long-term employee benefit plans, as well as cumulative translation adjustment was transferred to Chemours. This resulted in a $883 reduction to reinvested earnings. Cash, working capital and other accounts will be reconciled with Chemours and the net amount due to DuPont will be settled pursuant to the Separation Agreement.

The following table presents depreciation, amortization and purchases of property, plant and equipment of the discontinued operations related to Performance Chemicals:

	Nine Months Ended
	September 30,
	2015		2014
Depreciation	$	126	$	186
Amortization of intangible assets	2		2
Purchases of property, plant and equipment	235		350

Glass Laminating Solutions/Vinyls

In June 2014, the company sold Glass Laminating Solutions/Vinyls (GLS/Vinyls), a part of the Performance Materials segment, to Kuraray Co. Ltd. The sale resulted in a pre-tax gain of $391 ($273 net of tax). The gain was recorded in other income, net in the company's interim Consolidated Income Statements for the nine months ended September 30, 2014.

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Schedule of Segment Information

Three Months Ended September 30,	Agriculture1				Electronics & Communications		Industrial Biosciences		Nutrition & Health		Performance Materials			Safety & Protection		Other			Total
2015
Net sales	$	1,093			$	532	$	305	$	810	$	1,302		$	831	$	—		$	4,873
PTOI	(63		)	5	104		52		102		317			156		(88		)	580
2014
Net sales	$	1,563			$	620	$	314	$	899	$	1,531		$	976	$	2		$	5,905
PTOI	(56		)		90		42		99		366		4	195		(50		)	686

Nine Months Ended September 30,	Agriculture1			Electronics & Communications			Industrial Biosciences			Nutrition & Health			Performance Materials			Safety & Protection			Other				Total
2015
Net sales	$	8,248		$	1,577		$	870		$	2,449		$	4,021		$	2,663		$	3			$	19,831
PTOI	1,878		2,5	283		2	147		2	284		2	933		2	635		2,6	(215		)	2,7	3,945
2014
Net sales	$	9,564		$	1,810		$	925		$	2,686		$	4,618		$	2,950		$	4			$	22,557
PTOI	2,171		3	176		3	146		3	282		3	1,303		3,4	536		3	(166		)	3	4,448

¹  As of September 30, 2015, Agriculture net assets were $10,162, an increase of $3,467 from $6,695 at December 31, 2014. The increase was primarily due to higher trade receivables related to normal seasonality in the sales and cash collections cycle.

²  Included $(2) net adjustment to the estimated costs associated with the 2014 restructuring program, recorded in employee separation / asset related charges, net. These adjustments were primarily due to the identification of additional projects in certain segments, offset by lower than estimated individual severance costs and workforce reductions achieved through non-severance programs. The adjustments impacted segment results for the nine months ended September 30, 2015 as follows: Agriculture - $(4) , Electronics & Communications - $11, Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Materials - $(2), and Safety & Protection $1, and Other - $(3). See Note 3 for additional information.

³  Included a $(187) restructuring charge recorded in employee separation / asset related charges, net. The pre-tax charges by segment are: Agriculture -$(47) , Electronics & Communications -$(68) , Industrial Biosciences - $(2) , Nutrition & Health -$(8) , Performance Materials - $(29) , Safety & Protection - $(31), and Other - $(2). See Note 3 for additional information.

⁴  Included a gain of $391 recorded in other income, net associated with the sale of GLS/Vinyls. See Note 2 for additional information.

⁵  Included $147 and $182 of net insurance recoveries recorded in other operating charges for the three and nine months ended September 30, 2015, for recovery of costs for customer claims related to the use of the Imprelis^® herbicide. See Note 10 for additional information.

⁶  Included a gain of $112, net of legal expenses, recorded in other income, net related to the company’s settlement of a legal claim.

⁷  Included a $(37) pre-tax impairment charge recorded in employee separation / asset related charges, net for a cost basis investment. See Note 3 for additional information.

Reconciliation to Consolidated Income Statements

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Total segment PTOI	$	580		$	686		$	3,945		$	4,448
Non-operating pension and other postretirement employee benefit costs	(115		)	(32		)	(288		)	(96		)
Net exchange (losses) gains1	(36		)	250			54			44
Corporate expenses2	(120		)	(177		)	(439		)	(617		)
Interest expense3	(82		)	(93		)	(260		)	(290		)
Income from continuing operations before income taxes	$	227		$	634		$	3,012		$	3,489

¹  Included a charge of $(40) associated with remeasuring the company's Ukrainian hryvnia net monetary assets in the nine months ended September 30, 2015, as well as a charge of $(58) associated with remeasuring the company's Venezuelan net monetary assets from the official exchange rate to the SICAD II exchange system in the nine months ended September 30, 2014, which were recorded in other income, net in the company's interim Consolidated Income Statements. See Note 4 for additional information.

²  Included transaction costs associated with the separation of the Performance Chemicals segment of $(9) and $(10) in the three months ended September 30, 2015 and 2014, respectively, and $(26) and $(17) in the nine months ended September 30, 2015 and 2014, respectively, which were recorded in other operating charges in the company's interim Consolidated Income Statements.

³  Included transaction costs of $(20) in the nine months ended September 30, 2015, associated with the early retirement of debt exchanged for the notes received from Chemours in May 2015.

XML

Employee Separation / Asset Related Charges, Net (Narrative) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2015 USD ($)
Impaired Long-Lived Assets Held and Used [Line Items]
Cost basis investment ownership	6.00%
Cost basis investment impairment [Member]
Impaired Long-Lived Assets Held and Used [Line Items]
Cost basis investment impairment	$ 37
Other Segments [Member]
Impaired Long-Lived Assets Held and Used [Line Items]
Pre-tax impairment charge	$ 38

XML

Stockholders' Equity (Share Repurchase Program) (Narrative) (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended	9 Months Ended		20 Months Ended
	Sep. 30, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Jul. 28, 2015	Jan. 21, 2015	Jan. 31, 2014
Equity, Class of Treasury Stock [Line Items]
Prepayments / repurchase of common stock		$ 2,353	$ 2,000
January 2014 Buyback Plan [Member]
Equity, Class of Treasury Stock [Line Items]
Share buyback plan, Authorized Amount							$ 5,000
Repurchased and retired, shares				34.7
Repurchase of common stock				$ 2,353
YTD 2015 Open Market Purchases [Member]
Equity, Class of Treasury Stock [Line Items]
Repurchased and retired, shares		4.6
Repurchase of common stock		$ 353
2015 Share Buyback Plan [Member]
Equity, Class of Treasury Stock [Line Items]
Share buyback plan, Authorized Amount					$ 2,000
Prepayments / repurchase of common stock	$ 2,000
Repurchased and retired, shares	28.8
Percentage of share repurchase agreement completed	80.00%	80.00%		80.00%
2015 Share buyback announcement						$ 4,000

XML

Consolidated Income Statements - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015		Sep. 30, 2014
Net sales	$ 4,873	$ 5,905	$ 19,831		$ 22,557
Other income, net	98	364	552		749
Total	4,971	6,269	20,383		23,306
Cost of goods sold	3,084	3,698	11,703		13,350
Other operating charges	91	201	413		609
Selling, general and administrative expenses	1,046	1,157	3,540		3,833
Research and development expense	441	486	1,415		1,491
Interest expense	82	93	260	[1]	290
Employee separation / asset related charges, net	0	0	40		244
Total	4,744	5,635	17,371		19,817
Income from continuing operations before income taxes	227	634	3,012		3,489
Provision for income taxes on continuing operations	96	303	886		921
Income from continuing operations after taxes	131	331	2,126		2,568
Income from discontinued operations after taxes	104	103	89		385
Net income	235	434	2,215		2,953
Less: Net income attributable to noncontrolling interests	0	1	9		11
Net income attributable to DuPont	$ 235	$ 433	$ 2,206		$ 2,942
Basic earnings per share of common stock from continuing operations	$ 0.14	$ 0.36	$ 2.34		$ 2.78
Basic earnings per share of common stock from discontinued operations	0.12	0.11	0.10		0.42
Basic earnings per share of common stock	0.26	0.47	2.44		3.20
Diluted earnings per share of common stock from continuing operations	0.14	0.36	2.33		2.76
Diluted earnings per share of common stock from discontinued operations	0.12	0.11	0.10		0.42
Diluted earnings per share of common stock	0.26	0.47	2.43		3.17
Dividends per share of common stock	$ 0.38	$ 0.47	$ 1.34		$ 1.37

[1] Included transaction costs of $(20) in the nine months ended September 30, 2015, associated with the early retirement of debt exchanged for the notes received from Chemours in May 2015.

XML

Inventories (Details) - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014
Inventory, Net [Abstract]
Finished products	$ 3,260	$ 4,011
Semifinished products	2,083	2,277
Raw materials, stores and supplies	749	739
Total inventories before LIFO adjustment	6,092	7,027
Adjustment of inventories to a last-in, first-out (LIFO) basis	(204)	(240)
Total	$ 5,888	$ 6,787

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Operating activities
Net income	$ 2,215	$ 2,953
Adjustments to reconcile net income to cash used for operating activities:
Depreciation	856	944
Amortization of intangible assets	307	294
Net periodic pension benefit cost	445	305
Contributions to pension plans	(260)	(231)
Gain on sale of businesses	(48)	(418)
Other operating activities - net	89	272
Change in operating assets and liabilities - net	(5,449)	(5,921)
Cash used for operating activities	(1,845)	(1,802)
Investing activities
Purchases of property, plant and equipment	(1,291)	(1,311)
Investments in affiliates	(59)	(37)
Payments for businesses - net of cash acquired	(77)	0
Proceeds from sales of businesses - net	61	727
Proceeds from sales of assets - net	18	29
Purchases of short-term financial instruments	(928)	(853)
Proceeds from maturities and sales of short-term financial instruments	676	431
Foreign currency exchange contract settlements	543	97
Other investing activities - net	12	197
Cash used for investing activities	(1,045)	(720)
Financing activities
Dividends paid to stockholders	(1,210)	(1,268)
Net increase in short-term (less than 90 days) borrowings	1,161	2,416
Long-term and other borrowings - receipts	3,630	96
Long-term and other borrowings - payments	(1,529)	(1,763)
Prepayments / repurchase of common stock	(2,353)	(2,000)
Proceeds from exercise of stock options	208	285
Cash transferred to Chemours at spin-off	(250)	0
Other financing activities - net	(87)	1
Cash used for financing activities	(430)	(2,233)
Effect of exchange rate changes on cash	(266)	(204)
Decrease in cash and cash equivalents	(3,586)	(4,959)
Cash and cash equivalents at beginning of period	6,910	8,941
Cash and cash equivalents at end of period	$ 3,324	$ 3,982

XML

Financial Instruments (Debt) (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014
Fair Value, Inputs, Level 2 [Member]
Fair value of debt	$ 10,430	$ 11,394

XML

Divestitures and Other Transactions (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	May. 31, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Jul. 01, 2015	Jun. 23, 2015	May. 12, 2015	Dec. 31, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Chemours shares distributed to DD stockholders							1
Shares of DD stock converted							5
Common stock, par value		$ 0.30		$ 0.30			$ 0.30		$ 0.30
Separation related transaction costs		$ 68	$ 61	$ 289	$ 112
Restructuring charges					187
Dividend received from Chemours	$ 3,923
Cash distribution received from Chemours	3,416
Net assets transferred at spin-off						$ 415
Accumulated other comprehensive income transferred at spin-off						468
Impact of spin-off on reinvested earnings						$ 883
Discontinued Operations, Disposed of by Means Other than Sale, Spinoff [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Separation related transaction costs		59	51	243	95
GLS/Vinyls [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pre-tax gain					391
Pre-tax gain, net of tax					273
Corporate Expenses [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Separation related transaction costs		9	10	26	17
Corporate Expenses [Member] | Continuing Operations [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Separation related transaction costs		9	10	26	17
Corporate Expenses [Member] | Loss on extinguishment of debt [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Separation related transaction costs				20
Chemours [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Common stock, par value							$ 0.01
Chemours Restructuring Program [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Restructuring charges				59
Accounts and Notes Receivable [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnification assets		100		100
Other Assets [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnification assets		400		400
Other Accrued Liabilities [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnified liabilities		100		100
Other Liabilities [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnified liabilities		400		400
Other Long-Term Employee Benefit Plans [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Curtailment gain		274	0	274	0
Pension Plans [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Curtailment gain		$ 7	$ 0	$ 7	$ (4)
Chemours' Debt [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from issuance of debt	$ 4,000
7% notes due 2025 [Member] | Chemours Notes Received [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Senior notes								$ 507
Debt instrument, interest rate, stated percentage								7.00%

XML

Long-Term Employee Benefits (Schedules of Net Periodic Benefit Cost) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit cost			$ 445	$ 305
Pension Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 50	$ 61	179	181
Interest cost	270	290	815	875
Expected return on plan assets	(375)	(405)	(1,180)	(1,211)
Amortization of loss	172	151	591	450
Amortization of prior service (benefit) cost	(3)	1	(6)	2
Curtailment (gain) loss	(7)	0	(7)	4
Settlement loss	44	2	53	4
Net periodic benefit cost	151	100	445	305
Net periodic benefit cost, discontinued operations	(7)	9	(5)	31
Net periodic benefit cost, continuing operations	158	91	450	274
Other Long-Term Employee Benefit Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	3	4	12	13
Interest cost	28	30	83	91
Amortization of loss	20	15	58	43
Amortization of prior service (benefit) cost	(39)	(54)	(143)	(160)
Curtailment (gain) loss	(274)	0	(274)	0
Net periodic benefit cost	(262)	(5)	(264)	(13)
Net periodic benefit cost, discontinued operations	(274)	1	(272)	3
Net periodic benefit cost, continuing operations	$ 12	$ (6)	$ 8	$ (16)

XML

Divestitures and Other Transactions Divestitures and Other Transactions (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2015

Dec. 31, 2014

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Schedule of results of operations from discontinued operations

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Net sales	$	—		$	1,606		$	2,810		$	4,788
Other income, net	—			(7		)	27			33
Total	—			1,599			2,837			4,821
Cost of goods sold	—			1,183			2,215			3,530
Other operating charges	59			122			369			300
Selling, general and administrative expenses	(277		)	114			(87		)	347
Research and development expense	—			28			40			86
Interest expense	—			—			32			—
Employee separation / asset related charges, net	—			—			59			19
Total	(218		)	1,447			2,628			4,282
Income from discontinued operations before taxes	218			152			209			539
Provision for income taxes	108			49			114			154
Income from discontinued operations after taxes	$	110		$	103		$	95		$	385

Schedule of assets and liabilities of discontinued operations

	December 31, 2014
Accounts and notes receivable, net	$	887
Inventories	1,054
Prepaid expenses	15
Deferred income taxes - current	53
Property, plant and equipment, net of accumulated depreciation	3,378
Goodwill	197
Other intangible assets	11
Investment in affiliates	124
Deferred income taxes - noncurrent	42
Other assets - noncurrent	466
Total assets of discontinued operations	$	6,227
Accounts payable	1,036
Income taxes	9
Other accrued liabilities	373
Other liabilities - noncurrent	616
Deferred income taxes - noncurrent	433
Total liabilities of discontinued operations	$	2,467

Schedule of cash flow information of discontinued operations

	Nine Months Ended
	September 30,
	2015		2014
Depreciation	$	126	$	186
Amortization of intangible assets	2		2
Purchases of property, plant and equipment	235		350

XML

Divestitures and Other Transactions Divestitures and Other Transactions (Schedule of results of operations from discontinued operations) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income from discontinued operations after taxes	$ 104	$ 103	$ 89	$ 385
Performance Chemicals [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales	0	1,606	2,810	4,788
Other income, net	0	(7)	27	33
Total	0	1,599	2,837	4,821
Cost of goods sold	0	1,183	2,215	3,530
Other operating charges	59	122	369	300
Selling, general and administrative expenses	(277)	114	(87)	347
Research and development expense	0	28	40	86
Interest expense	0	0	32	0
Employee separation / asset related charges, net	0	0	59	19
Total	(218)	1,447	2,628	4,282
Income from discontinued operations before taxes	218	152	209	539
Provision for income taxes	108	49	114	154
Income from discontinued operations after taxes	$ 110	$ 103	$ 95	$ 385

XML

Other Income, Net (Tables)

9 Months Ended

Sep. 30, 2015

Other Income and Expenses [Abstract]

Schedule of Other Income

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2015			2014		2015		2014
Royalty income	$	27		$	34	$	91	$	99
Interest income	33			33		98		103
Equity in earnings of affiliates, net	1			1		19		8
Net gain on sales of businesses and other assets	43			27		74		428
Net exchange (losses) gains1	(36		)	250		54		44
Miscellaneous income and expenses, net 2	30			19		216		67
Other income, net	$	98		$	364	$	552	$	749

¹ The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The net pre-tax exchange gains (losses) are recorded in other income, net and the related tax impact is recorded in provision for income taxes on the company's interim Consolidated Income Statements. Refer to Note 5 for discussion of the tax impacts related to this program. The $54 net exchange gain for the nine months ended September 30, 2015, includes a net $(35) pre-tax exchange loss associated with the devaluation of the Ukrainian hryvnia. The $44 net exchange gain for the nine months ended September 30, 2014, includes $(58), $(46) and $(14) exchange losses, associated with the devaluation of the Venezuela bolivar, Ukrainian hryvnia, and Argentinian peso, respectively.

²   Miscellaneous income and expenses, net, includes interest items, certain insurance recoveries and litigation settlements and other items.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Interim Financial Statements

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included.  Results for interim periods should not be considered indicative of results for a full year.  These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2014, collectively referred to as the “2014 Annual Report”.  The Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained, as well as variable interest entities (VIEs) for which DuPont is the primary beneficiary. 

Basis of Presentation

Certain reclassifications of prior year's data have been made to conform to current year's presentation. On July 1, 2015, the company completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (Chemours). In accordance with GAAP, the financial position and results of operations of the Performance Chemicals segment are presented as discontinued operations and, as such, have been excluded from continuing operations and segment results for all periods presented. The sum of the individual earnings per share amounts from continuing operations and discontinued operations may not equal the total company earnings per share amounts due to rounding. The cash flows and comprehensive income related to the Performance Chemicals segment have not been segregated and are included in the Condensed Consolidated Statements of Cash Flows and Comprehensive Income, respectively, for all periods presented. Amounts related to the Performance Chemicals segment are consistently included or excluded from the Notes to the interim Consolidated Financial Statements based on the respective financial statement line item. See Note 2 for additional information.

The company revised accumulated other comprehensive loss at January 1, 2013 to adjust for currency translation of $97 and pension settlement charges of $54 that should have been recorded in prior years. The revision resulted in a $151 decrease in accumulated other comprehensive loss with a corresponding reduction in reinvested earnings. The currency translation was related to an adjustment to the exchange rates used by a foreign subsidiary in the translation of the financial statements to U.S. dollar (USD) in prior years. See further discussion of the pension settlement charges in Note 13. The impact of these adjustments is not material to the company’s current or previously issued financial statements.

The company’s cost structure is being impacted by the global, multi-year initiative to redesign its global organization and operating model to improve productivity and agility across all businesses and functions. Effective December 31, 2014, in order to better align to the transforming company’s organization and resulting cost structure, certain costs were reclassified from other operating charges to selling, general and administrative expenses. Prior year data have been reclassified to conform to current year presentation. Other operating charges primarily include, costs associated with the Performance Chemical separation, product claim charges and non-capitalizable costs associated with capital projects. Selling, general and administrative expense primarily includes selling and marketing expenses, commissions, functional costs, and business management expenses. Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead.

Foreign Currency Translation

The company's worldwide operations utilize the USD or local currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not clearly align with either category, factors are evaluated and a judgment is made to determine the functional currency.

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive loss in equity. Assets and liabilities denominated in other than the local currency are re-measured into the local currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed. As a result of the separation of its Performance Chemicals segment, coupled with the company’s ongoing redesign initiative, the functional currency at certain of the company’s foreign entities is being re-evaluated which, in some cases, has resulted in a change in the foreign entities’ functional currency.

Venezuelan Foreign Currency

Venezuela is considered a highly inflationary economy under GAAP and the USD is the functional currency for the company's subsidiaries in Venezuela. The official exchange rate continues to be set through the National Center for Foreign Commerce (CENCOEX, previously CADIVI). Based on its evaluation of the restrictions and limitations affecting the availability of specific exchange rate mechanisms, management concluded in the second quarter of 2014 that the Alternative Currency Exchange System (SICAD 2) auction process would be the most likely mechanism available. As a result, in the second quarter of 2014, the company changed from the official exchange rate to the SICAD 2 exchange rate, which resulted in a charge of $58 recorded within other income, net in the company's interim Consolidated Income Statements for the nine months ended September 30, 2014.

During the first quarter of 2015, the Venezuelan government enacted additional changes to the country’s foreign exchange systems including the introduction of the SIMADI (Foreign Exchange Marginal System) auction process. Management has concluded that the SIMADI auction process would be the most likely exchange mechanism available. As a result, effective in the first quarter of 2015, the company changed from the SICAD 2 to the SIMADI exchange rate, to re-measure its Bolivar Fuertes (VEF) denominated net monetary assets which resulted in a charge of $3 recorded within other income, net in the company's interim Consolidated Income Statements for the nine months ended September 30, 2015. The remaining net monetary assets and non-monetary assets are immaterial at September 30, 2015.

Recent Accounting Pronouncements

Accounting Pronouncements Implemented in 2015

In April 2014, the FASB issued authoritative guidance amending existing requirements for reporting discontinued operations.  Under the new guidance, discontinued operations reporting is limited to disposal transactions that represent strategic shifts having a major effect on operations and financial results. The amended guidance also enhances disclosures and requires assets and liabilities of a discontinued operation to be classified as such for all periods presented in the financial statements. Public entities will apply the amended guidance prospectively to all disposals occurring within annual periods beginning on or after December 15, 2014 and interim periods within those years. The company adopted this standard on January 1, 2015. Due to the change in requirements for reporting discontinued operations described above, presentation and disclosures of disposal transactions after adoption may be different than under previous standards.

New Accounting Pronouncements to be Implemented

In May 2015, the FASB issued ASU No. 2015-07, Fair Value Measurement (Topic 820), Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share or its Equivalent. This guidance removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient. The guidance also removes the requirement to make certain disclosures for all investments that are eligible to be measured at fair value using the net asset value per share practical expedient. Rather, those disclosures are limited to investments for which the entity has elected to measure the fair value using that practical expedient. The guidance is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. A reporting entity should apply the amendments retrospectively to all periods presented and early adoption is permissible. The company anticipates that this guidance will only impact disclosure and will not impact the company's financial position or results of operations.

In February 2015, the FASB issued ASU No. 2015-02 Consolidation (Topic 810), Amendments to the Consolidation Analysis. The amendments under the new guidance modify the evaluation of whether limited partnerships and similar legal entities are VIEs or voting interest entities and eliminate the presumption that a general partner should consolidate a limited partnership. The ASU is effective for public business entities for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. A reporting entity also may apply the amendments retrospectively. The company is currently evaluating the impact of adopting this guidance on its financial position and results of operations.

In May 2014, the FASB and the International Accounting Standards Board (IASB) jointly issued ASU No. 2014-9, Revenue from Contracts with Customers (Topic 606), which clarifies the principles for recognizing revenue and develops a common revenue standard for GAAP and International Financial Reporting Standards (IFRS). The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. In July 2015, the FASB approved a deferral of the ASU effective date from annual and interim periods beginning after December 15, 2016 to annual and interim periods beginning after December 15, 2017. The company is currently evaluating the impact of adopting this guidance on its financial position and results of operations.

XML

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions		3 Months Ended			9 Months Ended
		Sep. 30, 2015		Sep. 30, 2014	Sep. 30, 2015		Sep. 30, 2014
Net income		$ 235		$ 434	$ 2,215		$ 2,953
Cumulative translation adjustment		(125)		(428)	(1,405)	[1]	(559)	[1]
Additions and revaluations of derivatives designated as cash flow hedges	[2]	(22)		(3)	(36)		23
Clearance of hedge results to earnings		0		(2)	12		29
Net revaluation and clearance of cash flow hedges to earnings		(22)		(5)	(24)		52
Other comprehensive income (loss), before tax		380		(307)	(511)		(255)
Income tax expense related to items of other comprehensive income		(176)		(28)	(312)		(92)
Other comprehensive income (loss), net of tax		204		(335)	(823)		(347)
Comprehensive income		439		99	1,392		2,606
Less: comprehensive income attributable to noncontrolling interests		0		1	9		11
Comprehensive income attributable to DuPont		439		98	1,383		2,595
Pension Plans [Member]
Net gain (loss)	[2]	634	[3]	(5)	628	[3]	(107)
Prior service benefit (cost)	[2]	0		(1)	0		(1)
Effect of foreign exchange rates	[2]	54		0	92		0
Amortization of prior service (benefit) cost	[4]	(3)		1	(6)		2
Amortization of loss	[4]	172		151	591		450
Curtailment gain / settlement loss		37		2	46		8
Benefit plans, net		894		148	1,351		352
Other Long-Term Employee Benefit Plans [Member]
Net gain (loss)	[2]	(73)	[3]	(33)	(73)	[3]	(33)
Prior service benefit (cost)	[2]	0		50	0		50
Effect of foreign exchange rates	[2]	(1)		0	(1)		0
Amortization of prior service (benefit) cost	[4]	(39)		(54)	(143)		(160)
Amortization of loss	[4]	20		15	58		43
Curtailment gain / settlement loss		(274)		0	(274)		0
Benefit plans, net		$ (367)		$ (22)	$ (433)		$ (100)

[1] The increase in currency translation adjustment losses over prior year for the nine months ended September 30, 2015 is driven by the strengthening USD against primarily the Euro and Brazilian real. The change in both periods is also due to changes in certain foreign entity's functional currency as described in Note 1.

[2] These amounts represent changes in accumulated other comprehensive loss excluding changes due to reclassifying amounts to the interim Consolidated Income Statements.

[3] See Note 13 for discussion of the re-measurement of the principal U.S. pension plan and other long-term employee benefit plans as a result of the Performance Chemicals separation.

[4] These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other long-term employee benefit plans. See Note 13 for additional information.

XML

Stockholders' Equity

9 Months Ended

Sep. 30, 2015

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders’Equity

Share Repurchase Program

2015 Share Buyback Plan

In the first quarter 2015, DuPont announced its intention to buy back shares of about $4,000 using the distribution proceeds received from Chemours. In connection with the completion of the spin-off of Chemours, the Board of Directors authorized the use of the distribution proceeds to buy back shares of the company's common stock as follows: $2,000 to be purchased and retired by December 31, 2015 with the remainder to be purchased and retired by December 31, 2016. In August 2015, the company entered into an accelerated share repurchase (ASR) agreement. Under the terms of the August 2015 ASR agreement, the company paid $2,000 to the financial institution and received and retired an initial delivery of 28.8 million shares, which represent 80 percent of the $2,000 notional amount of the agreement. The purchase price per share and final number of shares retired will be determined using the volume-weighted price of the company's stock over the term of the ASR agreement. The August 2015 ASR will be completed in the fourth quarter 2015.

2014 Share Buyback Plan

In January 2014, the company's Board of Directors authorized a $5,000 share buyback plan that replaced the 2011 plan. During the nine months ended September 30, 2015, the company purchased and retired 4.6 million shares in the open market for a total cost of $353, which offset the dilution from employee compensation plans in the first and second quarter of 2015. As of September 30, 2015, the company has purchased 34.7 million shares at a total cost of $2,353 under the plan. There is no required completion date for the remaining stock purchases.

Noncontrolling Interest

In September 2015, the company obtained a controlling interest in a joint venture included in the Performance Materials segment. Accordingly, the company consolidated the entity at September 30, 2015 and recorded the fair value of the noncontrolling interest in the amount of $157 in the Condensed Consolidated Balance Sheet.

Other Comprehensive Income (Loss)

A summary of the changes in other comprehensive income (loss) for the three and nine months ended September 30, 2015 and 2014 is provided as follows:

	Three Months Ended									Three Months Ended									Affected Line Item in Consolidated Income Statements
	September 30, 2015									September 30, 2014
	Pre-Tax			Tax			After-Tax			Pre-Tax			Tax			After-Tax
Cumulative translation adjustment	$	(125	)	$	—		$	(125	)	$	(428	)	$	—		$	(428	)
Net revaluation and clearance of cash flow hedges to earnings:
Additions and revaluations of derivatives designated as cash flow hedges	(22		)	9			(13		)	(3		)	2			(1		)	See (1) below
Clearance of hedge results to earnings:
Foreign currency contracts	—			—			—			(2		)	1			(1		)	Net sales
Net revaluation and clearance of cash flow hedges to earnings	(22		)	9			(13		)	(5		)	3			(2		)
Pension benefit plans:
Net gain (loss)(3)	634			(228		)	406			(5		)	1			(4		)	See (1) below
Prior service cost	—			—			—			(1		)	—			(1		)	See (1) below
Effect of foreign exchange rates	54			(16		)	38			—			—			—			See (1) below
Reclassifications to net income:
Amortization of prior service (benefit) cost	(3		)	1			(2		)	1			—			1			See (2) below
Amortization of loss	172			(61		)	111			151			(52		)	99			See (2) below
Curtailment gain	(7		)	3			(4		)	—			—			—			See (2) below
Settlement loss	44			(16		)	28			2			(1		)	1			See (2) below
Pension benefit plans, net	894			(317		)	577			148			(52		)	96
Other benefit plans:
Net loss(3)	(73		)	27			(46		)	(33		)	10			(23		)	See (1) below
Prior service benefit	—			—			—			50			(1		)	49			See (1) below
Effect of foreign exchange rates	(1		)	1			—			—			—			—			See (1) below
Reclassifications to net income:
Amortization of prior service benefit	(39		)	13			(26		)	(54		)	18			(36		)	See (2) below
Amortization of loss	20			(7		)	13			15			(6		)	9			See (2) below
Curtailment gain	(274		)	98			(176		)	—			—			—			See (2) below
Other benefit plans, net	(367		)	132			(235		)	(22		)	21			(1		)
Other comprehensive income (loss)	$	380		$	(176	)	$	204		$	(307	)	$	(28	)	$	(335	)

	Nine Months Ended									Nine Months Ended									Affected Line Item in Consolidated Income Statements
	September 30, 2015									September 30, 2014
	Pre-Tax			Tax			After-Tax			Pre-Tax			Tax			After-Tax
Cumulative translation adjustment(4)	$	(1,405	)	$	—		$	(1,405	)	$	(559	)	$	—		$	(559	)
Net revaluation and clearance of cash flow hedges to earnings:
Additions and revaluations of derivatives designated as cash flow hedges	(36		)	12			(24		)	23			(8		)	15			See (1) below
Clearance of hedge results to earnings:
Foreign currency contracts	(10		)	4			(6		)	—			—			—			Net sales
Commodity contracts	22			(9		)	13			29			(11		)	18			Cost of goods sold
Net revaluation and clearance of cash flow hedges to earnings	(24		)	7			(17		)	52			(19		)	33
Pension benefit plans:
Net gain (loss)(3)	628			(226		)	402			(107		)	34			(73		)	See (1) below
Prior service cost	—			—			—			(1		)	—			(1		)	See (1) below
Effect of foreign exchange rates	92			(25		)	67			—			—			—			See (1) below
Reclassifications to net income:
Amortization of prior service (benefit) cost	(6		)	2			(4		)	2			—			2			See (2) below
Amortization of loss	591			(210		)	381			450			(155		)	295			See (2) below
Curtailment (gain) loss	(7		)	3			(4		)	4			(1		)	3			See (2) below
Settlement loss	53			(19		)	34			4			(1		)	3			See (2) below
Pension benefit plans, net	1,351			(475		)	876			352			(123		)	229
Other benefit plans:
Net loss(3)	(73		)	27			(46		)	(33		)	10			(23		)	See (1) below
Prior service benefit	—			—			—			50			(1		)	49			See (1) below
Effect of foreign exchange rates	(1		)	1			—			—			—			—			See (1) below
Reclassifications to net income:
Amortization of prior service benefit	(143		)	50			(93		)	(160		)	56			(104		)	See (2) below
Amortization of loss	58			(20		)	38			43			(15		)	28			See (2) below
Curtailment gain	(274		)	98			(176		)	—			—			—			See (2) below
Other benefit plans, net	(433		)	156			(277		)	(100		)	50			(50		)
Other comprehensive loss	$	(511	)	$	(312	)	$	(823	)	$	(255	)	$	(92	)	$	(347	)

¹  These amounts represent changes in accumulated other comprehensive loss excluding changes due to reclassifying amounts to the interim Consolidated Income Statements.

²  These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost of the company's pension and other long-term employee benefit plans. See Note 13 for additional information.

³  See Note 13 for discussion of the re-measurement of the principal U.S. pension plan and other long-term employee benefit plans as a result of the Performance Chemicals separation.

⁴  The increase in currency translation adjustment losses over prior year for the nine months ended September 30, 2015 is driven by the strengthening USD against primarily the Euro and Brazilian real.  The change in both periods is also due to changes in certain foreign entity's functional currency as described in Note 1.

The changes and after-tax balances of components comprising accumulated other comprehensive loss are summarized below:

	Cumulative Translation Adjustment			Net Revaluation and Clearance of Cash Flow Hedges to Earnings			Pension Benefit Plans			Other Benefit Plans			Unrealized Gain on Securities			Total
2015
Balance January 1, 2015	$	(919	)	$	(6	)	$	(7,895	)	$	262		$	2		$	(8,556	)
Other comprehensive (loss) income before reclassifications	(1,405		)	(24		)	469			(46		)	—			(1,006		)
Amounts reclassified from accumulated other comprehensive loss	—			7			407			(231		)	—			183
Spin-off of Chemours	191			—			278			—			(1		)	468
Balance September 30, 2015	$	(2,133	)	$	(23	)	$	(6,741	)	$	(15	)	$	1		$	(8,911	)

	Cumulative Translation Adjustment			Net Revaluation and Clearance of Cash Flow Hedges to Earnings			Pension Benefit Plans			Other Benefit Plans			Unrealized Gain on Securities		Total
2014
Balance January 1, 2014	$	(43	)	$	(48	)	$	(5,695	)	$	494		$	2	$	(5,290	)
Other comprehensive (loss) income before reclassifications	(559		)	15			(74		)	26			—		(592		)
Amounts reclassified from accumulated other comprehensive loss	—			18			302			(76		)	—		244
Balance September 30, 2014	$	(602	)	$	(15	)	$	(5,467	)	$	444		$	2	$	(5,638	)

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Oct. 15, 2015
Entity Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Entity Registrant Name	DUPONT E I DE NEMOURS & CO
Entity Central Index Key	0000030554
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		876,407,000

XML

Financial Instruments

9 Months Ended

Sep. 30, 2015

Financial Instruments Disclosure [Abstract]

Financial Instruments

Financial Instruments

Cash Equivalents

The fair value of cash equivalents approximates its stated value.  The estimated fair value of the company's cash equivalents was determined using level 1 and level 2 inputs within the fair value hierarchy, as described in the company's 2014 Annual Report in Note 1,“Summary of Significant Accounting Policies.”  Level 1 measurements are based on observable net asset values and level 2 measurements are based on current interest rates for similar investments with comparable credit risk and time to maturity.  The company held $0 and $1,436 of money market funds (level 1 measurements) as of September 30, 2015 and December 31, 2014, respectively.  The company held $1,680 and $3,293 of other cash equivalents (level 2 measurements) as of September 30, 2015 and December 31, 2014, respectively.     

Marketable Securities

Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investment. Investments classified as available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive loss. The company held $381 and $124 of held-to-maturity and $25 and $0 of available-for-sale securities as of September 30, 2015 and December 31, 2014, respectively.

Debt

The estimated fair value of the company's total debt, including interest rate financial instruments, was determined using level 2 inputs within the fair value hierarchy, as described in the company's 2014 Annual Report in Note 1,“Summary of Significant Accounting Policies.”Based on quoted market prices for the same or similar issues or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's debt was approximately$10,430and$11,394as ofSeptember 30, 2015andDecember 31, 2014, respectively.

Derivative Instruments

Objectives and Strategies for Holding Derivative Instruments

In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency, interest rate and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any nonderivatives as hedging instruments.

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company's derivative assets and liabilities are reported on a gross basis in the Condensed Consolidated Balance Sheets. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The notional amounts of the company's derivative instruments were as follows:

	September 30, 2015		December 31, 2014
Derivatives designated as hedging instruments:
Interest rate swaps	$	—	$	1,000
Foreign currency contracts	10		434
Commodity contracts	78		388
Derivatives not designated as hedging instruments:
Foreign currency contracts	7,819		10,586
Commodity contracts	15		166

Foreign Currency Risk

The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments and cash flows.

The company routinely uses forward exchange and option contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, net of related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. The objective of the hedge program is to reduce earnings and cash flow volatility related to changes in foreign currency exchange rates.

Commodity Price Risk

Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn, soybeans and soybean meal. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Cash Flow Hedges

Foreign Currency Contracts

The company uses foreign currency exchange instruments such as forwards and options to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues. In addition, the company occasionally uses forward exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated transactions such as capital expenditures.

Commodity Contracts

The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two-year period. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring. The following table summarizes the after-tax effect of cash flow hedges on accumulated other comprehensive loss for the three and nine months ended September 30, 2015 and 2014:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Beginning balance	$	(10	)	$	(13	)	$	(6	)	$	(48	)
Additions and revaluations of derivatives designated as cash flow hedges	(13		)	(1		)	(24		)	15
Clearance of hedge results to earnings	—			(1		)	7			18
Ending balance	$	(23	)	$	(15	)	$	(23	)	$	(15	)

At September 30, 2015, an after-tax net loss of $9 is expected to be reclassified from accumulated other comprehensive loss into earnings over the next 12 months.

Derivatives not Designated in Hedging Relationships

Foreign Currency Contracts

The company routinely uses forward exchange and options contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain foreign currency-denominated revenues so that gains and losses on these contracts offset changes in the USD value of the related foreign currency-denominated revenues.

Commodity Contracts

The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn, soybeans and soybean meal.

Fair Values of Derivative Instruments

The table below presents the fair values of the company's derivative assets and liabilities within the fair value hierarchy, as described in the company's 2014 Annual Report in Note 1, “Summary of Significant Accounting Policies.”

		Fair Value Using Level 2 Inputs
	Balance Sheet Location	September 30, 2015		December 31, 2014
Asset derivatives:
Derivatives designated as hedging instruments:
Interest rate swaps1	Accounts and notes receivable, net	$	—	$	1
Foreign currency contracts	Accounts and notes receivable, net	—		10
		—		11
Derivatives not designated as hedging instruments:
Foreign currency contracts2	Accounts and notes receivable, net	132		254
Total asset derivatives3		$	132	$	265
Cash collateral1,2	Other accrued liabilities	$	20	$	47
Liability derivatives:
Derivatives designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	$	—	$	10
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	63		62
Commodity contracts	Other accrued liabilities	1		1
		64		63
Total liability derivatives3		$	64	$	73

¹  Cash collateral held as of September 30, 2015 and December 31, 2014 represents $0 and $6, respectively, related to interest rate swap derivatives designated as hedging instruments.

²  Cash collateral held as of September 30, 2015 and December 31, 2014 represents $20 and $41, respectively, related to foreign currency derivatives not designated as hedging instruments.

³  The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $51 at September 30, 2015 and $67 at December 31, 2014.

Effect of Derivative Instruments

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion)						Amount of Gain (Loss) Recognized in Income2
Three Months Ended September 30,	2015			2014			2015			2014			Income Statement Classification
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps	$	—		$	—		$	—		$	(7	)	Interest expense
Cash flow hedges:
Foreign currency contracts	—			20			—			2			Net sales
Commodity contracts	(22		)	(23		)	—			—			Cost of goods sold
	(22		)	(3		)	—			(5		)
Derivatives not designated as hedging instruments:
Foreign currency contracts	—			—			174			403			Other income, net3
Commodity contracts	—			—			(2		)	4			Cost of goods sold
	—			—			172			407
Total derivatives	$	(22	)	$	(3	)	$	172		$	402

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion)					Amount of Gain (Loss) Recognized in Income2
Nine Months Ended September 30,	2015			2014		2015			2014			Income Statement Classification
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps	$	—		$	—	$	(1	)	$	(20	)	Interest expense
Cash flow hedges:
Foreign currency contracts	(1		)	19		10			—			Net sales
Commodity contracts	(35		)	4		(22		)	(29		)	Cost of goods sold
	(36		)	23		(13		)	(49		)
Derivatives not designated as hedging instruments:
Foreign currency contracts	—			—		435			287			Other income, net3
Foreign currency contracts	—			—		(3		)	—			Net sales
Commodity contracts	—			—		3			(21		)	Cost of goods sold
	—			—		435			266
Total derivatives	$	(36	)	$	23	$	422		$	217

¹   OCI is defined as other comprehensive income (loss).

²   For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. For the three and nine months ended September 30, 2015 and 2014, there was no material ineffectiveness with regard to the company's cash flow hedges.

³   Gain (loss) recognized in other income, net, was partially offset by the related gain (loss) on the foreign currency-denominated monetary assets and liabilities of the company's operations, which were $(210) and $(153) for the three months ended September 30, 2015 and 2014, respectively, and $(381) and $(243) for the nine months ended September 30, 2015 and 2014, respectively. See Note 4 for additional information.

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014
Assets
Cash and cash equivalents	$ 3,324	$ 6,910
Marketable securities	406	124
Accounts and notes receivable, net	6,656	5,238
Inventories	5,888	6,787
Prepaid expenses	287	264
Deferred income taxes	485	532
Assets of discontinued operations	0	6,227
Total current assets	17,046	26,082
Property, plant and equipment, net of accumulated depreciation (September 30, 2015 - $14,297; December 31, 2014 - $13,765)	9,769	10,008
Goodwill	4,249	4,332
Other intangible assets	4,214	4,569
Investment in affiliates	712	762
Deferred income taxes	3,252	3,734
Other assets	1,060	1,003
Total	40,302	50,490
Liabilities and Equity
Accounts payable	2,830	3,786
Short-term borrowings and capital lease obligations	1,781	1,422
Income taxes	569	534
Other accrued liabilities	3,174	5,596
Liabilities of discontinued operations	0	2,467
Total current liabilities	8,354	13,805
Long-term borrowings and capital lease obligations	8,155	9,233
Other liabilities	12,212	13,615
Deferred income taxes	359	459
Total liabilities	$ 29,080	$ 37,112
Commitments and contingent liabilities
Stockholders' equity
Preferred stock	$ 237	$ 237
Common stock, $0.30 par value; 1,800,000,000 shares authorized; Issued at September 30, 2015 - 963,347,000; December 31, 2014 - 992,020,000	289	298
Additional paid-in capital	10,678	11,174
Reinvested earnings	15,441	16,894
Accumulated other comprehensive loss	(8,911)	(8,556)
Common stock held in treasury, at cost (87,041,000 shares at September 30, 2015 and December 31, 2014)	(6,727)	(6,727)
Total DuPont stockholders' equity	11,007	13,320
Noncontrolling interests	215	58
Total equity	11,222	13,378
Total	$ 40,302	$ 50,490

XML

Earnings Per Share of Common Stock

9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Earnings Per Share of Common Stock

Earnings Per Share of Common Stock

Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings per share calculations for the periods indicated:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Numerator:
Income from continuing operations after income taxes attributable to DuPont	$	131		$	330		$	2,117		$	2,558
Preferred dividends	(2		)	(2		)	(7		)	(7		)
Income from continuing operations after income taxes available to DuPont common stockholders	$	129		$	328		$	2,110		$	2,551
Income from discontinued operations after income taxes available to DuPont common stockholders	$	104		$	103		$	89		$	384
Net income available to common stockholders	$	233		$	431		$	2,199		$	2,935
Denominator:
Weighted-average number of common shares outstanding - Basic	887,275,000			910,764,000			899,883,000			917,589,000
Dilutive effect of the company’s employee compensation plans	4,011,000			6,997,000			5,639,000			7,057,000
Weighted-average number of common shares outstanding - Diluted	891,286,000			917,761,000			905,522,000			924,646,000

The following average number of stock options were antidilutive, and therefore not included in the dilutive earnings per share calculations:

	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2015	2014	2015	2014
Average number of stock options	8,510,000	7,000	4,622,000	4,000

The change in the average number of stock options that were antidilutive in the three and nine months ended September 30, 2015 compared to the same period last year was due to changes in the company's average stock price.

XML

Provision for Income Taxes

9 Months Ended

Sep. 30, 2015

Income Tax Disclosure [Abstract]

Provision for Income Taxes

Income Taxes

In the third quarter 2015, the company recorded a tax provision on continuing operations of $96, including $4 of tax benefit associated with the company’s policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations and gains or losses on foreign currency contracts. The company recorded pre-tax exchange losses in the third quarter 2015, including the re-measurement of the net monetary asset positions as well as the impacts of hedging, of $36. The third quarter 2015 tax provision also included a $17 tax benefit associated with a foreign tax court decision.

Year to date 2015, the company recorded a tax provision on continuing operations of $886, including $176 of tax expense primarily associated withthe company’s policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations and gains or losses on foreign currency contracts. The company recorded pre-tax exchange gains year-to-date 2015, including the re-measurement of the net monetary asset positions as well as the impacts of hedging, of $54.

In the third quarter 2014, the company recorded a tax provision on continuing operations of $303, including $258 of tax expense, primarily associated with the company's policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations and gains or losses on foreign currency contracts. The company recorded pre-tax exchange gains in the third quarter 2014, including the re-measurement of the net monetary asset positions as well as the impacts of hedging, of $250.

Year to date 2014, the company recorded a tax provision on continuing operations of $921, including $233 of tax expense, primarily associated with the company's policy of hedging the foreign currency-denominated monetary assets and liabilities of its operations and gain or losses on foreign currency contracts. The company recorded pre-tax exchange gains year-to-date 2014, including the re-measurement of the net monetary asset positions as well as the impacts of hedging, of $44.

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company’s financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. It is reasonably possible that net reductions to the company’s global unrecognized tax benefits could be in the range of $225 to $250 within the next twelve months with the majority due to the settlement of uncertain tax positions with various tax authorities.

XML

Employee Separation / Asset Related Charges, Net (Tables)

9 Months Ended

Sep. 30, 2015

2014 Restructuring Program [Member]

Restructuring Cost and Reserve [Line Items]

Schedule of Restructuring Program

	Employee Separation Costs			Other Non-Personnel Charges 1			Total
Balance at December 31, 2014	$	264		$	4		$	268
Payments	(117		)	(1		)	(118		)
Net translation adjustment	(9		)	—			(9		)
Other adjustments	(2		)	—			(2		)
Balance as of September 30, 2015	$	136		$	3		$	139

¹  Other non-personnel charges consist of contractual obligation costs.

XML

Long-Term Employee Benefits

9 Months Ended

Sep. 30, 2015

General Discussion of Pension and Other Postretirement Benefits [Abstract]

Long-Term Employee Benefits

Long-Term Employee Benefits

In connection with the completed separation of its Performance Chemicals segment on July 1, 2015 (See Note 2), the company entered into an Employee Matters Agreement with Chemours which provides that employees of Chemours no longer participate in benefit plans sponsored or maintained by the company as of the separation date. Upon separation, the company pension and other long-term employee benefit plans transferred assets and obligations to the Chemours plans resulting in a net decrease in the underfunded status of the sponsored pension and other long-term employee benefit plans of $21. Additionally, as a result of the transfer of unrecognized losses to Chemours, deferred income tax liabilities and accumulated other comprehensive loss, net of tax, decreased $88 and $278, respectively.

Pension Plans

As a result of the separation, the company recorded a pension curtailment gain of $7 and re-measured the principal U.S. pension plan as of July 1, 2015. In connection with the re-measurement, the company updated the discount rate assumed at December 31, 2014, from 4.10 percent to 4.50 percent. The re-measurement decreased the underfunded status of the pension plan by $634 with a corresponding reduction to net loss within other comprehensive income (loss) for the three and nine months ended September 30, 2015.

In determining the U.S. pension plan 2015 net periodic benefit costs, the company updated the expected return on plan assets assumption from 8.75 percent to 8.50 percent.

The company recorded a charge of $32 ($21 after-tax) during the three and nine months ended September 30, 2015, which related to settlements that occurred in prior periods. In addition, accumulated other comprehensive loss at January 1, 2013 has been revised to adjust for $54, after-tax, for settlement charges that should have been recorded in previous periods with a corresponding reduction in reinvested earnings. The settlement charges were related to the company’s Pension Restoration Plan which provides for lump sum benefit payments to certain eligible retirees. The company recognizes pension settlements when lump sum payments exceed the sum of service and interest cost components of net periodic pension cost of the plan for the year. The impact of these adjustments is not material to the company’s current or previously issued financial statements.

The following sets forth the components of the company’s net periodic benefit cost for pensions:  

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Service cost	$	50		$	61		$	179		$	181
Interest cost	270			290			815			875
Expected return on plan assets	(375		)	(405		)	(1,180		)	(1,211		)
Amortization of loss	172			151			591			450
Amortization of prior service (benefit) cost	(3		)	1			(6		)	2
Curtailment (gain) loss	(7		)	—			(7		)	4
Settlement loss	44			2			53			4
Net periodic benefit cost - Total	$	151		$	100		$	445		$	305
Less: Discontinued operations	(7		)	9			(5		)	31
Net periodic benefit cost - Continuing operations	$	158		$	91		$	450		$	274

Other Long-Term Employee Benefit Plans

As a result of the separation noted above, the company recorded an other long-term employee benefit plans curtailment gain of $274 and re-measured the associated plans as of July 1, 2015. In connection with the re-measurement, the company updated the plans' demographics and the discount rate assumed at December 31, 2014, from 3.95 percent to 4.30 percent. The re-measurement resulted in a net increase of $73 to the company's other long-term employee benefit obligation with a corresponding increase to net loss within other comprehensive income (loss) for the three and nine months ended September 30, 2015.

The following sets forth the components of the company’s net periodic benefit cost for other long-term employee benefits:  

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2015			2014			2015			2014
Service cost	$	3		$	4		$	12		$	13
Interest cost	28			30			83			91
Amortization of loss	20			15			58			43
Amortization of prior service benefit	(39		)	(54		)	(143		)	(160		)
Curtailment gain	(274		)	—			(274		)	—
Net periodic benefit cost- Total	$	(262	)	$	(5	)	$	(264	)	$	(13	)
Less: Discontinued operations	(274		)	1			(272		)	3
Net periodic benefit cost - Continuing operations	$	12		$	(6	)	$	8		$	(16	)

XML

Long-Term Borrowings

9 Months Ended

Sep. 30, 2015

Long-term Debt, Unclassified [Abstract]

Long-Term Borrowings

In connection with the spin-off, as previously discussed in Note 2, the company received a dividend from Chemours in May 2015 of $3,923 comprised of a cash distribution of $3,416 and a distribution in-kind of $507 of 7% senior unsecured notes due 2025.

In the second quarter of 2015, DuPont exchanged the Chemours Notes Received for $488 of company debt due in 2016 as follows: $152 of 1.95% notes, $277 of 2.75% notes, and $59 of 5.25% notes. The company paid a premium of $20, recorded in interest expense in the company's interim Consolidated Income Statements for the nine months ended September 30, 2015, in connection with the early retirement of the $488 of 2016 notes. This debt for debt exchange was considered an extinguishment.

XML

Financial Instruments (Notional Amounts of Derivatives) (Details) - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014
Designated as Hedging Instrument [Member] | Interest Rate Swap [Member]
Derivative [Line Items]
Derivative notional amounts	$ 0	$ 1,000
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]
Derivative [Line Items]
Derivative notional amounts	10	434
Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative [Line Items]
Derivative notional amounts	78	388
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]
Derivative [Line Items]
Derivative notional amounts	7,819	10,586
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative [Line Items]
Derivative notional amounts	$ 15	$ 166

XML

Inventories

9 Months Ended

Sep. 30, 2015

Inventory, Net [Abstract]

Inventories

Inventories

	September 30, 2015			December 31, 2014
Finished products	$	3,260		$	4,011
Semi-finished products	2,083			2,277
Raw materials, stores and supplies	749			739
	6,092			7,027
Adjustment of inventories to a last-in, first-out (LIFO) basis	(204		)	(240		)
Total	$	5,888		$	6,787

XML

Other Intangible Assets

9 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Other Intangible Assets

Other Intangible Assets

The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 

	September 30, 2015							December 31, 2014
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (Definite-lived):
Customer lists	$	1,639	$	(514	)	$	1,125	$	1,699	$	(465	)	$	1,234
Patents	457		(211		)	246		474		(184		)	290
Purchased and licensed technology	1,131		(604		)	527		1,783		(1,069		)	714
Trademarks	26		(13		)	13		26		(12		)	14
Other 1	186		(72		)	114		202		(84		)	118
	3,439		(1,414		)	2,025		4,184		(1,814		)	2,370
Intangible assets not subject to amortization (Indefinite-lived):
In-process research and development	77		—			77		29		—			29
Microbial cell factories	306		—			306		306		—			306
Pioneer germplasm	1,050		—			1,050		1,064		—			1,064
Trademarks/tradenames	756		—			756		800		—			800
	2,189		—			2,189		2,199		—			2,199
Total	$	5,628	$	(1,414	)	$	4,214	$	6,383	$	(1,814	)	$	4,569

¹   Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.       

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $50 and $305 for the three and nine months ended September 30, 2015, respectively, and $48 and $292 for the three and nine months ended September 30, 2014, respectively. The estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 2015 and each of the next five years is approximately $51, $352, $217, $218, $205 and $188, respectively.

XML

Commitments and Contingent Liabilities

9 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingent Liabilities

Commitments and Contingent Liabilities

Guarantees

Indemnifications

In connection with acquisitions and divestitures as of September 30, 2015, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transaction. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited.

Obligations for Equity Affiliates & Others

The company has directly guaranteed various debt obligations under agreements with third parties related to equity affiliates, customers and suppliers. In connection with the separation, the company has directly guaranteed Chemours' purchase obligations under an agreement with a third party supplier. At September 30, 2015 and December 31, 2014, the company had directly guaranteed $375 and $513, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees. The company would be required to perform on these guarantees in the event of default by the guaranteed party.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

In certain cases, the company has recourse to assets held as collateral, as well as personal guarantees from customers and suppliers. Assuming liquidation, these assets are estimated to cover 41 percent of the $146 of guaranteed obligations of customers and suppliers. Set forth below are the company's guaranteed obligations at September 30, 2015:

	Short-Term		Long-Term		Total
Obligations for customers and suppliers1:
Bank borrowings (terms up to 6 years)	$	129	$	16	$	145
Leases on equipment and facilities (terms up to 3 years)	—		1		1
Obligations for equity affiliates2:
Bank borrowings (terms up to 1 year)	178		—		178
Obligations for Chemours3:
Chemours' purchase obligations (term up to 2 years)	40		11		51
Total	$	347	$	28	$	375

¹  Existing guarantees for customers and suppliers, as part of contractual agreements.

² Existing guarantees for equity affiliates' liquidity needs in normal operations.

³  Guarantee for Chemours' raw material purchase obligations under agreement with third party supplier.

Imprelis^® 

The company has received claims and lawsuits alleging that the use of Imprelis^® herbicide caused damage to certain trees. Sales of Imprelis^® were suspended in August 2011 and the product was last applied during the 2011 spring application season. The lawsuits seeking class action status were consolidated in multidistrict litigation in federal court in Philadelphia, Pennsylvania. In February 2014, the court entered the final order dismissing these lawsuits as a result of the class action settlement.

As part of the settlement, DuPont paid about $7 in plaintiffs' attorney fees and expenses. DuPont also provided a warranty, which expired on May 31, 2015, against new damage, if any, caused by the use of Imprelis^® on class members' properties. In the third quarter 2014, the company settled the majority of claims from class members that opted out of the class action settlement. About 30 opt-out actions are pending at September 30, 2015, a decrease of 10 from December 31, 2014.

DuPont recorded income of $150 and $185 for insurance recoveries, within other operating charges in the interim Consolidated Income Statements, for the three and nine months ended September 30, 2015, respectively. At September 30, 2015, DuPont had an accrual balance of $198 related to these claims which it continues to review as these claims are resolved.

Insurance recoveries are recognized when collection of payment is considered probable. The remaining coverage under the insurance program is $50 for costs and expenses. DuPont has submitted requests for payment related to its remaining coverage.

Litigation

The company is subject to various legal proceedings arising out of the normal course of its business including product liability, intellectual property, commercial, environmental and antitrust lawsuits. It is not possible to predict the outcome of these various proceedings. Although considerable uncertainty exists, management does not anticipate that the ultimate disposition of these matters will have a material adverse effect on the company's results of operations, consolidated financial position or liquidity.  However, the ultimate liabilities could be material to results of operations in the period recognized.  

PFOA 

DuPont used PFOA (collectively, perfluorooctanoic acids and its salts, including the ammonium salt), as a processing aid to manufacture some fluoropolymer resins at various sites around the world including its Washington Works plant in West Virginia. At September 30, 2015, DuPont has an accrual balance of $14 related to the PFOA matters discussed below. Pursuant to the Separation Agreement discussed in Note 2, the company is indemnified by Chemours for the PFOA matters discussed below. As a result, the company has recorded an indemnification asset of $14 corresponding to the accrual balance as of September 30, 2015.

The accrual includes charges related to DuPont's obligations under agreements with the U.S. Environmental Protection Agency and voluntary commitments to the New Jersey Department of Environmental Protection.  These obligations and voluntary commitments include surveying, sampling and testing drinking water in and around certain company sites and offering treatment or an alternative supply of drinking water if tests indicate the presence of PFOA in drinking water at or greater than the national Provisional Health Advisory.

Drinking Water Actions

In August 2001, a class action, captioned Leach v DuPont, was filed in West Virginia state court alleging that residents living near the Washington Works facility had suffered, or may suffer, deleterious health effects from exposure to PFOA in drinking water.

DuPont and attorneys for the class reached a settlement in 2004 that binds about 80,000 residents. In 2005, DuPont paid the plaintiffs’ attorneys’ fees and expenses of $23 and made a payment of $70, which class counsel designated to fund a community health project.  The company funded a series of health studies which were completed in October 2012 by an independent science panel of experts (the C8 Science Panel). The studies were conducted in communities exposed to PFOA to evaluate available scientific evidence on whether any probable link exists, as defined in the settlement agreement, between exposure to PFOA and human disease.

The C8 Science Panel found probable links, as defined in the settlement agreement, between exposure to PFOA and pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol.

In May 2013, a panel of three independent medical doctors released its initial recommendations for screening and diagnostic testing of eligible class members. In September 2014, the medical panel recommended follow-up screening and diagnostic testing three years after initial testing, based on individual results. The medical panel has not communicated its anticipated schedule for completion of its protocol. The company is obligated to fund up to $235 for a medical monitoring program for eligible class members and, in addition, administrative costs associated with the program, including class counsel fees.  In January 2012, the company put $1 in an escrow account to fund medical monitoring as required by the settlement agreement.  The court appointed Director of Medical Monitoring has established the program to implement the medical panel's recommendations and the registration process, as well as eligibility screening, is ongoing. Diagnostic screening and testing has begun and associated payments to service providers are being disbursed from the escrow account.

In addition, under the settlement agreement, the company must continue to provide water treatment designed to reduce the level of PFOA in water to six area water districts, including the Little Hocking Water Association (LHWA), and private well users.

Class members may pursue personal injury claims against DuPont only for those human diseases for which the C8 Science Panel determined a probable link exists. At September 30, 2015 and June 30, 2015, there were approximately 3,500 lawsuits pending in various federal and state courts in Ohio and West Virginia. In accordance with a stipulation reached in the third quarter 2014 and other court procedures, these lawsuits have been or will be served and consolidated in multi-district litigation in Ohio federal court (MDL). Based on information currently available to the company the majority of the lawsuits allege personal injury claims associated with high cholesterol and thyroid disease from exposure to PFOA in drinking water.  At September 30, 2015, 37 of the pending lawsuits allege wrongful death. In 2014, six plaintiffs from the MDL were selected for individual trial. On October 7, 2015, in the first individual trial involving a plaintiff who alleged that exposure to C8 had caused the plaintiff's kidney cancer, the jury awarded $1.6 in compensatory damages. DuPont expects to appeal the decision. The second trial is scheduled to begin in March 2016. DuPont denies the allegations in these lawsuits and is defending itself vigorously.

Additional Actions

An Ohio action brought by the LHWA is ongoing. In addition to general claims of PFOA contamination of drinking water, the action claims “imminent and substantial endangerment to health and or the environment” under the Resource Conservation and Recovery Act (RCRA). In the second quarter 2014, DuPont filed a motion for summary judgment and LHWA moved for partial summary judgment. In the first quarter of 2015, the court granted in part and denied in part both parties’ motions. As a result, the litigation process is continuing with respect to certain of the plaintiffs’ claims and trial has been set for January 2016.

PFOA Summary

While it is probable that the company will incur liabilities related to funding the medical monitoring program, such liabilities cannot be reasonably estimated due to uncertainties surrounding the level of participation by eligible class members and the scope of testing. DuPont believes that it is reasonably possible that it could incur additional liabilities related to the other PFOA matters discussed above; however, a range of such liabilities, if any, cannot be reasonably estimated at this time, due to the uniqueness of the individual MDL plaintiff's claims and the company's defenses to those claims both as to potential liability and damages on an individual claims basis, among other factors. As noted above, the company is indemnified by Chemours for these PFOA matters.

Environmental

The company is also subject to contingencies pursuant to environmental laws and regulations that in the future may require the company to take further action to correct the effects on the environment of prior disposal practices or releases of chemical or petroleum substances by the company or other parties. The company accrues for environmental remediation activities consistent with the policy as described in the company's 2014 Annual Report in Note 1, “Summary of Significant Accounting Policies.” Much of this liability results from the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA, often referred to as Superfund), Resource Conservation and Recovery Act (RCRA) and similar state and global laws. These laws require the company to undertake certain investigative, remediation and restoration activities at sites where the company conducts or once conducted operations or at sites where company-generated waste was disposed. The accrual also includes estimated costs related to a number of sites identified by the company for which it is probable that environmental remediation will be required, but which are not currently the subject of enforcement activities.

Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, diverse regulatory agencies and enforcement policies, as well as the presence or absence of potentially responsible parties. At September 30, 2015, the Condensed Consolidated Balance Sheet included a liability of $505, relating to these matters and, in management's opinion, is appropriate based on existing facts and circumstances. The average time frame over which the accrued or presently unrecognized amounts may be paid, based on past history, is estimated to be 15-20 years. Considerable uncertainty exists with respect to these costs and, under adverse changes in circumstances, the potential liability may range up to $1,100 above the amount accrued as of September 30, 2015. Pursuant to the Separation Agreement discussed in Note 2, the company is indemnified by Chemours for certain environmental matters, included in the liability of $505, that have an estimated liability of $299 as of September 30, 2015 and a potential exposure that ranges up to approximately $630 above the amount accrued. As such, the company has recorded an indemnification asset of $299 corresponding to the company’s accrual balance related to these matters at September 30, 2015.

XML

Long-Term Employee Benefits (Defined Benefit Plans) (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2015	Dec. 31, 2014	Jul. 01, 2015	Jan. 01, 2013
Defined Benefit Plan Disclosure [Line Items]
Transfer of plan assets and obligations to Chemours, impact							$ 21
United States Pension Plan of US Entity [Member]
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefits costs, expected return on plan assets assumption					8.50%	8.75%
Pension Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Curtailment gain	$ 7	$ 0	$ 7	$ (4)
Defined benefit plan, discount rate						4.10%	4.50%
Defined benefit plan, re-measurement impact, underfunded status							$ 634
Charge related to prior period settlements	32
Charge related to prior period settlements, after-tax	21
Accumulated other comprehensive loss revision for pension settlement charges								$ 54
Other Long-Term Employee Benefit Plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Curtailment gain	$ 274	$ 0	$ 274	$ 0
Defined benefit plan, discount rate						3.95%	4.30%
Defined benefit plan, re-measurement impact, benefit obligation							$ 73
Deferred Income Taxes [Member]
Defined Benefit Plan Disclosure [Line Items]
Transfer of unrecognized losses to Chemours, impact							88
Accumulated other comprehensive loss [Member]
Defined Benefit Plan Disclosure [Line Items]
Transfer of unrecognized losses to Chemours, impact							$ 278

XML

Segment Information (Schedule of Segment Information) (Details) - USD ($) $ in Millions	3 Months Ended				9 Months Ended
	Sep. 30, 2015		Sep. 30, 2014		Sep. 30, 2015		Sep. 30, 2014		Dec. 31, 2014
Net sales	$ 4,873		$ 5,905		$ 19,831		$ 22,557
PTOI	580		686		3,945		4,448
Restructuring reserve, accrual adjustment					(2)
Restructuring charges							(187)
Agriculture [Member]
Net sales	1,093		1,563		8,248		9,564
PTOI	(63)	[1]	(56)		1,878	[1],[2]	2,171	[3]
Segment net assets	10,162				10,162				$ 6,695
Increase in net assets					3,467
Electronics & Communications [Member]
Net sales	532		620		1,577		1,810
PTOI	104		90		283	[2]	176	[3]
Industrial Biosciences [Member]
Net sales	305		314		870		925
PTOI	52		42		147	[2]	146	[3]
Nutrition & Health [Member]
Net sales	810		899		2,449		2,686
PTOI	102		99		284	[2]	282	[3]
Performance Materials [Member]
Net sales	1,302		1,531		4,021		4,618
PTOI	317		366	[4]	933	[2]	1,303	[3],[4]
Safety & Protection [Member]
Net sales	831		976		2,663		2,950
PTOI	156		195		635	[2],[5]	536	[3]
Gain related to litigation settlement					112
Other Segment [Member]
Net sales	0		2		3		4
PTOI	(88)		$ (50)		(215)	[2],[6]	(166)	[3]
Imprelis [Member] | Agriculture [Member]
Insurance recoveries, net of legal expenses	$ 147				182
Cost basis investment impairment [Member]
Cost basis investment impairment					(37)
Cost basis investment impairment [Member] | Other Segment [Member]
Cost basis investment impairment					(37)
2014 Restructuring Program [Member]
Restructuring charges							(244)
2014 Restructuring Program [Member] | Agriculture [Member]
Restructuring reserve, accrual adjustment					(4)
Restructuring charges							(47)
2014 Restructuring Program [Member] | Electronics & Communications [Member]
Restructuring reserve, accrual adjustment					11
Restructuring charges							(68)
2014 Restructuring Program [Member] | Industrial Biosciences [Member]
Restructuring reserve, accrual adjustment					(1)
Restructuring charges							(2)
2014 Restructuring Program [Member] | Nutrition & Health [Member]
Restructuring reserve, accrual adjustment					(4)
Restructuring charges							(8)
2014 Restructuring Program [Member] | Performance Materials [Member]
Restructuring reserve, accrual adjustment					(2)
Restructuring charges							(29)
2014 Restructuring Program [Member] | Safety & Protection [Member]
Restructuring reserve, accrual adjustment					1
Restructuring charges							(31)
2014 Restructuring Program [Member] | Other Segment [Member]
Restructuring reserve, accrual adjustment					$ (3)
Restructuring charges							(2)
GLS/Vinyls [Member]
Pre-tax gain							391
GLS/Vinyls [Member] | Performance Materials [Member]
Pre-tax gain							$ 391

[1] Included $147 and $182 of net insurance recoveries recorded in other operating charges for the three and nine months ended September 30, 2015, for recovery of costs for customer claims related to the use of the Imprelis® herbicide. See Note 10 for additional information.

[2] Included $(2) net adjustment to the estimated costs associated with the 2014 restructuring program, recorded in employee separation / asset related charges, net. These adjustments were primarily due to the identification of additional projects in certain segments, offset by lower than estimated individual severance costs and workforce reductions achieved through non-severance programs. The adjustments impacted segment results for the nine months ended September 30, 2015 as follows: Agriculture - $(4) , Electronics & Communications - $11, Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Materials - $(2), and Safety & Protection $1, and Other - $(3). See Note 3 for additional information.

[3] Included a $(187) restructuring charge recorded in employee separation / asset related charges, net. The pre-tax charges by segment are: Agriculture -$(47) , Electronics & Communications -$(68) , Industrial Biosciences - $(2) , Nutrition & Health -$(8) , Performance Materials - $(29) , Safety & Protection - $(31), and Other - $(2). See Note 3 for additional information.

[4] Included a gain of $391 recorded in other income, net associated with the sale of GLS/Vinyls. See Note 2 for additional information.

[5] Included a gain of $112, net of legal expenses, recorded in other income, net related to the company’s settlement of a legal claim.

[6] Included a $(37) pre-tax impairment charge recorded in employee separation / asset related charges, net for a cost basis investment. See Note 3 for additional information.

XML

Financial Instruments (Effect of Derivative Instruments) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	[1]	$ (22)	$ (3)	$ (36)	$ 23
Amount of Gain (Loss) Recognized in Income		172	402	422	217
Other Income, net [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on foreign currency denominated monetary assets and liabilities		(210)	(153)	(381)	(243)
Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	[1]	(22)	(3)	(36)	23
Amount of Gain (Loss) Recognized in Income		0	(5)	(13)	(49)
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	[1]	0	20	(1)	19
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Net sales [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	[2]	0	2	10	0
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	[1]	(22)	(23)	(35)	4
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Cost of goods sold [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	[2]	0	0	(22)	(29)
Designated as Hedging Instrument [Member] | Interest Rate Swap [Member] | Fair Value Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	[1]	0	0	0	0
Designated as Hedging Instrument [Member] | Interest Rate Swap [Member] | Interest Expense [Member] | Fair Value Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income		0	(7)	(1)	(20)
Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	[1]	0	0	0	0
Amount of Gain (Loss) Recognized in Income		172	407	435	266
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	[1]	0	0	0	0
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Net sales [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income				(3)	0
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Income, net [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	[3]	174	403	435	287
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in OCI (effective portion)	[1]	0	0	0	0
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Cost of goods sold [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income		$ (2)	$ 4	$ 3	$ (21)

[1] OCI is defined as other comprehensive income (loss).

[2] For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. For the three and nine months ended September 30, 2015 and 2014, there was no material ineffectiveness with regard to the company's cash flow hedges.

[3] Gain (loss) recognized in other income, net, was partially offset by the related gain (loss) on the foreign currency-denominated monetary assets and liabilities of the company's operations, which were $(210) and $(153) for the three months ended September 30, 2015 and 2014, respectively, and $(381) and $(243) for the nine months ended September 30, 2015 and 2014, respectively. See Note 4 for additional information.

XML

Summary of Significant Accounting Policies Venezuelan Foreign Currency Translation (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Venezuelan Foreign Currency Translation [Abstract]
SICAD 2 pre tax charge		$ 58
SIMADI pre-tax charge	$ 3

XML

Commitments and Contingent Liabilities (Litigation) (Narrative) (Details) $ in Millions	1 Months Ended	12 Months Ended
	Jul. 31, 2005 USD ($)	Dec. 31, 2004 resident	Oct. 07, 2015 USD ($)	Sep. 30, 2015 USD ($)	Jan. 31, 2012 USD ($)
PFOA Matters [Member]
Loss Contingencies [Line Items]
Accrual balance				$ 14.0
Indemnification assets				14.0
PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Binding settlement agreement, class size | resident		80,000
Loss contingency, potential additional loss				$ 235.0
Escrow deposit					$ 1.0
PFOA Matters: Additional Actions [Member]
Loss Contingencies [Line Items]
Lawsuits alleging personal injury - Filed				3,500
Lawsuits alleging wrongful death				37
PFOA MDL plaintiffs				6
Compensatory damages awarded			$ 1.6
Payment for Plaintiffs Attorney Fees [Member] | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Settlement payments	$ 23.0
Payment to fund community health project [Member] | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Settlement payments	$ 70.0

XML

Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Interim Financial Statements

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included.  Results for interim periods should not be considered indicative of results for a full year.  These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2014, collectively referred to as the “2014 Annual Report”.  The Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained, as well as variable interest entities (VIEs) for which DuPont is the primary beneficiary. 

Basis of Presentation

Certain reclassifications of prior year's data have been made to conform to current year's presentation. On July 1, 2015, the company completed the separation of its Performance Chemicals segment through the spin-off of all of the issued and outstanding stock of The Chemours Company (Chemours). In accordance with GAAP, the financial position and results of operations of the Performance Chemicals segment are presented as discontinued operations and, as such, have been excluded from continuing operations and segment results for all periods presented. The sum of the individual earnings per share amounts from continuing operations and discontinued operations may not equal the total company earnings per share amounts due to rounding. The cash flows and comprehensive income related to the Performance Chemicals segment have not been segregated and are included in the Condensed Consolidated Statements of Cash Flows and Comprehensive Income, respectively, for all periods presented. Amounts related to the Performance Chemicals segment are consistently included or excluded from the Notes to the interim Consolidated Financial Statements based on the respective financial statement line item. See Note 2 for additional information.

The company revised accumulated other comprehensive loss at January 1, 2013 to adjust for currency translation of $97 and pension settlement charges of $54 that should have been recorded in prior years. The revision resulted in a $151 decrease in accumulated other comprehensive loss with a corresponding reduction in reinvested earnings. The currency translation was related to an adjustment to the exchange rates used by a foreign subsidiary in the translation of the financial statements to U.S. dollar (USD) in prior years. See further discussion of the pension settlement charges in Note 13. The impact of these adjustments is not material to the company’s current or previously issued financial statements.

The company’s cost structure is being impacted by the global, multi-year initiative to redesign its global organization and operating model to improve productivity and agility across all businesses and functions. Effective December 31, 2014, in order to better align to the transforming company’s organization and resulting cost structure, certain costs were reclassified from other operating charges to selling, general and administrative expenses. Prior year data have been reclassified to conform to current year presentation. Other operating charges primarily include, costs associated with the Performance Chemical separation, product claim charges and non-capitalizable costs associated with capital projects. Selling, general and administrative expense primarily includes selling and marketing expenses, commissions, functional costs, and business management expenses. Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead.

Foreign Currency Translations Policy [Policy Text Block]

Foreign Currency Translation

The company's worldwide operations utilize the USD or local currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent (USD functional currency) and 2) self-contained (local functional currency). If a foreign entity does not clearly align with either category, factors are evaluated and a judgment is made to determine the functional currency.

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during the year, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where the local currency is the functional currency, assets and liabilities denominated in local currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive loss in equity. Assets and liabilities denominated in other than the local currency are re-measured into the local currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during the period.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed. As a result of the separation of its Performance Chemicals segment, coupled with the company’s ongoing redesign initiative, the functional currency at certain of the company’s foreign entities is being re-evaluated which, in some cases, has resulted in a change in the foreign entities’ functional currency.

Venezuelan Foreign Currency

Venezuela is considered a highly inflationary economy under GAAP and the USD is the functional currency for the company's subsidiaries in Venezuela. The official exchange rate continues to be set through the National Center for Foreign Commerce (CENCOEX, previously CADIVI). Based on its evaluation of the restrictions and limitations affecting the availability of specific exchange rate mechanisms, management concluded in the second quarter of 2014 that the Alternative Currency Exchange System (SICAD 2) auction process would be the most likely mechanism available. As a result, in the second quarter of 2014, the company changed from the official exchange rate to the SICAD 2 exchange rate, which resulted in a charge of $58 recorded within other income, net in the company's interim Consolidated Income Statements for the nine months ended September 30, 2014.

During the first quarter of 2015, the Venezuelan government enacted additional changes to the country’s foreign exchange systems including the introduction of the SIMADI (Foreign Exchange Marginal System) auction process. Management has concluded that the SIMADI auction process would be the most likely exchange mechanism available. As a result, effective in the first quarter of 2015, the company changed from the SICAD 2 to the SIMADI exchange rate, to re-measure its Bolivar Fuertes (VEF) denominated net monetary assets which resulted in a charge of $3 recorded within other income, net in the company's interim Consolidated Income Statements for the nine months ended September 30, 2015. The remaining net monetary assets and non-monetary assets are immaterial at September 30, 2015.

Recent Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

Accounting Pronouncements Implemented in 2015

In April 2014, the FASB issued authoritative guidance amending existing requirements for reporting discontinued operations.  Under the new guidance, discontinued operations reporting is limited to disposal transactions that represent strategic shifts having a major effect on operations and financial results. The amended guidance also enhances disclosures and requires assets and liabilities of a discontinued operation to be classified as such for all periods presented in the financial statements. Public entities will apply the amended guidance prospectively to all disposals occurring within annual periods beginning on or after December 15, 2014 and interim periods within those years. The company adopted this standard on January 1, 2015. Due to the change in requirements for reporting discontinued operations described above, presentation and disclosures of disposal transactions after adoption may be different than under previous standards.

New Accounting Pronouncements to be Implemented

In May 2015, the FASB issued ASU No. 2015-07, Fair Value Measurement (Topic 820), Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share or its Equivalent. This guidance removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient. The guidance also removes the requirement to make certain disclosures for all investments that are eligible to be measured at fair value using the net asset value per share practical expedient. Rather, those disclosures are limited to investments for which the entity has elected to measure the fair value using that practical expedient. The guidance is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. A reporting entity should apply the amendments retrospectively to all periods presented and early adoption is permissible. The company anticipates that this guidance will only impact disclosure and will not impact the company's financial position or results of operations.

In February 2015, the FASB issued ASU No. 2015-02 Consolidation (Topic 810), Amendments to the Consolidation Analysis. The amendments under the new guidance modify the evaluation of whether limited partnerships and similar legal entities are VIEs or voting interest entities and eliminate the presumption that a general partner should consolidate a limited partnership. The ASU is effective for public business entities for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. A reporting entity also may apply the amendments retrospectively. The company is currently evaluating the impact of adopting this guidance on its financial position and results of operations.

In May 2014, the FASB and the International Accounting Standards Board (IASB) jointly issued ASU No. 2014-9, Revenue from Contracts with Customers (Topic 606), which clarifies the principles for recognizing revenue and develops a common revenue standard for GAAP and International Financial Reporting Standards (IFRS). The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. In July 2015, the FASB approved a deferral of the ASU effective date from annual and interim periods beginning after December 15, 2016 to annual and interim periods beginning after December 15, 2017. The company is currently evaluating the impact of adopting this guidance on its financial position and results of operations.

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2015

Inventory, Net [Abstract]

Schedule of Inventories

	September 30, 2015			December 31, 2014
Finished products	$	3,260		$	4,011
Semi-finished products	2,083			2,277
Raw materials, stores and supplies	749			739
	6,092			7,027
Adjustment of inventories to a last-in, first-out (LIFO) basis	(204		)	(240		)
Total	$	5,888		$	6,787

XML

Commitments and Contingent Liabilities (Guarantees) (Details) $ in Millions		9 Months Ended
		Sep. 30, 2015 USD ($) yr	Dec. 31, 2014 USD ($)
Guarantor Obligations [Line Items]
Guarantee obligations		$ 375	$ 513
Customer and Supplier Guarantee [Member]
Guarantor Obligations [Line Items]
Guarantee obligations		$ 146
Collateral assets and personal guarantees percentage		41.00%
Customer and Supplier Guarantee, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	[1]	$ 145
Guaranteed obligations maximum term | yr	[1]	6
Customer and Supplier Guarantee, Leases on Equipment and Facilities [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	[1]	$ 1
Guaranteed obligations maximum term | yr	[1]	3
Equity Affiliates, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	[2]	$ 178
Guaranteed obligations maximum term | yr	[2]	1
Chemours purchase obligations [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	[3]	$ 51
Guaranteed obligations maximum term | yr	[3]	2
Guarantee Obligations, Long Term [Member]
Guarantor Obligations [Line Items]
Guarantee obligations		$ 28
Guarantee Obligations, Long Term [Member] | Customer and Supplier Guarantee, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	[1]	16
Guarantee Obligations, Long Term [Member] | Customer and Supplier Guarantee, Leases on Equipment and Facilities [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	[1]	1
Guarantee Obligations, Long Term [Member] | Equity Affiliates, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	[2]	0
Guarantee Obligations, Long Term [Member] | Chemours purchase obligations [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	[3]	11
Guaranteed Obligations Short Term [Member]
Guarantor Obligations [Line Items]
Guarantee obligations		347
Guaranteed Obligations Short Term [Member] | Customer and Supplier Guarantee, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	[1]	129
Guaranteed Obligations Short Term [Member] | Customer and Supplier Guarantee, Leases on Equipment and Facilities [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	[1]	0
Guaranteed Obligations Short Term [Member] | Equity Affiliates, Bank Borrowings [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	[2]	178
Guaranteed Obligations Short Term [Member] | Chemours purchase obligations [Member]
Guarantor Obligations [Line Items]
Guarantee obligations	[3]	$ 40

[1] Existing guarantees for customers and suppliers, as part of contractual agreements.

[2] Existing guarantees for equity affiliates' liquidity needs in normal operations.

[3] Guarantee for Chemours' raw material purchase obligations under agreement with third party supplier.

XML

Other Income, Net (Schedule of Other Income) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015		Sep. 30, 2014
Component of Other Income [Line Items]
Net exchange (losses) gains		$ (36)	$ 250	$ 54	[1]	$ 44	[1]
Total		98	364	552		749
Other Income [Member]
Component of Other Income [Line Items]
Royalty income		27	34	91		99
Interest income		33	33	98		103
Equity in earnings of affiliates, net		1	1	19		8
Net gain on sales of businesses and other assets		43	27	74		428
Net exchange (losses) gains	[2]	(36)	250	54		44
Miscellaneous income and expenses, net	[3]	30	19	216		67
Total		$ 98	$ 364	552		749
Foreign currency loss due to devaluation of Venezuelan Bolivar [Member]
Component of Other Income [Line Items]
Net exchange (losses) gains						(58)
Foreign currency loss due to devaluation of Ukrainian hryvnia [Member]
Component of Other Income [Line Items]
Net exchange (losses) gains				$ (35)		(46)
Foreign currency loss due to devaluation of Argentinian peso [Member]
Component of Other Income [Line Items]
Net exchange (losses) gains						$ (14)

[1] Included a charge of $(40) associated with remeasuring the company's Ukrainian hryvnia net monetary assets in the nine months ended September 30, 2015, as well as a charge of $(58) associated with remeasuring the company's Venezuelan net monetary assets from the official exchange rate to the SICAD II exchange system in the nine months ended September 30, 2014, which were recorded in other income, net in the company's interim Consolidated Income Statements. See Note 4 for additional information.

[2] The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The net pre-tax exchange gains (losses) are recorded in other income, net and the related tax impact is recorded in provision for income taxes on the company's interim Consolidated Income Statements. Refer to Note 5 for discussion of the tax impacts related to this program. The $54 net exchange gain for the nine months ended September 30, 2015, includes a net $(35) pre-tax exchange loss associated with the devaluation of the Ukrainian hryvnia. The $44 net exchange gain for the nine months ended September 30, 2014, includes $(58), $(46) and $(14) exchange losses, associated with the devaluation of the Venezuela bolivar, Ukrainian hryvnia, and Argentinian peso, respectively

[3] Miscellaneous income and expenses, net, includes interest items, certain insurance recoveries and litigation settlements and other items.

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Accumulated depreciation	$ 14,297	$ 13,765
Common stock, par value	$ 0.30	$ 0.30
Common stock, shares authorized	1,800,000,000	1,800,000,000
Common stock, shares issued	963,347,000	992,020,000
Common stock held in treasury, shares	87,041,000	87,041,000

XML

Other Income, Net

9 Months Ended

Sep. 30, 2015

Other Income and Expenses [Abstract]

Other Income, Net

Other Income, Net

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2015			2014		2015		2014
Royalty income	$	27		$	34	$	91	$	99
Interest income	33			33		98		103
Equity in earnings of affiliates, net	1			1		19		8
Net gain on sales of businesses and other assets	43			27		74		428
Net exchange (losses) gains1	(36		)	250		54		44
Miscellaneous income and expenses, net 2	30			19		216		67
Other income, net	$	98		$	364	$	552	$	749

¹ The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The net pre-tax exchange gains (losses) are recorded in other income, net and the related tax impact is recorded in provision for income taxes on the company's interim Consolidated Income Statements. Refer to Note 5 for discussion of the tax impacts related to this program. The $54 net exchange gain for the nine months ended September 30, 2015, includes a net $(35) pre-tax exchange loss associated with the devaluation of the Ukrainian hryvnia. The $44 net exchange gain for the nine months ended September 30, 2014, includes $(58), $(46) and $(14) exchange losses, associated with the devaluation of the Venezuela bolivar, Ukrainian hryvnia, and Argentinian peso, respectively.

²   Miscellaneous income and expenses, net, includes interest items, certain insurance recoveries and litigation settlements and other items.

XML

Financial Instruments Financial Instruments (Marketable Securities) (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014
Investments, Debt and Equity Securities [Abstract]
Held-to-maturity securities	$ 381	$ 124
Available-for-sale securities	$ 25	$ 0

XML

Other Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets [Table Text Block]

	September 30, 2015							December 31, 2014
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (Definite-lived):
Customer lists	$	1,639	$	(514	)	$	1,125	$	1,699	$	(465	)	$	1,234
Patents	457		(211		)	246		474		(184		)	290
Purchased and licensed technology	1,131		(604		)	527		1,783		(1,069		)	714
Trademarks	26		(13		)	13		26		(12		)	14
Other 1	186		(72		)	114		202		(84		)	118
	3,439		(1,414		)	2,025		4,184		(1,814		)	2,370
Intangible assets not subject to amortization (Indefinite-lived):
In-process research and development	77		—			77		29		—			29
Microbial cell factories	306		—			306		306		—			306
Pioneer germplasm	1,050		—			1,050		1,064		—			1,064
Trademarks/tradenames	756		—			756		800		—			800
	2,189		—			2,189		2,199		—			2,199
Total	$	5,628	$	(1,414	)	$	4,214	$	6,383	$	(1,814	)	$	4,569

¹   Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.

XML

Divestitures and Other Transactions Divestitures and Other Transactions (Schedule of cash flow information of discontinued operations) (Details) - Performance Chemicals [Member] - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation	$ 126	$ 186
Amortization of intangible assets	2	2
Purchases of property, plant and equipment	$ 235	$ 350

XML

Segment Information

9 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Segment Information

Segment Information

Segment pre-tax operating income (loss) (PTOI) is defined as income (loss) from continuing operations before income taxes excluding non-operating pension and other postretirement employee benefit costs, exchange gains (losses), corporate expenses and interest. Effective July 1, 2015, certain corporate expenses will now be included in segment PTOI.  Reclassifications of prior year data have been made to conform to current year classifications. 

Three Months Ended September 30,	Agriculture1				Electronics & Communications		Industrial Biosciences		Nutrition & Health		Performance Materials			Safety & Protection		Other			Total
2015
Net sales	$	1,093			$	532	$	305	$	810	$	1,302		$	831	$	—		$	4,873
PTOI	(63		)	5	104		52		102		317			156		(88		)	580
2014
Net sales	$	1,563			$	620	$	314	$	899	$	1,531		$	976	$	2		$	5,905
PTOI	(56		)		90		42		99		366		4	195		(50		)	686

Nine Months Ended September 30,	Agriculture1			Electronics & Communications			Industrial Biosciences			Nutrition & Health			Performance Materials			Safety & Protection			Other				Total
2015
Net sales	$	8,248		$	1,577		$	870		$	2,449		$	4,021		$	2,663		$	3			$	19,831
PTOI	1,878		2,5	283		2	147		2	284		2	933		2	635		2,6	(215		)	2,7	3,945
2014
Net sales	$	9,564		$	1,810		$	925		$	2,686		$	4,618		$	2,950		$	4			$	22,557
PTOI	2,171		3	176		3	146		3	282		3	1,303		3,4	536		3	(166		)	3	4,448

¹  As of September 30, 2015, Agriculture net assets were $10,162, an increase of $3,467 from $6,695 at December 31, 2014. The increase was primarily due to higher trade receivables related to normal seasonality in the sales and cash collections cycle.

²  Included $(2) net adjustment to the estimated costs associated with the 2014 restructuring program, recorded in employee separation / asset related charges, net. These adjustments were primarily due to the identification of additional projects in certain segments, offset by lower than estimated individual severance costs and workforce reductions achieved through non-severance programs. The adjustments impacted segment results for the nine months ended September 30, 2015 as follows: Agriculture - $(4) , Electronics & Communications - $11, Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Materials - $(2), and Safety & Protection $1, and Other - $(3). See Note 3 for additional information.

³  Included a $(187) restructuring charge recorded in employee separation / asset related charges, net. The pre-tax charges by segment are: Agriculture -$(47) , Electronics & Communications -$(68) , Industrial Biosciences - $(2) , Nutrition & Health -$(8) , Performance Materials - $(29) , Safety & Protection - $(31), and Other - $(2). See Note 3 for additional information.

⁴  Included a gain of $391 recorded in other income, net associated with the sale of GLS/Vinyls. See Note 2 for additional information.

⁵  Included $147 and $182 of net insurance recoveries recorded in other operating charges for the three and nine months ended September 30, 2015, for recovery of costs for customer claims related to the use of the Imprelis^® herbicide. See Note 10 for additional information.

⁶  Included a gain of $112, net of legal expenses, recorded in other income, net related to the company’s settlement of a legal claim.

⁷  Included a $(37) pre-tax impairment charge recorded in employee separation / asset related charges, net for a cost basis investment. See Note 3 for additional information.

Reconciliation to Consolidated Income Statements 

	Three Months Ended September 30,						Nine Months Ended September 30,
	2015			2014			2015			2014
Total segment PTOI	$	580		$	686		$	3,945		$	4,448
Non-operating pension and other postretirement employee benefit costs	(115		)	(32		)	(288		)	(96		)
Net exchange (losses) gains1	(36		)	250			54			44
Corporate expenses2	(120		)	(177		)	(439		)	(617		)
Interest expense3	(82		)	(93		)	(260		)	(290		)
Income from continuing operations before income taxes	$	227		$	634		$	3,012		$	3,489

¹  Included a charge of $(40) associated with remeasuring the company's Ukrainian hryvnia net monetary assets in the nine months ended September 30, 2015, as well as a charge of $(58) associated with remeasuring the company's Venezuelan net monetary assets from the official exchange rate to the SICAD II exchange system in the nine months ended September 30, 2014, which were recorded in other income, net in the company's interim Consolidated Income Statements. See Note 4 for additional information.

²  Included transaction costs associated with the separation of the Performance Chemicals segment of $(9) and $(10) in the three months ended September 30, 2015 and 2014, respectively, and $(26) and $(17) in the nine months ended September 30, 2015 and 2014, respectively, which were recorded in other operating charges in the company's interim Consolidated Income Statements.

³  Included transaction costs of $(20) in the nine months ended September 30, 2015, associated with the early retirement of debt exchanged for the notes received from Chemours in May 2015.